Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGRP,Agouti-related protein,42296,-0.18420033651921,0.00455116695875763,-0.193120623758375,-0.175280049280045,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCG,Pro-glucagon,41843,-0.486225374853644,0.0108148374384004,-0.507422456232909,-0.465028293474379,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.179262857262255,0.00450932589081776,-0.188101136008258,-0.170424578516252,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFGE8,Lactadherin,42137,-0.21106529999683,0.00381900573490338,-0.218550551237241,-0.203580048756419,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,42262,-0.228222838643305,0.00560008903424653,-0.239199013150428,-0.217246664136182,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C9,Complement component C9,39990,0.194539525338802,0.00509996018282795,0.184543603380459,0.204535447297145,9.90400573353733e-300
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,42070,-0.285764369698646,0.00782846561843113,-0.301108162310771,-0.270420577086521,2.79552678068931e-278
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.118538081711103,0.00349523796924829,-0.125388748130829,-0.111687415291376,3.01986174481789e-240
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN1,CCN family member 1,42047,-0.20838473899949,0.00644838330270125,-0.221023570272785,-0.195745907726196,1.03193322999221e-220
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PYY,Peptide YY,39575,-0.291354063353682,0.00898397781910966,-0.308962659879137,-0.273745466828227,2.09065219752775e-220
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,39958,-0.243094140537725,0.00776360743761003,-0.258310811115441,-0.22787746996001,1.64320731128835e-206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,42163,-0.238763699696514,0.00765374780068108,-0.253765045385849,-0.22376235400718,2.18068754450038e-206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS8,Prostasin,42080,-0.106186860412445,0.00379121697276123,-0.113617645679057,-0.0987560751458331,7.7676157760499e-168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,42145,-0.156943501823259,0.00567044435580173,-0.16805757276063,-0.145829430885887,4.5811803964072e-164
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTH,Parathyroid hormone,39649,-0.210274295600217,0.00757475989822465,-0.225120825000738,-0.195427766199697,5.17938012868584e-164
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0827917642287244,0.00301990660735688,0.076872747278305,0.0887107811791439,4.19905324354699e-161
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.308347987909008,0.0115344820657036,0.28574040306023,0.330955572757787,1.65658221375664e-153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.122192162221202,0.00462361999087503,-0.131254457403317,-0.113129867039087,2.72600527359339e-149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.135334070517646,0.00516647951349031,-0.145460370364087,-0.125207770671205,6.91555482743278e-147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.162948047905412,0.00625497436802561,-0.175207797666742,-0.150688298144081,5.25897151262052e-146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.154099281274596,0.00592856872380474,-0.165719275973253,-0.142479286575939,2.4730037053299e-145
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,42089,-0.240471929487306,0.00938011005620532,-0.258856945197468,-0.222086913777143,1.43318564961294e-141
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MVK,Mevalonate kinase,41913,-0.187739509271953,0.00754855977402822,-0.202534686429049,-0.172944332114858,1.67270090410994e-133
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.123611200102912,0.00497309463938787,-0.133358465596112,-0.113863934609712,2.40116003935716e-133
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.0647239433115416,0.00264890166690195,-0.0699157905786694,-0.0595320960444138,4.60763344480681e-129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC13,Mucin-13,41839,-0.113653170785784,0.0048109651676577,-0.123082662514393,-0.104223679057175,6.84385836993975e-121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.0633763894673144,0.00268474017263192,0.0581142987289558,0.0686384802056729,8.85929830980266e-121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0651573610583731,0.00277282334988949,-0.0705920948241565,-0.0597226272925897,1.08604601581822e-119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCG2,Secretogranin-2,42193,-0.0709819279234462,0.00302227688480576,-0.0769055906176655,-0.0650582652292269,1.33746881419131e-119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOF,Apolipoprotein F,39990,0.0558101254513187,0.00237813149990871,0.0511489877114977,0.0604712631911398,5.60530507522887e-119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.0693149792415381,0.00295954301483657,-0.0751156835506178,-0.0635142749324584,5.7037884483515e-119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.176984058494486,0.0076561934822561,-0.191990197719708,-0.161977919269264,5.99746960356745e-116
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.254199471998155,0.0110008345846447,-0.275761107784059,-0.232637836212251,6.47671020940941e-116
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.306306502715876,0.0133823992831734,-0.332536005310896,-0.280077000120856,9.2796034861875e-114
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.170935431299313,0.00747140218777309,-0.185579379587348,-0.156291483011278,1.16935153576192e-113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,42145,0.100416579268989,0.00440325835349972,0.0917861928961296,0.109046965641849,5.41266549595363e-113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KITLG,Kit ligand,42145,0.079727071489428,0.00349664334780027,0.0728736505277394,0.0865804924511165,5.91470424000188e-113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSD,Cathepsin D,41225,-0.0858264687529474,0.00379044146984919,-0.0932557340338518,-0.078397203472043,2.65886572939243e-111
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,42145,-0.129514396614809,0.0057586847036904,-0.140801418634042,-0.118227374595576,5.27727533279012e-110
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MME,Neprilysin,42070,-0.158548665327756,0.00713920037781207,-0.172541498068267,-0.144555832587244,2.3916965834772e-107
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,39958,-0.185195975970853,0.00834055427978105,-0.201543462359224,-0.168848489582482,5.78460335531359e-107
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.107727084329809,0.00486046162383034,-0.117253589112516,-0.0982005795471011,6.07925259474873e-107
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFASC,Neurofascin,42296,-0.0584976431324858,0.00267373734722769,-0.0637381683330521,-0.0532571179319196,2.51778664726245e-104
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.0665600686246352,0.00306937641105241,-0.0725760463902979,-0.0605440908589725,1.5036373852336e-102
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.0955429529976144,0.00443360903745842,-0.104232826711033,-0.0868530792841959,2.59261381119622e-101
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELN,Elastin,39958,-0.0684894388924737,0.00320147971341749,-0.074764339130772,-0.0622145386541754,1.40953154097884e-99
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0382745595731234,0.00179592941478955,0.0347545379201359,0.0417945812261109,3.7915888168161e-99
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.116956222589257,0.00550830473712372,-0.12775249987402,-0.106159945304495,2.06375368904226e-98
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.148583695828797,0.00701499468196084,-0.16233308540544,-0.134834306252153,1.10692599554441e-97
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0653057238456507,0.00311038121481486,-0.0714020710266879,-0.0592093766646136,2.5061523715467e-96
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.0594517293720326,0.00284962171607436,-0.0650369879355384,-0.0538664708085269,3.61850308424684e-95
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0655016799000852,0.00323104803680094,-0.071834534052215,-0.0591688257479553,4.80256985481498e-90
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.269726811403303,0.0133198169305373,-0.295833652587156,-0.24361997021945,7.37903114123024e-90
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.158671916481553,0.00785220481145711,-0.174062237912009,-0.143281595051097,1.77986986924707e-89
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,42070,-0.0652200541719831,0.00323679067757993,-0.0715641639000398,-0.0588759444439264,5.52609374651192e-89
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.119839194560557,0.00600672494777287,-0.131612375458192,-0.108066013662922,2.80789027376124e-87
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.145727875912887,0.00736079538091767,-0.160155034859486,-0.131300716966289,5.16864214776724e-86
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.0514363243269206,0.00260422466648333,-0.0565406046732279,-0.0463320439806132,1.22382453904285e-85
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.157809996758767,0.00799302963665927,-0.173476334846619,-0.142143658670915,2.4768831914363e-85
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.0571867793430575,0.00292178126012091,-0.0629134706128945,-0.0514600880732205,3.7677699018615e-84
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,39638,-0.096809486522674,0.0049470422057024,-0.106505689245851,-0.0871132837994973,7.40664830374716e-84
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,42310,-0.0914053742529709,0.00472114793510472,-0.100658824205776,-0.0821519243001656,2.07323075324606e-82
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.0898088737408354,0.00465180482995423,-0.0989264112075457,-0.0806913362741251,6.3388343383657e-82
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FURIN,Furin,42181,-0.0583070655845157,0.0030445085694615,-0.0642743023806603,-0.0523398287883712,1.08433414128469e-80
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,41827,-0.103318144488929,0.00545754798923114,-0.114014938547822,-0.0926213504300361,6.93798465100786e-79
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS4,Galectin-4,42123,-0.0981717861991936,0.00519578167909996,-0.10835551829023,-0.0879880541081577,1.29866655636641e-78
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.145908406559494,0.00774789319097258,-0.1610942772138,-0.130722535905187,4.31088033407703e-78
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.13390155976951,0.00711980207627833,-0.147856371839015,-0.119946747700004,1.00599781761381e-77
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSE,Cathepsin E,39736,-0.0919665568911058,0.00491614147675764,-0.101602194185551,-0.0823309195966609,6.5078218336295e-77
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.098460764810149,0.00529444680113318,-0.10883788054037,-0.088083649079928,2.96782370602236e-76
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F7,Coagulation factor VII,42194,-0.0530753831654906,0.0028576473469572,-0.0586763719655267,-0.0474743943654545,4.62083688294838e-76
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,39736,-0.0474890631352547,0.00255577826081938,-0.0524983885264606,-0.0424797377440487,6.39191441431067e-76
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0701037492450368,0.00381734270479452,-0.0775857409464341,-0.0626217575436396,2.03954223876354e-74
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.180108313909215,0.00984615083238001,-0.19940676954068,-0.16080985827775,7.4572707707001e-74
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0545461023495703,0.00299719595390215,-0.0604206064192185,-0.0486715982799221,6.30464968496664e-73
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GH1,Somatotropin,42129,0.297463963860459,0.0163818990348551,0.265355441752143,0.329572485968775,8.09758398315504e-73
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.0373940545576205,0.00207609152067674,-0.0414631939381469,-0.0333249151770941,1.07349115892189e-71
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.0940508479628727,0.00521762967891449,-0.104277402133545,-0.0838242937922003,1.22655704486378e-71
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,39979,0.11342806772845,0.00637500278444809,0.100933062270932,0.125923073185968,7.09924096164588e-70
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,42310,-0.0711537874111571,0.00401662596046072,-0.0790263742936601,-0.0632812005286541,1.91132228342404e-69
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.201674148321581,0.0114161490310782,-0.224049800422494,-0.179298496220667,4.50972081136318e-69
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,42224,-0.0793645272012602,0.00449562784256075,-0.0881759577726793,-0.0705530966298411,5.57620984555116e-69
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,42205,-0.107422323149361,0.0061366128921868,-0.119450084418047,-0.095394561880675,7.24448788826313e-68
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.104570633079892,0.00598482321889092,-0.116300886588918,-0.092840379570866,1.26038485267348e-67
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.0934003103535677,0.00534266757282243,-0.1038719387963,-0.0829286819108358,1.59100411725531e-67
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,39990,0.0755893476180188,0.00434699745762255,0.0670692326010786,0.084109462634959,7.29395115262691e-67
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.0775390910380133,0.00452152523785752,-0.086401280504214,-0.0686769015718125,3.19013019430643e-65
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.0583500292310281,0.00341958521509452,-0.0650524162526134,-0.0516476422094429,1.32297570149219e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0586566240937621,0.0034422763751496,-0.0654034857890554,-0.0519097623984689,1.9338331107763e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,39713,-0.061795511844829,0.00364116917149674,-0.0689322034209626,-0.0546588202686954,8.4904078340806e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.0485153767429304,0.00286168016358541,0.042906483622303,0.0541242698635578,1.13797767419892e-63
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.0808064707574919,0.00478445671645525,-0.0901840059217442,-0.0714289355932396,2.40223461260955e-63
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KYNU,Kynureninase,42296,-0.0706362100213466,0.00419790905043334,-0.0788641117601959,-0.0624083082824972,6.67459352361426e-63
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.089572129566213,0.00532835357102353,-0.100015702565419,-0.0791285565670069,8.96699266705707e-63
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0570219192863049,0.00339896987314346,-0.063683900237666,-0.0503599383349437,1.53723449059373e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.155143050495553,0.00924656101126289,-0.173266310077628,-0.137019790913478,1.56788952561803e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.127821944915807,0.00762598605134087,-0.142768877576435,-0.112875012255179,2.05429446845934e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,42137,-0.0612383451344481,0.00366935498188988,-0.0684302808989523,-0.0540464093699439,6.52817582150269e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,42195,-0.0522278201993791,0.00313893105402388,-0.0583801250652659,-0.0460755153334923,1.48229046304922e-61
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0556532627201126,0.00335976481941182,-0.0622384017661598,-0.0490681236740655,5.06192351352283e-61
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.129512823920267,0.00782728773059222,-0.144854307872228,-0.114171339968306,6.74918760924805e-61
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,42145,-0.0960896659261644,0.0058295053394885,-0.107515496391562,-0.084663835460767,1.87328350403738e-60
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,39930,-0.170659456301198,0.010365156698058,-0.190975163429391,-0.150343749173004,3.28308590006701e-60
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,42296,-0.0522522547888355,0.00318991277978238,-0.058504483837209,-0.0460000257404621,9.74398980198357e-60
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KHK,Ketohexokinase,39638,-0.0960628104775873,0.00586593440436187,-0.107560041910137,-0.084565579045038,1.4179928150591e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.052559522579584,0.00321704437922899,-0.0588649295628728,-0.0462541155962951,2.51385709749496e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.0736421252829374,0.00451379583387959,-0.0824891651173414,-0.0647950854485334,3.74909787702267e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,42267,0.0568053823513003,0.00349205794212571,0.0499609487847339,0.0636498159178667,6.04948899619691e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.0998183923836742,0.00613457284606443,-0.11184215516196,-0.0877946296053879,7.27463452186548e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0650652856259575,0.00400553164009003,-0.0729161276405339,-0.057214443611381,8.86426167513724e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.0790640916306129,0.00487435752259165,-0.0886178323748926,-0.0695103508863333,1.29572924776856e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.0808747419712818,0.0049864362294992,0.0711013269614634,0.0906481569811002,1.34636769687385e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.137171095678982,0.00846489441041566,-0.153762288723396,-0.120579902634567,1.69548028704654e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.0731784291377004,0.00452379118709921,-0.0820450598644149,-0.064311798410986,2.6100410795261e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,42262,0.0548097583152674,0.00339726357414308,0.048151121709947,0.0614683949205879,5.09449169931467e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO3,Beta-enolase,39638,-0.0939673866398335,0.00585656926128553,-0.105446262391953,-0.0824885108877139,2.75762475681157e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.0852842365349445,0.00532737206526589,-0.0957258857828657,-0.0748425872870234,4.66885015086242e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.113388100137164,0.00714180596690647,-0.1273860398323,-0.099390160442027,3.03356809274443e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELE,E-selectin,42310,-0.0737508709410531,0.00466768427338575,-0.0828995321168891,-0.064602209765217,9.60151741699189e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL11,Eotaxin,42296,-0.0545205276559122,0.00345641326725613,-0.0612950976597343,-0.0477459576520902,1.45395811584591e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0493872261180684,0.00313670383102436,-0.0555351656268762,-0.0432392866092607,2.30236359781523e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,42185,-0.0613881377074729,0.00390845298349667,-0.0690487055551263,-0.0537275698598194,4.16492929008618e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.0621443238792695,0.00395944785407788,-0.0699048416732621,-0.0543838060852768,4.94890276095104e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.0466385159448759,0.0029732819346478,0.0408108833529662,0.0524661485367856,5.7545140727186e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.077624364437515,0.00495108836110209,-0.0873284976252751,-0.0679202312497549,8.02578953232118e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTR,Transthyretin,39862,-0.0359884913428813,0.00230635975439965,-0.0405089564615046,-0.031468026224258,2.52815552741555e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0472548619757864,0.0030343677640854,-0.0532022227933938,-0.041307501158179,3.28473373959386e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.0571557299438739,0.00367836984001198,-0.0643653348302974,-0.0499461250574504,5.50624391661917e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.107924844193646,0.00698350080594805,-0.121612505773304,-0.0942371826139881,1.99369187294773e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,42123,0.0637322395894098,0.00413276377451667,0.0556320225913571,0.0718324565874624,3.34181922447925e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0396738744809011,0.00257301859393541,-0.0447169909250145,-0.0346307580367877,3.4472165010452e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0403522283266925,0.00262975650300082,-0.0455065510725741,-0.0351979055808109,1.30223069928919e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.0710027787668972,0.00465203216735387,-0.0801207618149108,-0.0618847957188836,4.55010766639535e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.0547130834021268,0.00359382117745449,-0.0617569729099376,-0.047669193894316,6.50190403549693e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.0399348602596127,0.00262090653870145,-0.0450718370754675,-0.0347978834437578,6.53735180691609e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.0959791963739881,0.00632584660599516,-0.108377855721739,-0.0835805370262376,1.45758072886079e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.0765427921969699,0.00506217604126587,-0.086464657237851,-0.0666209271560888,3.1866527912339e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.0964192098011406,0.00637311110604028,-0.10891050756898,-0.0839279120333016,3.41495833606431e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PVR,Poliovirus receptor,42249,-0.0521679044876131,0.0034608468134249,-0.0589511642419259,-0.0453846447333003,6.1930672320641e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.0958811093416917,0.00637159614658662,-0.108369437789001,-0.0833927808943819,9.08282829643469e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS2,Trypsin-2,42217,-0.0793605491440174,0.0052900565319839,-0.0897290599467058,-0.0689920383413289,1.80641403257358e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.027734316891734,0.00185181863017898,-0.0313638814068848,-0.0241047523765832,2.63801466862663e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.0520742292449307,0.00348909085837937,-0.0589128473273543,-0.0452356111625072,6.8845388466693e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.100526529371932,0.00676191481173881,-0.11377988240294,-0.0872731763409241,1.34750523324469e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG2,Desmoglein-2,42137,0.0371208345840595,0.00250271416461723,0.0322155148214097,0.0420261543467092,2.21294541704103e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN3,Contactin-3,42137,-0.0388672641988719,0.00262152314020076,-0.0440054495536654,-0.0337290788440784,2.41697013084252e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.069737689006973,0.00473733294759504,-0.0790228615842593,-0.0604525164296867,1.11622778538333e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGF,Placenta growth factor,42296,-0.0356584795212,0.00242467932054542,-0.040410850989469,-0.0309061080529309,1.37444333394362e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,42119,-0.0714925887643428,0.00486957826039279,-0.0810369621547127,-0.061948215373973,1.99830836080755e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,39736,-0.0882372016162454,0.00600850596993611,-0.10001387331732,-0.0764605299151706,2.26380635907397e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,42137,-0.0755773075051021,0.005156047995884,-0.0856831615770347,-0.0654714534331694,2.80620063451971e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHR,Growth hormone receptor,39736,-0.0386284332548183,0.00263620593837659,-0.0437953968940364,-0.0334614696156002,3.613248216316e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.0596409053517142,0.00407399971871475,-0.0676259448003951,-0.0516558659030333,3.72581765198724e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.105171373984777,0.00719461804476758,-0.119272825352522,-0.0910699226170329,4.98744998868724e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.170826674048364,0.0116801510763739,-0.193719770158057,-0.147933577938671,5.4244694461429e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,42211,-0.0825280372638712,0.00565022856527716,-0.0936024852518145,-0.071453589275928,5.91582739991762e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.0318063774168688,0.00219065325619552,-0.036100057799012,-0.0275126970347256,2.07419317207509e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,42070,-0.0756432919230429,0.00521407471078609,-0.0858628783561836,-0.0654237054899021,2.46869081659329e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,42249,-0.0615099791454912,0.00424221767966631,-0.0698247257976372,-0.0531952324933452,2.74094623639563e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.113729397366501,0.0078669755580085,-0.129148669460198,-0.0983101252728044,5.12340455764117e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.0804190084706222,0.00556873269085821,-0.0913337245447043,-0.0695042923965401,6.32984423633734e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFM,Afamin,39979,-0.0271533596555253,0.00188018879250994,-0.0308385296888448,-0.0234681896222058,7.32224064917169e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.0495031821799999,0.00343576316946116,-0.0562372779921437,-0.042769086367856,1.02699505254849e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0446402108203502,0.00310083313485554,0.0385625778760334,0.0507178437646671,1.1960632838457e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.102267198265408,0.00709824802132925,-0.116179764387214,-0.0883546321436031,1.19751081588224e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMBP,Protein AMBP,42239,-0.0267683004047609,0.0018687985151814,-0.0304311454945165,-0.0231054553150054,3.36060847271876e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,42310,-0.0821888568763686,0.00574648687986297,-0.0934519711609,-0.0709257425918372,4.52990873160292e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POSTN,Periostin,39966,0.05032899537451,0.00351880695153576,0.0434321337494999,0.0572258569995201,5.26174630827105e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.0273629636824083,0.00191451670019292,-0.0311154164147864,-0.0236105109500301,5.40098465377396e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0403987462267506,0.00282754662679061,-0.0459407376152602,-0.034856754838241,5.6171396748039e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA9,Serpin A9,42025,-0.0956957556329164,0.00669781453922743,-0.108823472129802,-0.0825680391360306,5.6789015171921e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SBSN,Suprabasin,39954,0.0471687493917205,0.00330305512443999,0.0406947613478181,0.0536427374356229,7.23613058155347e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F9,Coagulation factor IX,42199,-0.0242168767133862,0.00169837473200064,-0.0275456911881075,-0.020888062238665,8.44243130502184e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.165989719920279,0.011693088752422,-0.188908173875027,-0.143071265965532,2.07437154948399e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.149769779571067,0.0105775304688283,-0.17050173928997,-0.129037819852164,3.45305395670494e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0682843360955135,0.00482399111299589,-0.0777393586769855,-0.0588293135140416,3.62134715196087e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.0255969912044638,0.00181863413661024,-0.0291615141122199,-0.0220324682967078,1.11169189739161e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.0713144696673391,0.00506963935012624,-0.0812509627935865,-0.0613779765410916,1.26459490040461e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH2,Cadherin-2,42145,-0.0459348329000904,0.00326896044819751,-0.0523419953785575,-0.0395276704216233,1.54237526718708e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EZR,Ezrin,42249,-0.0316193226026699,0.00225164586130972,-0.036032548490837,-0.0272060967145029,1.74007295754197e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0536007143193096,0.00382866782574278,-0.0611049032577654,-0.0460965253808537,3.69615693384096e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.0686995290093014,0.00493042365800543,-0.0783631593789921,-0.0590358986396108,7.92353012143395e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.144186483580082,0.0103572184279039,-0.164486631698774,-0.123886335461391,9.55314561312191e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOD,Apolipoprotein D,39468,0.0547230389369286,0.00393320855011571,0.0470139501787018,0.0624321276951554,1.24759730002347e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.0496992754288089,0.00357965428460596,0.0426831530309812,0.0567153978266366,1.57162014246737e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,42296,-0.0543721140002986,0.00391973041034898,-0.0620547856045826,-0.0466894423960146,1.8573816101738e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0424353349061596,0.00306066749124904,-0.0484342431890077,-0.0364364266233114,2.03542829176618e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.0433614076991701,0.00312772008004406,-0.0494917390560564,-0.0372310763422837,2.07126455104479e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0519428018896627,0.00374981680012084,-0.0592924428178995,-0.0445931609614259,2.44267171387453e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.0934167845860598,0.00676899950449973,-0.106684023614879,-0.0801495455572403,5.60702373320694e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.0462312635331859,0.00336352732989343,-0.052823777099777,-0.0396387499665948,1.06467325739882e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0410930246409811,0.00298982606460011,-0.0469530837275973,-0.0352329655543649,1.06492555676825e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.0977077301316036,0.00711984443670915,-0.111662625227554,-0.0837528350356536,1.63193199872584e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.116587567562588,0.00850375813050993,-0.133254933498388,-0.0999202016267889,1.92141125012025e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.124086877570133,0.00905978654314089,-0.141844059194689,-0.106329695945576,2.05053396281467e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AREG,Amphiregulin,42070,-0.0497236977972847,0.00363166968549667,-0.0568417703808582,-0.0426056252137112,2.1872957522233e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,42255,-0.0310141860559544,0.00226756262794751,-0.0354586088067315,-0.0265697633051773,2.63498748856185e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,42137,-0.0294700224077351,0.00215532453782787,-0.0336944585018777,-0.0252455863135924,2.80482399527085e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.0613565643825846,0.00449141554150296,-0.0701597388439304,-0.0525533899212388,3.75037506762927e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0742575908775219,0.00545413853639358,-0.0849477024088533,-0.0635674793461905,6.17120862703825e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.0906914519405865,0.00669110251400368,-0.103806012868034,-0.0775768910131393,1.409281443429e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORT1,Sortilin,42129,-0.0478625114365528,0.00353461694201281,-0.0547903606428979,-0.0409346622302077,1.66724799371311e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0474951228028395,0.00352257854733451,-0.0543993767556152,-0.0405908688500639,3.63035035127611e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,42129,-0.0379787902736743,0.00281872069820806,-0.043503482842162,-0.0324540977051865,4.10855232276632e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.0955401324321921,0.00711745862238264,-0.109490351332062,-0.0815899135323221,8.04578468710059e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.0816486623179739,0.00609354504049325,-0.0935920105973407,-0.0697053140386071,1.11072326720747e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.0375719330549828,0.00280334991059365,-0.0430664988797464,-0.0320773672302193,1.19168710078036e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.0577307842522746,0.00431780760992517,-0.0661936871677279,-0.0492678813368213,1.85562264071775e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,39919,-0.125177735761356,0.0093751912770472,-0.143553110664368,-0.106802360858343,2.32723485591005e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.0273627575903625,0.00205962971121797,-0.0313996318243498,-0.0233258833563753,5.67415324636249e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,42262,-0.0322270807791166,0.00242900206317099,-0.0369879248229318,-0.0274662367353015,6.29885752813301e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PXN,Paxillin,41839,-0.062878013554871,0.00474917629127621,-0.0721863990857724,-0.0535696280239697,9.25070766137355e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HJV,Hemojuvelin,39934,-0.051911965607497,0.00392974128314332,-0.0596142585224579,-0.0442096726925361,1.50465969690712e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.0826108076101936,0.00625840848040201,-0.0948772882317816,-0.0703443269886057,1.54434506732469e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA4,Kallistatin,39802,-0.028818534806201,0.00218265037424823,-0.0330965295397275,-0.0245405400726745,1.65240169589194e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.0697449667857546,0.00528315132761668,0.0593899901836259,0.0800999433878832,1.71462492284877e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.023597723520371,0.00179689974995158,-0.0271196470302761,-0.0200758000104659,3.73045803166453e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUMB,Protein numb homolog,39657,-0.102943289111667,0.00783684833716694,-0.118303511852514,-0.0875830663708194,4.02811372192215e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,42119,-0.0679590235406708,0.00518058751591139,-0.0781129750718572,-0.0578050720094845,4.49724609670828e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0471854885204992,0.00360009360318862,-0.0542416719827489,-0.0401293050582495,5.17210036164088e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.0712707408354969,0.00545045781109376,-0.0819536381452407,-0.0605878435257532,7.75741128288026e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.0509826226543011,0.00392083360591343,-0.0586674565218915,-0.0432977887867108,1.98952967340302e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.0861628045648638,0.00663045353893401,-0.0991584935011744,-0.0731671156285531,2.45456215623871e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.0818133861299192,0.00630396789607819,-0.0941691632062324,-0.0694576090536059,3.1122582586329e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,39736,-0.142663794259088,0.0110143501046383,-0.164251920464179,-0.121075668053997,4.28106674272716e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH9,Myosin-9,39966,-0.136973184257148,0.0105825630735081,-0.157715007881223,-0.116231360633072,4.75986175406926e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,42262,-0.076722983689896,0.00593173867777341,-0.0883491914983318,-0.0650967758814601,4.81857264469908e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.0777284729879706,0.00600986442863951,0.0659491387078372,0.0895078072681041,4.90077871063476e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST3,Cystatin-C,42184,-0.0343741978671723,0.00265853285099052,-0.0395849222551137,-0.0291634734792309,5.12394328779848e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.132792778318719,0.0102670586414081,-0.152916213255879,-0.112669343381559,5.38611463541493e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.0962157704052893,0.00745681371717447,-0.110831125290951,-0.0816004155196274,7.24896721374575e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.0730558016688115,0.00567007665019233,-0.0841691519031885,-0.0619424514344346,1.03293741415425e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRP1,Neuropilin-1,42230,0.0325821217845856,0.00253291688888106,0.0276176046823787,0.0375466388867925,1.19621317743495e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,42310,-0.0771084876451873,0.00600093515736816,-0.0888703205536289,-0.0653466547367457,1.42761007907489e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0373755917695114,0.00290972492481543,-0.0430786526221496,-0.0316725309168731,1.52192152663375e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,42016,-0.104751293990759,0.00815860529588135,-0.120742160370686,-0.0887604276108311,1.6406949148919e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAXX,Protein PAXX,39736,-0.0555008623575955,0.00432331791914651,-0.0639745654791226,-0.0470271592360683,1.86099575423453e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPO,Erythropoietin,42119,-0.0867141357129515,0.00676117106379466,-0.099966030997989,-0.073462240427914,1.95515326100133e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0412234880667113,0.00321504851062813,-0.0475249831475424,-0.0349219929858801,2.02873977605696e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.126206496882083,0.00986143634306659,-0.145534912114493,-0.106878081649672,2.76901415985184e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEPH,Hephaestin,39958,-0.0332818508257048,0.00260500347786395,-0.0383876576423182,-0.0281760440090915,4.01310256646257e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MENT,Protein MENT,39736,0.0283722826473834,0.00222073631010143,0.0240196394795845,0.0327249258151822,4.06280610823021e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISM1,Isthmin-1,42119,-0.0466231245909319,0.00366189337781877,-0.0538004356114567,-0.0394458135704071,6.39894855708495e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0502618552326308,0.00395102021102701,-0.0580058548462438,-0.0425178556190179,7.28454187590736e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.035145309194071,0.00276498017469429,-0.0405646703364718,-0.0297259480516702,8.33667313284183e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.0542221943275758,0.00427524213275497,-0.0626016689077755,-0.045842719747376,1.19586478778447e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.0538099055946014,0.00424643570769823,-0.06213291958169,-0.0454868916075129,1.35943738155065e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0503146582551425,0.0039736248955863,-0.0581029630504917,-0.0425263534597934,1.53959629037142e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0553242440772163,0.00437774003950037,-0.063904614554637,-0.0467438735997955,2.09293052568108e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.0716636823405948,0.00567582460444061,-0.0827882985652984,-0.0605390661158912,2.43427038706565e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.0590141972260907,0.00469430594780393,-0.0682150368837864,-0.049813357568395,4.80051385583776e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0319095687660416,0.00253960167500122,-0.036887188049044,-0.0269319494830392,5.23901159219198e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0461794175471328,0.00368631250430117,-0.0534045900555631,-0.0389542450387025,8.32040433224628e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.034736201013078,0.00277864913753884,-0.0401823533226541,-0.0292900487035019,1.26261004657738e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.106101430190841,0.00849900794357899,-0.122759485760256,-0.0894433746214262,1.43115259564292e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,39645,-0.0323592887389537,0.00259299558837266,-0.0374415600921641,-0.0272770173857433,1.67561113613788e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.0300311906418798,0.00241430978076738,-0.0347632378121839,-0.0252991434715757,2.51592261153308e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.104868392705257,0.00847607585970845,-0.121481501390286,-0.0882552840202286,5.70763269809135e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,42145,-0.0305837608702355,0.00247413606890889,-0.0354330675652969,-0.0257344541751741,6.52093577057012e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0465926256170848,0.00377053428037503,-0.0539828728066199,-0.0392023784275498,6.90821077985125e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0480934307044491,0.00391662824792115,-0.0557700220703746,-0.0404168393385237,1.78500924793115e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.0834793392823588,0.00680508302077268,-0.0968173020030733,-0.0701413765616443,2.08842836652888e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.0600574521888747,0.00489612572167295,-0.0696538586033537,-0.0504610457743957,2.09946018349088e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0666326019891367,0.00545151367824491,-0.0773175687984967,-0.0559476351797766,3.85242438550895e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.113322574214627,0.00927937198144773,-0.131510143298264,-0.095135005130989,4.04138964122951e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0670050267638446,0.00555183582772575,-0.0778866249861871,-0.0561234285415021,2.28929847697852e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BECN1,Beclin-1,39638,-0.0672083647104012,0.00556560609567641,-0.078116952657927,-0.0562997767628754,2.30424135101104e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0325967775429373,0.00270171570703246,0.0273014147571537,0.0378921403287209,2.38655433232239e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSF,Cathepsin F,42181,-0.0451657266272409,0.00374583499286517,-0.0525075632132566,-0.0378238900412251,2.61696029649814e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,42258,-0.0299881133971961,0.00248797948764503,-0.0348645531929804,-0.0251116736014119,2.75246256194569e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.0895244301359975,0.00742558207244195,-0.104078570997984,-0.0749702892740113,2.87490767107153e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0294618302620759,0.00244532434349987,-0.0342546659753356,-0.0246689945488161,3.17723113467479e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0628849622923054,0.00522312902075896,-0.0731222951729929,-0.0526476294116178,3.55445479361395e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,39958,-0.0756007249627159,0.00628414369886906,-0.0879176466124993,-0.0632838033129326,3.91019259328755e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OCLN,Occludin,39934,-0.0497051734125517,0.00413486196145238,-0.0578095028569984,-0.0416008439681051,4.37923414596602e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.0337275935465477,0.00281003492198881,-0.0392352619936458,-0.0282199250994496,5.48040208551241e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAST,Gastrin,39929,-0.146518135806272,0.0122078002542828,-0.170445424304667,-0.122590847307878,5.49503488211576e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.0902134262299345,0.00752304008659823,-0.104958584799667,-0.0754682676602019,6.29008589192336e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,39930,-0.106872381567838,0.00891521204906253,-0.124346197184001,-0.0893985659516757,6.52168138994848e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.0832488103037319,0.0069585509570685,-0.0968875701795861,-0.0696100504278776,8.0785673620886e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.0708672105249075,0.00592335128299999,-0.0824769790395875,-0.0592574420102276,8.09294323205692e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.0663442805757264,0.00555288167564836,-0.0772279286599972,-0.0554606324914556,9.75222999087046e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.0667785251828259,0.00561090583937159,0.0557811497376575,0.0777759006279942,1.68017672215201e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.0264857004594212,0.00222743888792995,-0.0308514806797639,-0.0221199202390785,1.91982621775619e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0487900578742921,0.00411350334315354,-0.056852524426873,-0.0407275913217111,2.73351947348694e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.078080435751569,0.00658413210570429,-0.0909853346787494,-0.0651755368243885,2.81336602633351e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCHE,Cholinesterase,39806,-0.0296786127097648,0.00251053460499125,-0.0345992605355477,-0.024757964883982,4.67763230141808e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.0722342580762437,0.00611516685017525,-0.0842199851025872,-0.0602485310499002,4.85197634394375e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.0957185518325549,0.00811605835211673,-0.111626026202704,-0.0798110774624061,6.52969359407824e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0757078077242018,0.00642527028338677,-0.0883013374796399,-0.0631142779687638,7.42567985011699e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.0712493213118401,0.00605252682035495,-0.0831122738797359,-0.0593863687439444,7.85639589948908e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0432201449150317,0.00367207604211881,-0.0504174139575846,-0.0360228758724788,8.52668920301522e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.0266783078169217,0.00226882727568243,-0.0311252092772593,-0.0222314063565842,9.08931970724593e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.0307442483431648,0.00261572095362212,-0.0358710614122641,-0.0256174352740654,9.66484752609581e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.0388292887250237,0.00330785419010733,-0.045312682937634,-0.0323458945124133,1.14878727977959e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.0465963226711657,0.00397529912517349,-0.0543879089565058,-0.0388047363858257,1.40662497365008e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH1,Cadherin-1,41697,-0.0438685773739039,0.00374255050680884,-0.0512039763672492,-0.0365331783805585,1.42073205060618e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AXIN1,Axin-1,42119,-0.104983242606481,0.0089575511354372,-0.122540042831938,-0.0874264423810245,1.42949810877218e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,42115,-0.100381818603566,0.00858467056715816,-0.117207772915196,-0.0835558642919363,1.9578185801662e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGRN,Agrin,42185,-0.0388842209259275,0.00332913832309239,-0.0454093320391886,-0.0323591098126664,2.27883701713192e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.0899079792622812,0.00772327712597339,-0.105045602429189,-0.0747703560953734,3.57838342032739e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0492909116717982,0.00423437353816609,-0.0575902838066038,-0.0409915395369927,3.62254197812942e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.108547507109955,0.00932757076243058,-0.126829545804319,-0.0902654684155913,4.00306126794701e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMA,Granzyme A,42296,-0.0365820089583961,0.00315075455900107,-0.0427574878940382,-0.030406530022754,5.08900581469528e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0526380553174197,0.00453532381745375,-0.0615272899996291,-0.0437488206352104,5.4107994735857e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.0907670676309583,0.00781754917296419,-0.106089464009968,-0.0754446712519485,5.44083214652449e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEP,Leptin,42145,-0.0748870167357162,0.00646024630005219,-0.0875490994838185,-0.0622249339876139,6.33299798831235e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.0965518843939841,0.00834625464996111,-0.112910543507908,-0.0801932252800603,8.35748923485789e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOE,Apolipoprotein E,39979,-0.0752055616001591,0.00651240489788763,-0.0879698752000189,-0.0624412480002993,1.11927766288934e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.0747191832801871,0.0064763315313116,-0.0874127930815579,-0.0620255734788164,1.28131372169557e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMOT,Angiomotin,39736,-0.0412924808934778,0.00358497254395633,-0.0483190270796323,-0.0342659347073234,1.59000117632697e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.123070055715692,0.0106876319670631,-0.144017814371136,-0.102122297060249,1.64497577947857e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0657455793824012,0.00573248778903319,-0.0769812554489062,-0.0545099033158962,2.62216739057756e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.0542118295324286,0.00473664764238299,-0.0634956589114993,-0.044928000153358,3.421272237923e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.0295235036074272,0.00258074860520623,-0.0345817708736314,-0.0244652363412229,3.63422399897188e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.03848459087437,0.0033625515846615,-0.0450751919803066,-0.0318939897684335,3.69039449064828e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,42070,-0.0753166424271394,0.00660136116404017,-0.0882553103086581,-0.0623779745456207,5.1627101833589e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0351476139697584,0.0030846763987178,-0.0411935797112453,-0.0291016482282715,6.52022050427023e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.109997636452631,0.00965921125288445,-0.128929690508284,-0.0910655823969773,6.57898330919197e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM2,Paralemmin-2,39929,-0.0411661520793251,0.00361902386369635,-0.0482594388521699,-0.0340728653064802,8.08918895308825e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.0830481111829211,0.0073212995199811,-0.0973978582420841,-0.0686983641237582,1.15711823936269e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.0374890459884965,0.00331274231268951,0.030996071055625,0.0439820209213679,1.47459860390519e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0393363073220423,0.00347711577594433,-0.0461514542428932,-0.0325211604011914,1.53765592301443e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0880866335785945,0.00779112804687526,-0.10335724455047,-0.072816022606719,1.67560790122208e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.0653959528124508,0.00578387514799251,-0.0767323481025161,-0.0540595575223854,1.75074631104885e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.114516344519326,0.0101667206047446,-0.134443116904626,-0.0945895721340266,2.83168242653051e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMN,Protein amnionless,41913,-0.0492792822285541,0.00438963841094525,-0.0578829735140068,-0.0406755909431014,4.09439104286086e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBKS,Ribokinase,41830,-0.0514970775705345,0.00459270941748186,-0.0604987880287989,-0.0424953671122701,4.77093947648587e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A4,Protein S100-A4,42181,-0.0583775988197325,0.00520879971850882,-0.0685868462680098,-0.0481683513714552,5.02309628667692e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.0782689645893311,0.00698940046430753,-0.0919681894993739,-0.0645697396792884,5.96853043904633e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0344304374918892,0.00307851206734462,-0.0404643211438846,-0.0283965538398937,6.5195062896645e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,42119,-0.0957840080889852,0.00857349322513125,-0.112588054810242,-0.0789799613677279,7.4692257907877e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.109209527243987,0.00980480837364832,-0.128426951656337,-0.089992102831636,1.08926279190335e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANG,Angiogenin,42152,-0.0338585391147413,0.00304516678492753,-0.0398270660131992,-0.0278900122162833,1.35142169336728e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOM,Apolipoprotein M,42199,0.0292928907247198,0.00263523859257314,0.0241278230832764,0.0344579583661631,1.39490322690709e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0281172711730975,0.0025345763779525,0.0231495014723106,0.0330850408738844,1.88706075649245e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.0677937908735969,0.00617048447181834,-0.0798879404383609,-0.055699641308833,5.78669127397254e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.0716873081887208,0.00652317116043905,-0.0844727236631813,-0.0589018927142603,5.93165554976128e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.0537805284392577,0.00489574411552048,-0.0633761869056778,-0.0441848699728375,5.94712798022116e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0152486648671105,0.00138796151442985,0.012528260298828,0.017969069435393,6.14403251050902e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.0293568956082722,0.00267354458563898,-0.0345970429961246,-0.0241167482204198,6.23331224247903e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,39929,-0.0674365428180238,0.00614282440713967,-0.0794764786560176,-0.0553966069800301,6.73117503780541e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0576224226443332,0.0052598682486385,-0.0679317644116647,-0.0473130808770018,8.19884672196966e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.0298220728904793,0.00272208531865803,-0.035157360115049,-0.0244867856659096,8.60283220391884e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0529807473716165,0.00484040263783365,-0.0624679365417704,-0.0434935582014625,9.09995276961062e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.0851527857378677,0.0077801108517948,-0.100401803007385,-0.0699037684683499,9.19755566680622e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.0622697965336748,0.00568927402570694,-0.0734207736240605,-0.0511188194432892,9.22146679853569e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0400150861988389,0.00366939343120721,-0.0472070973240051,-0.0328230750736728,1.41774560993706e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,42181,-0.0549129631150814,0.00504434151640304,-0.0647998724872314,-0.0450260537429315,1.74463358112502e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.0763749829241541,0.00704279491454894,-0.09017886095667,-0.0625711048916382,2.73638960121039e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.0614339525390047,0.00566871334226394,-0.072544630689842,-0.0503232743881674,2.97911829534202e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.0856467978726886,0.00790596474238002,-0.101142488767753,-0.0701511069776238,3.10062979942849e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,39638,-0.0524464949974837,0.00484454991462359,-0.0619418128301459,-0.0429511771648214,3.55407081203412e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,42296,-0.0493875065904434,0.0045645722183537,-0.0583340681384167,-0.0404409450424701,3.57443690023632e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0592389429895449,0.00547611091275215,-0.0699721203785391,-0.0485057656005507,3.65741589354395e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0382443728162015,0.00353947714215656,-0.0451817480148284,-0.0313069976175747,4.44776599381604e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.0869319600939969,0.00806050211628633,-0.102730544241918,-0.0711333759460757,5.22311605275344e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,39990,0.0497741662101887,0.00462025272805667,0.0407184708631977,0.0588298615571798,6.22160724931179e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0520095577342948,0.00482823693343385,-0.0614729021238252,-0.0425462133447645,6.35097791538416e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.0212014480854356,0.00197156750392704,0.0173371757777386,0.0250657203931326,7.30169034223353e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,42296,-0.0945881283601582,0.00880666670817676,-0.111849195108185,-0.0773270616121318,8.3972537152683e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.0369358652760504,0.00344107125707906,-0.0436803649399254,-0.0301913656121754,9.04693184134371e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0325709747828632,0.00303328570894418,-0.0385162147723938,-0.0266257347933326,9.15848210938348e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0273985534566841,0.00255694715659277,-0.032410169883606,-0.0223869370297623,1.10240395608462e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMD,Osteomodulin,42185,0.0408367142280694,0.00381525611974263,0.0333588122333739,0.048314616222765,1.25092065145987e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.0841840820229832,0.00787922374298719,-0.0996273605592381,-0.0687408034867283,1.53693497503853e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XCL1,Lymphotactin,42262,-0.0540975205550851,0.00507489215916183,-0.0640443091870423,-0.0441507319231279,1.99245862746205e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,42016,-0.0525254854229519,0.0049398813043702,-0.0622076527795175,-0.0428433180663863,2.6647000544258e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,42145,0.0501903317114427,0.00472527240359987,0.0409287978003869,0.0594518656224984,2.99686280961707e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0367953955180661,0.00346574181195322,0.0300025415666378,0.0435882494694944,3.15378955514534e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.027983902931968,0.00263774643762186,0.0228139199142291,0.0331538859497068,3.4184435092811e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNST,Consortin,42145,-0.107386557044346,0.0101221169413299,-0.127225906249352,-0.0875472078393394,3.42518391938648e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD63,CD63 antigen,41992,-0.0496605496145067,0.0046817560368683,-0.0588367914467686,-0.0404843077822448,3.50257362347327e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSO,Cathepsin O,42296,-0.0301522403211479,0.00284376131700097,-0.0357260125024699,-0.024578468139826,3.64697319613537e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.0322365445986364,0.00304168173169781,-0.0381982407927641,-0.0262748484045086,3.84655742092694e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.0555525574177898,0.00524385873193326,-0.065830520532379,-0.0452745943032006,4.04470708742367e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.0842707836174153,0.00796176542432873,-0.0998758438490996,-0.068665723385731,4.46701712340446e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BSG,Basigin,42284,-0.0205093597789978,0.00194157048612732,-0.0243148379318073,-0.0167038816261882,5.55151224125326e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.022808515292371,0.00216377307797381,-0.0270495105251996,-0.0185675200595423,7.39192729415447e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0513985869321059,0.0048805078136058,-0.0609643822467733,-0.0418327916174386,7.80760719167078e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0249239511553608,0.00237234906836744,0.0202741469813606,0.0295737553293609,1.0150796771835e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.0835465984425785,0.00794972807983523,-0.0991280654790556,-0.0679651314061015,1.03431654514289e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.0437391488648836,0.00417629570218566,-0.0519246884411675,-0.0355536092885997,1.51040651474935e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.032016643436257,0.00306441184435103,-0.038022890651185,-0.026010396221329,1.88360579161731e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.0566907810951876,0.00542635121089148,-0.0673264294685349,-0.0460551327218403,1.88363087262687e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0284340048242365,0.00272578644424837,-0.0337765462549633,-0.0230914633935097,2.23338726825614e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KAZN,Kazrin,39930,-0.10229660719051,0.00981865964891677,-0.121541180102386,-0.0830520342786326,2.65325909872572e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.0643829218125415,0.00618217347566623,-0.0764999818248473,-0.0522658618002357,2.67214623675509e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.040534448448757,0.00389469708003425,-0.0481680547256242,-0.0329008421718899,2.97491345907981e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.0536787909352265,0.00517424734390843,-0.0638203157292871,-0.043537266141166,4.05015879565703e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.0400151713670463,0.00385707127561159,-0.047575031067245,-0.0324553116668476,4.19564625036e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN2,CCN family member 2,42146,-0.0544445113606316,0.00525261415089354,-0.0647396350963829,-0.0441493876248803,4.42916438223039e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.0760971909763788,0.00734366764566166,-0.0904907795618757,-0.061703602390882,4.5888913055812e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,41992,-0.0310810845072591,0.00300121405830342,-0.0369634640615338,-0.0251987049529844,4.87716604032328e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.0474959071443685,0.00459272039819047,-0.0564976391248219,-0.0384941751639152,5.68785309770812e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,42137,-0.0370785753868214,0.00358920264975163,-0.0441134125803346,-0.0300437381933082,6.34194822262419e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.083311459128301,0.00807553309639739,-0.0991395039972399,-0.0674834142593621,7.33321155993666e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,42231,-0.0359218183697522,0.00348596051043774,-0.0427543009702102,-0.0290893357692942,8.27372225078445e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,42119,-0.0829297856407881,0.00805109927397386,-0.0987099402177768,-0.0671496310637993,8.66234217811231e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,39966,0.0551753951409353,0.0053633561484648,0.0446632170899443,0.0656875731919263,1.02990373238736e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.106019945641849,0.0103133259443773,-0.126234064492828,-0.0858058267908692,1.11482077413732e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.0356791714762683,0.00347717673807442,-0.0424944378828942,-0.0288639050696424,1.35379805742403e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCOF1,Treacle protein,39958,-0.0311087597801276,0.00303703863992181,-0.0370613555143743,-0.0251561640458808,1.62409569878132e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELOA,Elongin-A,42070,-0.0510505859075698,0.00500252571806135,-0.06085553631497,-0.0412456355001696,2.31048624755976e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.0803961612028748,0.0078974470430716,-0.0958751574072952,-0.0649171649984545,2.99108865862918e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.036680487066896,0.00360979059784772,-0.0437556766386775,-0.0296052974951145,3.61600430130442e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0441255160413249,0.00434573554741488,-0.0526431577142581,-0.0356078743683917,4.04166808808784e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBIN,Erbin,42070,-0.0963990924785505,0.00952993593731103,-0.11507776691568,-0.0777204180414208,5.74950273214403e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.089756241522684,0.00887685876066835,-0.107154884693594,-0.0723575983517741,5.9802247464837e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0336151684973212,0.00332466759900386,-0.0401315169913687,-0.0270988200032736,6.04175704999019e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.0420831011257099,0.00417276709452804,-0.0502617246309849,-0.033904477620435,8.09909379239466e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,42166,-0.0547947873897094,0.00543557068871599,-0.0654485059395928,-0.0441410688398261,8.1501640365723e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0714794230703923,0.00709952060602237,-0.0853944834581961,-0.0575643626825884,9.25830949548833e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.0357891455077027,0.00355637919609685,-0.0427596487320525,-0.0288186422833528,9.76220573727113e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.128008182867825,0.0127502702413707,-0.152998712540911,-0.103017653194738,1.23557725761811e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0541400865529005,0.00539105389843119,-0.0647065521938257,-0.0435736209119754,1.24402709324934e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.0343560898754909,0.00342305888588316,-0.0410652852918219,-0.0276468944591599,1.27319784469098e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0294332906391489,0.00293424024992284,-0.0351844015289977,-0.0236821797493001,1.3467575348937e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,41839,-0.0621725688009176,0.00620099246696305,-0.0743265140361652,-0.05001862356567,1.41870933380611e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.0220442875123114,0.00220322657816987,-0.0263626116055244,-0.0177259634190985,1.73761406072238e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0470250857273565,0.00470107374435797,-0.0562391902662981,-0.0378109811884149,1.78294749888532e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.0233066899795398,0.00233416822038365,-0.0278816596914918,-0.0187317202675878,2.13468756613643e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.0720011482787307,0.00721538124096901,-0.08614329551103,-0.0578590010464315,2.3539234092682e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0578242844078264,0.00580364884211026,-0.0691994361383625,-0.0464491326772903,2.74676858340814e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.0777717128184938,0.00780842061516194,-0.0930762172242112,-0.0624672084127764,2.84309315539469e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCA,Calcitonin,41997,-0.0641201938630619,0.0064505842534771,-0.076763338999877,-0.0514770487262468,3.34750909038729e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.0802192299695747,0.00807465786739396,-0.0960455593896669,-0.0643929005494826,3.65730106059438e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,41797,-0.06479465845331,0.00653806441104475,-0.0776092646989577,-0.0519800522076623,4.51734729060529e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.0347471607238399,0.00351009744560892,-0.0416269517172334,-0.0278673697304464,5.03927095867048e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.0749734344830912,0.00757786649578726,-0.0898260528148342,-0.0601208161513482,5.29547279300072e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0361457683772937,0.00366236478564657,-0.043324003357161,-0.0289675333974264,7.01843193943882e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.0896407783960491,0.00909053035262628,-0.107458217887197,-0.0718233389049016,7.32808005940765e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.0217208658986379,0.00220285189777338,-0.0260384556182737,-0.017403276179002,7.63661129194248e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,41843,-0.0689896675075506,0.00700043147360745,-0.0827105131958212,-0.05526882181928,7.80980484035911e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.113635226129684,0.0115381352240559,-0.136249971168834,-0.0910204810905347,8.62066078079406e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.0602973064922332,0.00612936364198128,-0.0723108592305165,-0.0482837537539498,9.25116801240037e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.0560628112590712,0.00570086720097619,-0.0672365109729846,-0.0448891115451579,9.57154828645375e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.052308914673234,0.00532424186768154,-0.0627444287338898,-0.0418734006125782,1.048516246702e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMPR,GMP reductase 1,42296,-0.0434897695011113,0.00442763443521858,-0.0521679329941397,-0.0348116060080829,1.07213143187569e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN2,Nectin-2,42129,-0.0282570680755284,0.00287703799045867,-0.0338960625368273,-0.0226180736142294,1.0825405672806e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.0707941210048407,0.00721496009954581,-0.0849354427999505,-0.0566527992097309,1.18905444241052e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.104790623123659,0.0106865821343287,-0.125736324106943,-0.0838449221403744,1.30766898259638e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,42119,-0.073255874286961,0.00747811234112132,-0.0879129744755588,-0.0585987740983632,1.39203842647003e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.023366740283747,0.0023867990604065,-0.0280448664421437,-0.0186886141253502,1.47575110395442e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0734049717578162,0.00750208070875518,-0.0881090499469763,-0.058700893568656,1.557300435804e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.0536183991271206,0.00548377161118033,-0.064366591485034,-0.0428702067692072,1.67379618377714e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0314098774403386,0.00321415546335704,-0.0377096221485184,-0.0251101327321588,1.81346266159322e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,41831,-0.0361103713832233,0.0036967854412474,-0.0433560708480682,-0.0288646719183784,1.83887354640456e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.0663156358842598,0.0067903231972159,-0.079624669350803,-0.0530066024177167,1.86312160097969e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,42217,-0.0915591484216633,0.00937843067698153,-0.109940872548547,-0.0731774242947796,1.92753443703393e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0290417078920092,0.00297813989080615,0.0232045537060291,0.0348788620779892,2.14899498689157e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN4,CCN family member 4,42262,-0.0354970328860609,0.003641753518318,-0.0426348697819642,-0.0283591959901576,2.24204729956867e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.127753501848404,0.0131405095073937,-0.153508900482896,-0.101998103213912,2.96480053832776e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,39736,-0.0311747011999223,0.00320899196720547,-0.037464325455645,-0.0248850769441995,3.19476013829884e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.0566447663985545,0.00583668476634813,-0.0680846685405968,-0.0452048642565121,3.3920644766458e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,41843,-0.058094937781318,0.00598852139452972,-0.0698324397145963,-0.0463574358480398,3.53689270371598e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.0576900423125664,0.00594650723323252,-0.0693451964897022,-0.0460348881354307,3.62307401064646e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100P,Protein S100-P,41900,-0.0481969169943594,0.00497160180080837,-0.0579412565239438,-0.038452577464775,3.76890272290638e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.0680123442178624,0.00701621996862416,-0.0817641353563657,-0.054260553079359,3.91103232043757e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.0597562093811566,0.00617441228550695,-0.0718580574607502,-0.047654361301563,4.42372912866885e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.0752278011494158,0.00777252430296976,-0.0904619487832365,-0.0599936535155951,4.53747118229915e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.0611312183950884,0.00632789895628041,-0.073533900349398,-0.0487285364407788,5.21382827715351e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.0457064778103212,0.00474261978367574,-0.0550020125863256,-0.0364109430343167,6.52709220049544e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTBDN,Retbindin,42070,-0.0268381952705993,0.00278861139102422,-0.0323038735970068,-0.0213725169441918,7.42935779822635e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.0516329905990808,0.00536509470424256,-0.0621485762193962,-0.0411174049787653,7.44105588481126e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0766956910008959,0.00797040610924775,-0.0923176869750215,-0.0610736950267703,7.53896014447177e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0590085524359412,0.00613277490517228,-0.0710287912500789,-0.0469883136218035,7.59762019522059e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD302,CD302 antigen,42070,-0.0278081969417651,0.00289800160143453,-0.0334882800805767,-0.0221281138029534,9.78654247942432e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0618681986843859,0.00644914103404178,-0.0745085151111078,-0.049227882257664,1.00095526257284e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0352390308786963,0.00367922206906008,-0.042450306134054,-0.0280277556233385,1.16052790361181e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELP,P-selectin,42217,-0.0496767078021262,0.00518822986442956,-0.0598456383364081,-0.0395077772678443,1.19299587848695e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,42249,-0.0202060210029889,0.00211516790213891,-0.0243517500911812,-0.0160602919147967,1.4726358697e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.0281209039730108,0.00294731742475664,-0.0338976461255338,-0.0223441618204878,1.70885162593737e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.0842683723494681,0.00883672302317275,-0.101588349474887,-0.0669483952240495,1.73053573175375e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,39929,-0.0345694061776486,0.00362560646321758,-0.041675594845555,-0.0274632175097421,1.80776710161577e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UMOD,Uromodulin,42274,0.0477094764439474,0.0050061143994035,0.0378974922211165,0.0575214606667782,1.82943304773523e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLIN1,Perilipin-1,41839,-0.0300251499247004,0.00315222123467397,-0.0362035035446614,-0.0238467963047394,1.9317333012883e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0471665333278595,0.00495627560011937,-0.0568808335040934,-0.0374522331516255,2.09621767040662e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.0456756488263551,0.00480247394227364,-0.0550884977532114,-0.0362627998994988,2.28437124992487e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0688266898156648,0.00723897670222933,-0.0830150841520343,-0.0546382954792953,2.35316699233144e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,39919,-0.0746678842944896,0.00785715351294286,-0.0900679051798576,-0.0592678634091216,2.44509612366264e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH17,Cadherin-17,42145,-0.0602953573493299,0.00634799164742272,-0.0727374209782784,-0.0478532937203814,2.48496841373399e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0706484311052019,0.00744131116100431,0.0560634612296335,0.0852334009807704,2.58780111934267e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,42119,0.0298610417511331,0.00314808724414699,0.023690790752605,0.0360312927496612,2.81038596144022e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.110342179141452,0.0116614770937749,-0.13319867424525,-0.0874856840376529,3.50678708352046e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.0867515549197028,0.0091784170088305,-0.104741252257011,-0.068761857582395,3.88649825499588e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL15,Interleukin-15,42119,-0.0288778800713465,0.00306239589647058,-0.0348801760284288,-0.0228755841142641,4.76666192195824e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.074401880246464,0.00789666667593798,-0.0898793469313024,-0.0589244135616255,5.13948028262343e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.0242074233518987,0.00256978104618856,-0.0292441942024283,-0.0191706525013691,5.22623836307747e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,39586,-0.0358380108670215,0.0038040621441603,-0.0432939726695757,-0.0283820490644673,5.36243533268209e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.0552047420256905,0.00586256618990839,-0.0666953717579109,-0.04371411229347,5.56242169537176e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.0175326377172447,0.00186286985482231,-0.0211838626326964,-0.0138814128017929,5.66489680420771e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.0453815629267411,0.00482052544267015,-0.0548297927943746,-0.0359333330591076,5.68409458367987e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFC1,Cryptic protein,41843,-0.0419227764708229,0.00445710381557693,-0.0506586999493537,-0.0331868529922921,5.99979482016335e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.0855238426684074,0.00909133573063085,-0.103342860700444,-0.067704824636371,6.10371948587569e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MATN2,Matrilin-2,42144,-0.0258395311676643,0.00275702238371531,-0.0312432950397463,-0.0204357672955823,8.20756059335467e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0352138066692191,0.00375938211764333,-0.0425821956198,-0.0278454177186382,8.61617037395999e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.049343156310517,0.0052737414334468,-0.0596796895200728,-0.0390066231009613,9.56074621246825e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0454426083743504,0.0048578760327484,-0.0549640453985373,-0.0359211713501636,9.70511611896566e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.0784914585293264,0.0083952246146631,-0.094946098774066,-0.0620368182845867,1.0451062062489e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINH1,Serpin H1,39757,-0.11305822084449,0.0120938925985083,-0.136762250337567,-0.0893541913514141,1.05935672547243e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAG1,Dystroglycan,42185,-0.0412007217491817,0.0044157962558483,-0.0498556824106444,-0.032545761087719,1.21680671083268e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.0299060479717294,0.00320729493691643,-0.0361923460480856,-0.0236197498953732,1.32228427705379e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_E,,42119,-0.0253833809066272,0.00272860176494847,-0.0307314403659262,-0.0200353214473282,1.57660442410423e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0336929080926,0.00362834834178641,-0.0408044708425013,-0.0265813453426986,1.84811442865488e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.0300446241101551,0.003237477633814,-0.0363900802724305,-0.0236991679478797,1.94376999630558e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0603790911842805,0.00650884942019672,-0.0731364360478661,-0.047621746320695,2.01864255756373e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.053835927544736,0.00580803801907641,-0.0652196820621258,-0.0424521730273462,2.21387671212375e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0341583193349002,0.00368975665419774,-0.0413902423771278,-0.0269263962926726,2.40086374413218e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0544769012000911,0.00589171429687854,-0.0660246612219731,-0.0429291411782092,2.73728952253378e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,39929,-0.0937789386583657,0.0101482880526266,-0.113669583241514,-0.0738882940752175,2.88049398503579e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUCA2A,Guanylin,42083,-0.0302144394951342,0.00327133245464897,-0.0366262511062462,-0.0238026278840222,2.93256720614766e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0410481727955359,0.00444510654676741,-0.0497605816272,-0.0323357639638718,2.98191177377626e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,41742,0.078720401341057,0.00852634641930137,0.0620087623592263,0.0954320403228876,3.04071891741573e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.063027650173479,0.00683368955816784,0.04963361863947,0.076421681707488,3.39590031860605e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0551180242089044,0.00598784677618162,-0.0668542038902203,-0.0433818445275884,4.01562748137632e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.0760740418451348,0.00826655188572517,-0.0922764835411562,-0.0598716001491135,4.10376873525812e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0421468755107771,0.00458201618607137,-0.051127627235477,-0.0331661237860772,4.27096049751209e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,42185,-0.0327510020080288,0.00356201157806503,-0.0397325447010363,-0.0257694593150214,4.30694834613512e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0539804637028204,0.005870478642303,-0.0654866018417343,-0.0424743255639065,4.41645874616642e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.0425268332422882,0.00463293763926605,0.0334462754693268,0.0516073910152497,5.09158099776992e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,41693,-0.0768268848248207,0.00838027150559766,-0.0932522169757921,-0.0604015526738493,5.55005490677793e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFI,Complement factor I,39979,-0.0166266727805379,0.00181538973297512,-0.0201848366571691,-0.0130685089039066,6.14656048754724e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0213980559683526,0.00233946356389197,0.0168127073831243,0.0259834045535808,6.69407212686742e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCTN3,Tectonic-3,39958,-0.0260586047155855,0.00284809726216835,-0.0316408753494355,-0.0204763340817356,6.69441811534241e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.0395545757498739,0.00432701848767691,-0.0480355319857206,-0.0310736195140271,7.03703317530571e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0233933582505951,0.00255849450089244,-0.0284080074723443,-0.018378709028846,7.10803751258455e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,42016,-0.0567136815492652,0.00621030866560872,-0.0688858865338583,-0.0445414765646721,7.66153346296534e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0457737926686159,0.00501788170791973,-0.0556088408161385,-0.0359387445210932,8.41133603956098e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.0806869243727359,0.00884539173410066,-0.0980238921715732,-0.0633499565738986,8.42818736010853e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0187233277207425,0.00205447420455006,0.0146965582798243,0.0227500971616606,9.10923304243983e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0403145540330884,0.00442539058547564,-0.0489883195806207,-0.0316407884855562,9.39466540920903e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.0866354862035165,0.00953343365482793,-0.105321016166979,-0.0679499562400537,1.15108176770294e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAB2,Stabilin-2,39966,-0.0238774158828989,0.00262728474390254,-0.0290268939809479,-0.0187279377848499,1.17279265318577e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.047846392591535,0.00526766732726924,-0.0581710205529827,-0.0375217646300873,1.20376537370744e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.092512109768007,0.0101897230995842,-0.112483967043192,-0.0725402524928219,1.27713324376235e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COCH,Cochlin,39958,-0.0390300446009424,0.00430156544695745,-0.047461112876979,-0.0305989763249058,1.34242197869794e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK14,Kallikrein-14,42262,0.0391365937622736,0.00431502507659397,0.0306791446121494,0.0475940429123978,1.35238555562232e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MLN,Promotilin,42119,-0.0753453701282075,0.00830712893418061,-0.0916273428392014,-0.0590633974172135,1.35266034901186e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.0210200355021979,0.00231872636022029,-0.0255647391682297,-0.0164753318361662,1.45176277921562e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.0378152423709398,0.00417614114929858,0.0296300057183146,0.046000479023565,1.58755318771427e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSS,Cathepsin S,39358,-0.0204384285883319,0.00225710182863842,-0.0248623481724632,-0.0160145090042006,1.59898516844932e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0438937187888981,0.00485960386562007,-0.0534185423655134,-0.0343688952122827,1.90977109957963e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GET3,ATPase GET3,39958,-0.0456169858569782,0.00506384421247752,-0.0555421205134341,-0.0356918512005222,2.42453560595519e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.0469807918182324,0.00522099645856464,-0.0572139448770191,-0.0367476387594457,2.59362356389319e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.037804354529887,0.00420847959361542,-0.0460529745333732,-0.0295557345264008,2.98204912909929e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.0911406828710506,0.0101477998296568,-0.111030370537178,-0.0712509952049233,3.09711452576969e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.0462839706196481,0.00515820828947614,-0.0563940588670214,-0.0361738823722749,3.26282443465302e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.0556229182923546,0.00619711319439663,-0.067769260153372,-0.0434765764313372,3.26908325501273e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,41843,-0.0328900723636681,0.00366580103158567,-0.040075042385576,-0.0257051023417602,3.2948625732473e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADD1,Alpha-adducin,39736,-0.0586575188286657,0.00653843546909905,-0.0714728523480999,-0.0458421853092316,3.40232425405071e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.0191996412216195,0.00214242505019444,-0.0233987943200006,-0.0150004881232384,3.61700580816123e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,39937,-0.0270743518556016,0.00302456926828292,-0.0330025076214361,-0.0211461960897671,4.05268212926922e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,41880,-0.0302226209730993,0.00338106510151596,-0.0368495085720706,-0.023595733374128,4.44825311409567e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,39930,-0.07330717327974,0.00820053744845961,-0.0893802266787209,-0.0572341198807592,4.52130772501584e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,42084,-0.0666658940215819,0.00748567085733058,-0.0813378089019498,-0.0519939791412139,5.97052871733539e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.0313309715631611,0.00351987000679091,-0.0382299167764713,-0.0244320263498509,6.22141575497285e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,42137,-0.0205790765625254,0.00231245632972998,-0.0251114909687962,-0.0160466621562547,6.32974677692896e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0608483717580488,0.0068429232111121,-0.0742605012518285,-0.0474362422642691,6.89882237374673e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0560405823439828,0.00630737421830592,-0.0684030358118624,-0.0436781288761032,7.1964684545636e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0235115146278226,0.00265000064782405,-0.0287055158975577,-0.0183175133580874,8.06248120765329e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0211497657644461,0.00238507377847099,-0.0258245103702492,-0.0164750211586429,8.59133699588199e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0549257959312752,0.00620171112420119,-0.0670811497347096,-0.0427704421278409,9.47858250755915e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.0255871160439099,0.00288919555935881,-0.0312499393402532,-0.0199242927475667,9.51438484605372e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,39934,-0.0885315264288818,0.0100025794570633,-0.108136582164726,-0.0689264706930378,9.97067844993258e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.0615975793706515,0.00696699138737531,-0.0752528824899071,-0.0479422762513959,1.08920799073713e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0303265508050108,0.00343119698024073,-0.0370516968862826,-0.023601404723739,1.11345986323143e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.0633275226796672,0.00716771531724851,-0.0773762447014743,-0.0492788006578602,1.12250450575972e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,42070,-0.0263961520432702,0.0029886061434319,-0.0322538200843967,-0.0205384840021436,1.15125409706661e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0472746124799651,0.00535463481809882,-0.0577696967234388,-0.0367795282364915,1.21657727706504e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0604189501510181,0.00684454736091522,-0.0738342629784119,-0.0470036373236242,1.23380656040876e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPPK1,Epiplakin,39638,-0.0612737694485754,0.00695045779335728,-0.0748966667235557,-0.0476508721735952,1.36656770257594e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.0407451320649351,0.00462518945026816,-0.0498105033874607,-0.0316797607424095,1.41322777130235e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.059550772956147,0.00676417077159219,-0.0728085476684677,-0.0462929982438263,1.5137523918434e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCN1,Ficolin-1,39978,-0.0459750879777193,0.0052245586046339,-0.0562152228428017,-0.0357349531126368,1.56792347677338e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.0456787874594043,0.00519304930950682,-0.0558571641060377,-0.0355004108127709,1.58395037753881e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.0438945614532108,0.00499546865232883,-0.0536856800117753,-0.0341034428946463,1.72183829749386e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.0378014362016323,0.00430452836309955,-0.0462383117933074,-0.0293645606099572,1.80015732320245e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,-0.0307472452803426,0.0035019012228385,-0.0376109716771061,-0.0238835188835792,1.8272352761246e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.0196000869294685,0.00223335369941942,-0.0239774601803306,-0.0152227136786064,1.89355318084953e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0457500757036849,0.00521320169189235,-0.0559679510197939,-0.0355322003875759,1.9392958721709e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0233152559704099,0.00265786674576971,-0.0285246747921185,-0.0181058371487013,1.95765420118527e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.0251488172208811,0.00286711668284859,-0.0307683659192643,-0.0195292685224979,2.01986755273636e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.0402897627758397,0.00459659694386045,-0.0492990927858062,-0.0312804327658732,2.08581378477172e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.0379815979477712,0.00433597172105839,0.0294830933744968,0.0464801025210457,2.18679350956656e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN3,Ataxin-3,39929,-0.0499878170459941,0.00571376442904103,-0.0611867953269145,-0.0387888387650736,2.46363785852303e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.0237772002278077,0.00271934422549044,-0.029107114909769,-0.0184472855458464,2.57338225534126e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.02689867638914,0.00308088926041593,-0.0329372193395552,-0.0208601334387248,2.88062488066133e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.0836809084228048,0.00960013844094671,-0.10249717976706,-0.0648646370785493,3.26422184878562e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.0216172272487941,0.00248837556755813,0.0167400111363802,0.026494443361208,4.21838071781283e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.037382038017002,0.00430370891637263,-0.0458173074930924,-0.0289467685409117,4.27753707737276e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.062744271103221,0.007224872840273,-0.0769050218701561,-0.0485835203362859,4.33504100060165e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0480773505774314,0.00553916863678341,-0.0589341211055269,-0.0372205800493359,4.43184884305811e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F10,Coagulation factor X,39990,-0.0235717776419233,0.00271633141989126,-0.0288957872249102,-0.0182477680589364,4.58232831363585e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.0631496677855073,0.00728057413467809,-0.0774195930894764,-0.0488797424815383,4.75137604370875e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0154829272618436,0.00178775830343527,0.0119789209871105,0.0189869335365767,5.22152557299066e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.0352296708181562,0.00407250129194354,-0.0432117733503656,-0.0272475682859469,5.8241821995304e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD248,Endosialin,39966,0.0327496543580288,0.00378602643626612,0.0253290425429472,0.0401702661731104,5.83362937356134e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.0175703744533025,0.00203158233480587,-0.021552275829522,-0.013588473077083,5.9099414792066e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,39930,-0.0550639998478166,0.00637025071893049,-0.0675496912569204,-0.0425783084387128,6.15996412700492e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0590058473399389,0.00684273043736938,-0.0724175989971829,-0.0455940956826949,7.38155187497262e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.024197886382281,0.00280706490346777,-0.0296997335930778,-0.0186960391714842,7.40889565686845e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0623027333602515,0.0072268280237488,-0.0764673162867991,-0.0481381504337038,7.51567654832408e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PENK,Proenkephalin-A,39736,-0.0249994725834938,0.00290809493868402,-0.0306993386633145,-0.0192996065036731,9.31497849760911e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.0195181852313413,0.00227189742238467,-0.0239711041792152,-0.0150652662834673,9.54756138408656e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,39813,-0.0885524224252892,0.0103108681568378,-0.108761724012691,-0.0683431208378871,9.99545658205815e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.024818255130297,0.00289051526005572,-0.0304836650400062,-0.0191528452205878,1.02217406586104e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0281385932550926,0.00327949703436633,-0.0345664074424506,-0.0217107790677346,1.04876146218983e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0496759448496483,0.00579281052189862,-0.0610298534725696,-0.038322036226727,1.09314160740712e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0342608847633191,0.00400029783081018,-0.042101468511707,-0.0264203010149311,1.20187951206529e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.0231877206205527,0.00271009953506131,-0.0284995157092729,-0.0178759255318326,1.29273638453936e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,39638,-0.0703476986884222,0.00822212743874868,-0.0864630684683696,-0.0542323289084748,1.32408474952708e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.0227029650632595,0.00265990676880802,-0.0279163823301233,-0.0174895477963958,1.54489609045704e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,41839,-0.0499934001459051,0.00587682098832833,-0.0615119692830286,-0.0384748310087816,1.97716529305321e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0305424432765826,0.00359443348517494,-0.0375875329075255,-0.0234973536456397,2.14430352496665e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOK2,Docking protein 2,42145,-0.0970798744620161,0.0114359990885667,-0.119494432675607,-0.0746653162484254,2.29971624726853e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.0249977491055343,0.00294631920534619,-0.0307725347480128,-0.0192229634630558,2.39679458292413e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.0322736745135325,0.00381332267888849,-0.039747786964154,-0.0247995620629111,2.91596081758563e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,42016,-0.0477055572748164,0.00563974818606435,-0.0587594637195025,-0.0366516508301303,2.97844970956422e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0405972192027282,0.00480165565092572,-0.0500084642785426,-0.0311859741269137,3.07598777253229e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0603944642065246,0.00714332309159112,-0.0743953774660432,-0.046393550947006,3.08295321045282e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA2,Annexin A2,39492,-0.0558305307148269,0.00662316878152254,-0.0688119415266111,-0.0428491199030427,3.90599239552944e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.0309890216043632,0.00367752013578583,0.023781082138223,0.0381969610705034,3.91492948698974e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0574417713295176,0.0068178653435238,-0.0708047874028243,-0.044078755256211,4.03491062356557e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0630841727933605,0.00749032512558954,-0.077765210039516,-0.048403135547205,4.06832644698695e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.0492504994475822,0.00585052278028042,-0.0607175240969318,-0.0377834747982326,4.20320862419126e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,42103,0.0490202343946487,0.00582340837086275,0.0376063539877577,0.0604341148015397,4.21983892449105e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0426769518054423,0.00506866090549456,-0.0526115271802116,-0.032742376430673,4.23324066102071e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.0224687900399959,0.00267023215783014,-0.027702445069343,-0.0172351350106489,4.34334147044042e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.0873697238864609,0.0103907123002632,-0.107735519994977,-0.0670039277779449,4.571522916265e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0405315074758109,0.00482128428598445,-0.0499812246763405,-0.0310817902752814,4.6363931485089e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.0493708933894549,0.00588937841507068,-0.0609140750829934,-0.0378277116959163,5.67484190683496e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0462719955556811,0.00552071443049024,-0.0570925958394419,-0.0354513952719202,5.73691428287944e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0651937353207047,0.00778097865677596,-0.0804444534879856,-0.0499430171534239,5.88162548572022e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP7,Matrilysin,41881,-0.0403876195422646,0.00482090136817063,-0.0498365862238791,-0.0309386528606502,5.93984067041791e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.0227174737633602,0.00271411256661998,-0.0280371343939353,-0.017397813132785,6.44303455335966e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0520992361597257,0.00622632266588431,-0.0643028285848589,-0.0398956437345925,6.56673757023226e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.0712388397980738,0.0085204871621038,-0.0879389946357973,-0.0545386849603504,6.97054759761164e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LARP1,La-related protein 1,39919,-0.0487949113330146,0.00583705485839616,-0.0602355388554711,-0.0373542838105581,7.0336482520722e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.0308159446115026,0.00368770337977037,-0.0380438432358525,-0.0235880459871526,7.23836421398149e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,42081,-0.0327584801571824,0.00392286746646685,-0.0404473003914575,-0.0250696599229074,7.44645312173955e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.0387340384570071,0.00464358235005256,-0.0478354598631101,-0.0296326170509041,8.04537384925419e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.0273070322140001,0.00327821757688656,-0.0337323386646978,-0.0208817257633025,8.87860217856142e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0173053414172108,0.00207779642885222,-0.0213778224177612,-0.0132328604166605,9.11373869718037e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.0586344029621091,0.00704711915620413,-0.0724467565082692,-0.044822049415949,9.6103599750939e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.0632322377990854,0.00760158251647477,-0.078131339531376,-0.0483331360667949,9.94317079055766e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.0129326103045355,0.00155853680797123,-0.0159873424481591,-0.00987787816091191,1.1788704275841e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,42168,-0.0247686818040526,0.00300233789083088,-0.0306532640700811,-0.0188840995380241,1.7317923858722e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.0867434968868112,0.0105168894644919,-0.107356600237215,-0.0661303935364071,1.7582004183369e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,39979,0.0233161826039916,0.00282787058404061,0.017773556259272,0.0288588089487112,1.83067972368297e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.0420552573181999,0.00510232883002604,-0.0520558218250509,-0.0320546928113488,1.84080791930723e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,42070,0.0597978568989928,0.00725834720556166,0.045571496376092,0.0740242174218937,1.90377016015561e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.0422024931969132,0.00512880478897918,-0.0522549505833124,-0.032150035810514,2.07137142216829e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0259953808180746,0.00317068870510478,-0.03220993068008,-0.0197808309560693,2.64752136808159e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.0815397880043545,0.00994815034104381,-0.1010381626728,-0.0620414133359086,2.69558416435964e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.0294909930467546,0.00359822355586586,-0.0365435112162516,-0.0224384748772575,2.70845499004074e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0320299529003741,0.00391056549766671,-0.0396946612758008,-0.0243652445249473,2.83455214494022e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.0443774888232055,0.0054235712206063,-0.0550076884155938,-0.0337472892308171,3.03646347346745e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0369726352020341,0.00452179187144487,-0.045835347270066,-0.0281099231340022,3.18402713376998e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18,Interleukin-18,42069,-0.0337254259025791,0.0041256191736074,-0.0418116394828496,-0.0256392123223086,3.23116740926833e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.0223104187626872,0.00273430503367303,-0.0276696566286863,-0.016951180896688,3.72304397980895e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0645058367652175,0.00790863031800072,-0.0800067521884989,-0.0490049213419361,3.81561305842255e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.0641938006889779,0.00787224457444284,-0.0796234000548859,-0.0487642013230699,3.88920344141868e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.0240284985482786,0.00294721649567735,-0.0298050428798062,-0.018251954216751,3.93558030196567e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NBN,Nibrin,41913,-0.0412371542299596,0.00506175893985967,-0.0511582017520845,-0.0313161067078346,4.06787826896791e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.0717393303129901,0.00882618959334925,-0.0890386619159546,-0.0544399987100255,4.74412618216302e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.0279026427461997,0.00343333490342082,-0.0346319791569045,-0.0211733063354949,4.78776548059032e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.0542747691393361,0.00668772688313471,-0.0673827138302802,-0.0411668244483921,5.24389229658244e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.0210347004284768,0.00259674520547326,-0.0261243210312044,-0.0159450798257492,5.9417803272321e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.0782942922440096,0.00968163444629092,-0.0972702957587398,-0.0593182887292794,6.63620882537272e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0262597039213353,0.00324887057212238,-0.0326274902426952,-0.0198919175999755,6.99339193614121e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0338590971050153,0.00419883703875349,-0.0420888177009722,-0.0256293765090585,8.14323192622117e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAN,Brevican core protein,42016,0.0258432184237055,0.00321164562467355,0.0195483929993453,0.0321380438480656,9.21486202015748e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0228966624915052,0.00284791647627104,-0.0284785787849965,-0.017314746198014,9.89247387775898e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.0456082309538636,0.00567591648976547,-0.0567330272738039,-0.0344834346339233,1.00967565957896e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,42262,-0.0349566633646037,0.00435242764908729,-0.0434874215568148,-0.0264259051723927,1.04096898077742e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.0362316601600796,0.00451141902203931,-0.0450740414432767,-0.0273892788768826,1.06147752139935e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0506128544100597,0.00630735985665047,-0.0629752797290946,-0.0382504290910248,1.12245767038778e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0412797096119511,0.00514615965349696,-0.0513661825328052,-0.0311932366910971,1.12935281995069e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0437682452008244,0.00546012596553529,-0.0544700920932736,-0.0330663983083752,1.1837929902118e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,39929,-0.0406923977610326,0.00507673489863417,-0.0506427981623556,-0.0307419973597096,1.2048006109815e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.0543744487324059,0.00678537868607282,-0.0676737909571087,-0.0410751065077032,1.20759818520171e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.0729385296812808,0.00910117252006443,-0.0907768278206071,-0.0551002315419545,1.22009363100236e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0386147880291837,0.00482100089925997,-0.0480639497917332,-0.0291656262666341,1.24500811735194e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0507795582395795,0.00634058523086245,-0.0632071052920699,-0.0383520111870891,1.25289339716168e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100G,Protein S100-G,39934,0.036700989143377,0.00458584816309629,0.0277127267437083,0.0456892515430457,1.33145638295027e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.0365095667153281,0.00456202689031677,-0.045451139420349,-0.0275679940103073,1.33648098396038e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.0398060707301799,0.00497618318720133,-0.0495593897770945,-0.0300527516832653,1.37613469132722e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0249242403264923,0.00312360219187044,-0.0310465006225583,-0.0188019800304262,1.58793756765064e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.0705021189692439,0.00884401545660749,-0.0878363892641946,-0.0531678486742932,1.69165114911492e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.0405481868195604,0.00508708845481202,-0.050518880190992,-0.0305774934481289,1.7308013526431e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.0451019539679337,0.00566910300637522,-0.0562133958604291,-0.0339905120754382,1.92078623405617e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0474758976035116,0.00597448528575641,-0.0591858887635942,-0.0357659064434291,2.10111163087207e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.033908700095812,0.00427165587783356,-0.0422811456163657,-0.0255362545752582,2.24747745518582e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSN,Gelsolin,39943,0.0140890205018608,0.00177577369011171,0.0106085040692418,0.0175695369344798,2.32092258159813e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.0236623995936713,0.00298821493699504,0.017805498317161,0.0295193008701816,2.58786908618034e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0421527129924007,0.00532472499212077,-0.0525891739769574,-0.031716252007844,2.63748399650192e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0492545910985563,0.00622212576113691,-0.0614499575903847,-0.037059224606728,2.68028443320172e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.0320798020203351,0.00405370908179148,-0.0400250718206464,-0.0241345322200238,2.69638238527142e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREH,Trehalase,39966,-0.0557292470876634,0.00704463674296639,-0.0695367351038776,-0.0419217590714493,2.7925017952298e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTDH,Protein LYRIC,39657,-0.070752793356829,0.00894585493072561,-0.0882866690210512,-0.0532189176926068,2.84158851873105e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,41997,-0.0463154847912143,0.00585816311325289,-0.0577974844931899,-0.0348334850892386,2.86158387857279e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,39709,-0.0380462126802251,0.00483452134677942,-0.0475218745199128,-0.0285705508405375,3.88500747633451e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,39900,-0.0335011202186766,0.00426133087929519,-0.0418533287420951,-0.025148911695258,4.13507543813615e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0699969362569666,0.00891276876134568,-0.0874659630292041,-0.052527909484729,4.3476413643632e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0465173471629436,0.00592878623223836,-0.0581377681781308,-0.0348969261477564,4.68022756017918e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS8,Galectin-8,42249,-0.0444097707230834,0.00566565738835422,-0.0555144592042577,-0.0333050822419091,4.89925370642035e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.0336488403661527,0.00429565824643467,-0.0420683305291646,-0.0252293502031407,5.19074503201034e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH15,Cadherin-15,42230,-0.0503910861761026,0.00643766642051299,-0.063008912360308,-0.0377732599918971,5.3405355420222e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,39919,-0.0296949738772677,0.00379383274301519,-0.0371308860535774,-0.0222590617009579,5.43394253935002e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.0416069589409463,0.00532149108618526,-0.0520370814698694,-0.0311768364120232,5.74072634657448e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.0929154227525181,0.0118950783530385,-0.116229776324474,-0.0696010691805626,6.07618435189373e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0458970531177482,0.00588645792505416,-0.0574345106508544,-0.0343595955846421,6.90668864288983e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.0324747181836107,0.00417160244120499,-0.0406510589683725,-0.024298377398849,7.61170641378103e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.0202670952280159,0.00260441938131659,-0.0253717572153965,-0.0151624332406354,7.67767711194058e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,39930,-0.0254534593643049,0.00327306859417549,-0.0318686738088888,-0.0190382449197209,8.09293384421283e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0435106390883882,0.00559784563846284,0.0325388616370011,0.0544824165397754,8.22707221402906e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.074833628312859,0.00963077456175786,-0.0937099464539044,-0.0559573101718135,8.50852741572625e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.0179889334618379,0.00231752259964306,-0.0225312777571383,-0.0134465891665375,9.06464109885326e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0230308042765997,0.00297066565833065,-0.0288533089669278,-0.0172082995862716,9.78313253576801e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0249116016484526,0.00321676676209004,-0.0312164645021491,-0.0186067387947561,1.02927097574034e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,42134,0.0282170667487923,0.00364542047835317,0.0210720426112201,0.0353620908863645,1.06098127180403e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0271142108128451,0.00350853412693561,-0.0339909377016389,-0.0202374839240513,1.16986127048259e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0402066767868843,0.00521106553284421,-0.0504203652312589,-0.0299929883425096,1.28858005195722e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0216832702023863,0.00281333373411876,-0.027197404321259,-0.0161691360835135,1.37409005294368e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EREG,Proepiregulin,41997,-0.0574169709449475,0.00746047878984991,-0.0720395093730533,-0.0427944325168417,1.50012860856344e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0520519125456346,0.00676772421364299,-0.0653166520043749,-0.0387871730868944,1.55894447187499e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.0464393201549601,0.00605253619552647,-0.058302291098192,-0.0345763492117282,1.79850742701929e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.0375004732502325,0.00488905534509742,0.0279179247738416,0.0470830217266235,1.83312051274263e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD209,CD209 antigen,42171,0.0278568647208082,0.00363614228183536,0.0207300258484109,0.0349837035932055,1.9680376159157e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0414433627941933,0.00541568436976575,-0.0520581041589342,-0.0308286214294524,2.10580758130537e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0242068901935557,0.00316352264676728,-0.0304073945812196,-0.0180063858058918,2.14121620387041e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.030631486964372,0.0040050400738837,0.0227816084195599,0.038481365509184,2.17390680714488e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0430383252040333,0.00562689749943553,-0.054067044302927,-0.0320096061051397,2.19482534952834e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.0201773171518047,0.00263993582084954,-0.0253515913606698,-0.0150030429429397,2.29720123991231e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0216852565609644,0.00284155299655776,-0.0272547004342176,-0.0161158126877112,2.4742656069988e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,39736,-0.0389464178908367,0.00510240960169732,-0.0489471407101635,-0.02894569507151,2.4819341582007e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD83,CD83 antigen,42119,-0.0245074639532432,0.00321250632750232,-0.0308039763551478,-0.0182109515513387,2.52821363341024e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0260876642912072,0.00342134219027856,-0.0327934949841532,-0.0193818335982612,2.64074670571139e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,41994,0.0194184548176221,0.00254762418485728,0.0144251114153019,0.0244117982199424,2.66165564109443e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,42070,-0.0632052352361773,0.0082935742271869,-0.0794606407214637,-0.046949829750891,2.68528961316306e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOST,Sclerostin,42129,-0.0274725165601205,0.00360708215233479,-0.0345423975786967,-0.0204026355415443,2.78400472526258e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAYN,Layilin,41997,-0.025347637924938,0.00332918485464955,-0.0318728402400511,-0.0188224356098249,2.84006181908684e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0499829851120247,0.00657594993819334,-0.0628718469908836,-0.0370941232331657,3.17943215856335e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.0194475582481389,0.00256300349419532,-0.0244710450967618,-0.0144240713995161,3.50803698042367e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,41843,-0.0679678444759542,0.0089592119269465,-0.0855278998527693,-0.0504077890991391,3.50927525303105e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0355402478410407,0.00468522357592776,-0.0447232860498591,-0.0263572096322223,3.52211769704834e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.0194377251811158,0.00256334260893501,-0.0244618766946284,-0.0144135736676032,3.59456884943082e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGRN,Neugrin,39929,-0.0158675398254724,0.00209975383614178,-0.0199830573443102,-0.0117520223066345,4.44737106532144e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0303913919350842,0.00402425704366028,-0.0382789357406583,-0.02250384812951,4.55694011764892e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,41991,-0.0364372329376765,0.0048274844033044,-0.0458991023681531,-0.0269753635071999,4.70975955631977e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.0287440653098762,0.00380759134531533,-0.0362069443466942,-0.0212811862730581,4.71619386747273e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.0591165247926242,0.00783151640977913,-0.0744662969557913,-0.0437667526294571,4.73915774911687e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0414046505183319,0.0054981412761954,-0.0521810074196749,-0.0306282936169889,5.43866198535238e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0289472469263778,0.00385090371404796,-0.0364950182059118,-0.0213994756468439,6.03486568608424e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0194272843511976,0.0025852284583962,-0.0244943321296541,-0.014360236572741,6.13520650987213e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,41839,-0.0333823581745912,0.00444622625262455,-0.0420969616297353,-0.024667754719447,6.38639700077566e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,42310,-0.0404185080488229,0.00538641892261562,-0.0509758891371495,-0.0298611269604963,6.58163715916775e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REN,Renin,42145,-0.0566691849543685,0.00756154681931315,-0.0714898167202223,-0.0418485531885147,7.07341550646477e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.0335141049276891,0.00447117600708101,-0.0422776099015679,-0.0247505999538103,7.0917230735894e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0455915685795737,0.00608353000003014,-0.0575152873796327,-0.0336678497795146,7.16247352520358e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.0310914393087733,0.00416622104322642,-0.0392572325534971,-0.0229256460640495,9.11006116848451e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0309868700422218,0.00415584715126733,0.0228414096257378,0.0391323304587058,9.44426261785188e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.0576024429341333,0.00773386371723983,-0.0727608158199234,-0.0424440700483432,1.00451511134077e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0347468552668408,0.00466702541370832,-0.0438942250777091,-0.0255994854559724,1.04178945023568e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.0279202902093959,0.00375595551969739,-0.0352819630280027,-0.020558617390789,1.13427982063e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,39919,-0.0230373875411006,0.00310238049279922,-0.029118053306987,-0.0169567217752141,1.20229146784238e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.0370655050526686,0.0049921076892576,-0.0468500361236134,-0.0272809739817237,1.21349990127449e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.0539377040218327,0.0072704831936937,-0.0681878510814723,-0.039687556962193,1.25232180789125e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0400047627019804,0.0054028107968118,-0.0505942718637315,-0.0294152535402292,1.41216858770552e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0533497210728338,0.00721139431140523,-0.0674840539231881,-0.0392153882224795,1.46597139823865e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,39930,-0.0495720157231423,0.00670064065192493,-0.0627052714009151,-0.0364387600453694,1.47907440676163e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.0717771206639798,0.00971248720674339,-0.0908135955891968,-0.0527406457387627,1.55253622267561e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST5,Cystatin-D,41846,-0.0386706847881992,0.00523291469208724,-0.0489271975846902,-0.0284141719917082,1.55747823906732e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.0250182167465132,0.00338838198663608,-0.03165944544032,-0.0183769880527065,1.63158620200763e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0571930687645201,0.0077544272578321,-0.0723917461898711,-0.0419943913391692,1.73491645977661e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,39979,0.0189336290047054,0.00256745606481161,0.0139014151176747,0.0239658428917362,1.76457126973428e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.0228020579415613,0.00309691560513276,-0.0288720125276215,-0.0167321033555011,1.90340735179839e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0305729530986093,0.00415170819319377,-0.0387103011572691,-0.0224356050399495,1.9093573111222e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.0599106774476774,0.0081371177868267,-0.0758594283098577,-0.0439619265854971,1.92802608178476e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0142582163824399,0.00193694386796331,-0.018054626363648,-0.0104618064012319,1.92839145219679e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRP2,Neuropilin-2,42137,0.0192717072749251,0.00261816363773379,0.0141401065449668,0.0244033080048833,1.93390272098129e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.0651198294644431,0.00885539381453302,-0.0824764013409278,-0.0477632575879583,2.06097607093241e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.0696072046877783,0.00947433656160015,-0.0881769043485146,-0.051037505027042,2.14444703695107e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0211972484103808,0.00288672255799802,-0.0268552246240569,-0.0155392721967046,2.20757225690836e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0322783352624255,0.00441068066079824,-0.0409232693575901,-0.023633401167261,2.65518085172243e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.0256021768112488,0.00350131965532332,-0.0324647633356825,-0.0187395902868151,2.77926494461974e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0667681196041709,0.00913791686199634,-0.0846784366536837,-0.0488578025546581,2.89101259129499e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0420353879363419,0.00576180024508155,-0.0533285164167017,-0.0307422594559821,3.14053293633853e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.0736303012953124,0.010101309541425,-0.0934288679965054,-0.0538317345941193,3.32534722932488e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN8,Septin-8,39906,-0.0222441364964198,0.00305261108100907,-0.0282272542151976,-0.016261018777642,3.38237865600448e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.070333578651278,0.00966113972659243,-0.0892694125153991,-0.0513977447871568,3.56389601706622e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.0247814266392928,0.00340751428201972,-0.0314601546320515,-0.0181026986465342,3.75922915278192e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPARC,SPARC,42181,-0.0473047466596493,0.00651622167899033,-0.0600765411504704,-0.0345329521688283,4.09526756865175e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0382979195526596,0.00528326024336451,-0.0486531096296541,-0.0279427294756652,4.42896945039296e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0759639728085776,0.0104854014831309,-0.0965153597155141,-0.055412585901641,4.56773529417493e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,42137,-0.0182126031579343,0.00251453495709086,-0.0231410916738324,-0.0132841146420363,4.62810157140177e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.0337767146805176,0.00466360432521637,-0.0429173791579417,-0.0246360502030935,4.6370408595982e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDK,Midkine,42129,-0.034548039662787,0.00477184821097176,-0.0439008621562917,-0.0251952171692824,4.73000917890467e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSM,Oncostatin-M,42051,-0.04654274263833,0.00643248137526261,-0.0591504061338447,-0.0339350791428153,4.88640609053461e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0446602971760236,0.00619636742392531,-0.0568051773269172,-0.03251541702513,5.99899168757203e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNM3,Dynamin-3,39934,-0.0372709177712851,0.00517153531604381,-0.0474071269907309,-0.0271347085518392,6.08608015867815e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.0165341820267653,0.00229881252782477,-0.0210398545813018,-0.0120285094722287,6.69228783832556e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0263421894932064,0.00366418964331254,-0.033524001194099,-0.0191603777923139,6.86752967366122e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0530368144550697,0.00738208844650431,-0.0675057078102182,-0.0385679210999213,7.17799488540984e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.018348964117181,0.00255579980950081,-0.0233583317438026,-0.0133395964905594,7.36870162345122e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.0353192249452261,0.00491953409656929,-0.0449615117745019,-0.0256769381159503,7.4486496711248e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.055563471478592,0.0077409084237114,-0.0707356519890664,-0.0403912909681177,7.52047352132209e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,39966,-0.0174212043716809,0.00242944218069251,-0.0221829110458383,-0.0126594976975236,7.91507701687306e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.034044136608906,0.00475212733590253,-0.0433583061872749,-0.024729967030537,8.3353808668871e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.0341498986060641,0.00477494983765044,-0.043508800287859,-0.0247909969242692,9.09614294798085e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0425425042903715,0.00595002719353879,-0.0542045575897075,-0.0308804509910354,9.12602877912034e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.01639036749211,0.00229311334354007,0.0118958653387714,0.0208848696454485,9.36791445445767e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0283589771638896,0.0039704400332516,-0.0361410396290627,-0.0205769146987164,9.63097513908102e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0175668081272982,0.00246073644935268,-0.0223898515680295,-0.012743764686567,9.8917414580026e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0159101721860286,0.00222882077880163,-0.0202786609124798,-0.0115416834595774,9.92925268098965e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.0303929592659621,0.00425904011022803,-0.0387406778820091,-0.0220452406499152,1.00895113752324e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.0441987969997133,0.00619489402094843,-0.0563407892807722,-0.0320568047186544,1.0290444448434e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP10,Caspase-10,41839,-0.0472543734595492,0.00663426579448602,-0.0602575344167418,-0.0342512125023566,1.11241716833802e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.023637170474151,0.00331896839295762,-0.0301423485243479,-0.0171319924239541,1.12950824293774e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKD1,Polycystin-1,39958,-0.0181465139971778,0.00255124263856751,-0.0231469495687701,-0.0131460784255855,1.20535381857616e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL8,Interleukin-8,42035,-0.0449703948685298,0.00632937890050816,-0.0573759775135258,-0.0325648122235338,1.26362722504379e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.0427148848651546,0.00603307669733994,-0.0545397151919409,-0.0308900545383683,1.51075004016846e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.0231652953101376,0.00327658317964011,-0.0295873983422322,-0.016743192278043,1.62490960507729e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,39575,-0.0260454080060817,0.00368626573097037,-0.0332704888387836,-0.0188203271733798,1.69706830490204e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0379559328036086,0.00537453690063257,-0.0484900251288485,-0.0274218404783688,1.72094352756146e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0379389004454009,0.0053725789229335,-0.0484691551343506,-0.0274086457564513,1.72723889631995e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0477816434735335,0.00676711857631332,-0.0610451958831076,-0.0345180910639594,1.73561807368969e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.0385532655244272,0.00546132817107578,0.0278490623091186,0.0492574687397357,1.75422131583218e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINI2,Serpin I2,39930,-0.0382606560091348,0.00542326374525296,-0.0488902529498306,-0.027631059068439,1.82779011521937e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0477207227550272,0.00677487127167908,-0.0609994704475182,-0.0344419750625362,1.9613703839865e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.0633236429245409,0.00899328791525328,-0.0809504872384374,-0.0456967986106445,1.99850158064001e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0338224208468291,0.00480778269635227,-0.0432456749316796,-0.0243991667619787,2.09158890963051e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,39649,-0.0328043587885201,0.00467182636791779,-0.041961138469639,-0.0236475791074013,2.31982829062591e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0449722106120887,0.00640728957482475,-0.0575304981787452,-0.0324139230454322,2.34157513006621e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDN1,Endothelin-1,39638,-0.0193529564843777,0.00276026816477543,-0.0247630820873376,-0.0139428308814179,2.49978460897507e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PF4,Platelet factor 4,39914,-0.0639416787950075,0.00913143206490621,-0.0818392856422236,-0.0460440719477913,2.65926015058987e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.0306789637544001,0.00438445987077569,-0.0392725051011204,-0.0220854224076797,2.76249604549428e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.0223481390403427,0.00319462700979681,-0.0286096079795444,-0.0160866701011409,2.76613540737149e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0208749683977982,0.0029877093631123,0.0150190580460981,0.0267308787494983,2.93895793986331e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.0260399651099763,0.00372800131168067,-0.0333468476808704,-0.0187330825390822,2.98485177617811e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,42262,-0.0721846812039323,0.0103365890471,-0.0924443957362483,-0.0519249666716164,3.01407250465189e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.0327229922007474,0.00468524128372262,-0.0419060651168438,-0.0235399192846511,3.02628359638918e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.0219285825628565,0.00314090769381776,-0.0280847616427393,-0.0157724034829737,3.05736448832416e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD27,CD27 antigen,42181,-0.0277796415695473,0.00398272098186023,-0.0355857746939934,-0.0199735084451013,3.19932929059694e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.0263618384888866,0.00377983537713252,-0.0337703158280663,-0.0189533611497068,3.24447872007071e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0429540536005081,0.00616999727075634,-0.0550472482511906,-0.0308608589498257,3.54609543962001e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,42296,-0.0561080301951661,0.00806138109598614,-0.0719083371432989,-0.0403077232470332,3.5549541513697e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TALDO1,Transaldolase,39948,-0.0288062065642492,0.00413868615836621,-0.036918031434647,-0.0206943816938515,3.58448088783191e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0287667451335952,0.00413524719904934,-0.0368718296437319,-0.0206616606234585,3.64935741072114e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0498625821649164,0.00716880547213848,-0.0639134408903078,-0.035811723439525,3.70670670130167e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,42166,-0.0565037678289602,0.00813146142632606,-0.0724414322245592,-0.0405661034333611,3.85262905530445e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.033933148059489,0.00488940203316466,-0.0435163760444917,-0.0243499200744863,4.13106396219534e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.018810708019321,0.00271348754796036,-0.0241291436133233,-0.0134922724253187,4.32812179346163e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0182526314884278,0.00263365074290498,-0.0234145869445216,-0.013090676032334,4.38044453395628e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.038451818997572,0.00555564722269621,0.0275627504410874,0.0493408875540566,4.67760298477041e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0317893488917374,0.00459253842858944,-0.0407907242117727,-0.0227879735717021,4.69500704708505e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,42249,-0.0726018160087328,0.0105192951980569,-0.0932196345969244,-0.0519839974205412,5.36231901892313e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,39638,-0.0450196958959043,0.00652499241017772,-0.0578086810198526,-0.032230710771956,5.50131739449572e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.0429219732182597,0.0062227443389633,-0.0551185521226277,-0.0307253943138916,5.52106964840133e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,42112,-0.042465044595399,0.00616047624914307,-0.0545395780437194,-0.0303905111470786,5.69943268167684e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0257216849623175,0.00373130263292373,-0.033035038122848,-0.0184083318017869,5.73323767512211e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.0308966664564698,0.00448549860065915,-0.0396882437137618,-0.0221050891991779,5.95272527259099e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.069998458961985,0.0101820424226508,-0.0899552621103806,-0.0500416558135894,6.48336793272205e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0301504126655101,0.00438874015775369,-0.0387523433747074,-0.0215484819563129,6.75914736403964e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAL,Galanin peptides,42185,0.042617866939002,0.00620554313368759,0.0304550023969743,0.0547807314810296,6.80775918996495e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,39575,-0.042544180668293,0.00619509359325512,-0.054686564111073,-0.030401797225513,6.89171891867937e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,39930,-0.0218117268727655,0.00317778395980666,-0.0280401834339866,-0.0155832703115445,7.05451990838434e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0503298700837239,0.00734181115883868,-0.0647198199550477,-0.0359399202124001,7.48906586146611e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.0509293185022426,0.00743461274149524,-0.0655011594755732,-0.0363574775289119,7.76207948436701e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.0249110658568161,0.00363887849848965,-0.0320432677138558,-0.0177788639997763,7.93095218677597e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0292007420702691,0.00426563481300028,-0.0375613863037496,-0.0208400978367885,8.01140386297629e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0314836410427542,0.00460156236348947,-0.0405027032751936,-0.0224645788103149,8.22607443675086e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL32,Interleukin-32,42119,0.0282914372588633,0.00413911797475201,0.0201787660283493,0.0364041084893772,8.54393125524889e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0241046548244958,0.00352641445690881,-0.0310164271600371,-0.0171928824889546,8.60806177378695e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASN,Vasorin,41975,0.0174272550722667,0.00255424873019846,0.0124209275610777,0.0224335825834556,9.30928143983289e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.0661907684116497,0.00970986273232185,-0.0852220993670006,-0.0471594374562989,9.69992643937249e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0680721668904977,0.00999461368068799,-0.0876616097046461,-0.0484827240763492,1.01907940371426e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0283576776189184,0.00416670574102252,0.0201909343665143,0.0365244208713226,1.0473372620108e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,42310,-0.0361544570893461,0.00531500893102031,-0.0465718745941459,-0.0257370395845463,1.07206646480314e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0330128738425639,0.00485376803744352,0.0234994884891746,0.0425262591959532,1.07886263847018e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.0464926377184322,0.00684152410650943,-0.0599020249671907,-0.0330832504696737,1.13370841487892e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.0225470429880813,0.00331948767782441,-0.0290532388366172,-0.0160408471395455,1.1503043069461e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,39735,0.0197890189449745,0.00291337235532813,0.0140788091285314,0.0254992287614177,1.15840904658368e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0417794309177553,0.00615242095359554,-0.0538381759868025,-0.029720685848708,1.17332317785295e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0431889721485306,0.00636687196358051,-0.0556680411971484,-0.0307099030999128,1.23338843377129e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CETN2,Centrin-2,41839,-0.0429527707241888,0.00633483605579278,-0.0553690493935427,-0.030536492054835,1.24919843782089e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,42077,-0.0145642596918942,0.00214840745235498,-0.0187751382985099,-0.0103533810852784,1.25963229131252e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A14,Protein S100-A14,39934,-0.0329434387123649,0.00485900781058335,-0.0424670940211083,-0.0234197834036216,1.26260241143131e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.035207965819956,0.00520115332550401,-0.0454022263379439,-0.0250137053019682,1.35995656837403e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAN,Neurocan core protein,42249,0.02361149532324,0.00349120439073192,0.0167687347174055,0.0304542559290746,1.40530728595361e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0178651890743877,0.00264359316644946,-0.0230466316806286,-0.0126837464681468,1.45668175996152e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.0499510376690161,0.00739135299602449,-0.0644380895412241,-0.0354639857968081,1.4572919387437e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,39736,-0.0342140618325476,0.00506713201111779,-0.0441456405743385,-0.0242824830907567,1.52913061889617e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0370073785016375,0.00548334143521927,-0.0477547277146673,-0.0262600292886077,1.56069303290878e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,39930,-0.0441592302433964,0.00655066894385758,-0.0569985413733572,-0.0313199191134355,1.64737660687858e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.0393876126550443,0.00585552177697343,-0.0508644353379122,-0.0279107899721763,1.82062810878541e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0568667345078672,0.00845761693692666,-0.0734436637042434,-0.0402898053114909,1.84392881413062e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.033825694412435,0.00503183236915847,-0.0436880858559856,-0.0239633029688844,1.8599930446877e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,42119,-0.0215445260290582,0.00320566668319635,-0.0278276327281231,-0.0152614193299934,1.88020742497921e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.0183036807586789,0.00272351274920027,-0.0236417657471114,-0.0129655957702464,1.88140861839717e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,42144,-0.0149939751879451,0.00223206576977643,-0.019368824096707,-0.0106191262791833,1.92206701332624e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.0285563525254861,0.00425212789806163,-0.0368905232056869,-0.0202221818452853,1.9623904927955e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.0191871497449402,0.00285938073936122,-0.0247915359940882,-0.0135827634957922,2.03561673876992e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.0283250700538739,0.00422667871123313,-0.0366093603278908,-0.020040779779857,2.14500936996235e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.0145534330908759,0.00217260061295043,-0.0188117302922588,-0.0102951358894931,2.20323128311151e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.0365900014505291,0.0054677243742432,-0.0473067412240457,-0.0258732616770124,2.28749146061819e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0230836735402484,0.00345410847005688,0.0163136209389369,0.0298537261415599,2.4514766433761e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.027804333876168,0.00417381047502625,-0.0359850024072195,-0.0196236653451166,2.81528718808461e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0538452128561849,0.00809035642349532,-0.0697023114462357,-0.0379881142661341,2.95418837731596e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0398573244013298,0.00599272597147112,-0.0516030673054132,-0.0281115814972464,3.02642185748155e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.027776524084923,0.00418307202276064,-0.0359753452495338,-0.0195777029203121,3.27895031499542e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRL,Prolactin,42249,-0.045497077154187,0.00685704444680699,-0.0589368842699287,-0.0320572700384453,3.36544702024712e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,39826,0.0684497606649859,0.010327864880767,0.0482071454986827,0.0886923758312892,3.56630369172281e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0250516337254169,0.00378313438739149,-0.0324665771247043,-0.0176366903261296,3.67802603793834e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS9,Galectin-9,42129,-0.0193864243083225,0.00292786704582145,-0.0251250437181325,-0.0136478048985124,3.6937265970152e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,42107,-0.017665536286408,0.0026700438245566,-0.0228988221825389,-0.012432250390277,3.82445767836256e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0355989561375381,0.00538070280286441,-0.0461451336311523,-0.0250527786439238,3.82805966638343e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,41932,-0.0254185945533258,0.00384297454921267,-0.0329508246697826,-0.017886364436869,3.87548233065537e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0268405644542845,0.00405959738901702,-0.0347973753367578,-0.0188837535718111,3.97133836540811e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.0290569487414975,0.00439585166831294,-0.0376728180113908,-0.0204410794716041,3.98321374993333e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0247664613502561,0.00375049281729415,-0.0321174272721526,-0.0174154954283595,4.16345329124026e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,42181,-0.0330944654859062,0.0050154929179393,-0.0429248316050672,-0.0232640993667452,4.3089132516996e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.026711649352873,0.00405103291473412,-0.0346516738657518,-0.0187716248399941,4.47827217553251e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,42310,0.00980485687816529,0.00148754172901065,0.00688927508930441,0.0127204386670262,4.51886710180796e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGN,Secretagogin,41913,-0.0272836041145251,0.00414099184223414,-0.035399948125304,-0.0191672601037462,4.60494422302845e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0212990705441363,0.00323334467308861,0.0149617149848826,0.02763642610339,4.64406930409542e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.040020091953339,0.00607673888396387,-0.0519305001659082,-0.0281096837407698,4.73030168011006e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.0473377225344788,0.00718824107410056,-0.0614266750397159,-0.0332487700292418,4.73599523337267e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD48,CD48 antigen,42166,-0.0188686682031925,0.00286613478386214,-0.0244862923795622,-0.0132510440268227,4.76994905331354e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0534087342521784,0.00811690717962889,-0.069317872324251,-0.0374995961801058,4.91392126558284e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.0167628918190878,0.00254793366840511,0.0117689418290138,0.0217568418091618,4.94378106216249e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0420017215523403,0.00638724931101139,-0.0545207302019226,-0.029482712902758,5.04969850378149e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.0409994077884041,0.00623648850073515,-0.053222925249845,-0.0287758903269632,5.11637451780926e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0513310993567508,0.00781483045119151,-0.0666481670410862,-0.0360140316724154,5.30780470359136e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.0223280732260043,0.00340035922932167,-0.0289927773154748,-0.0156633691365338,5.38658799468466e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.0198482277735177,0.00302381252400822,-0.0257749003205738,-0.0139215552264616,5.43789655700946e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COLEC12,Collectin-12,42123,-0.0167411128916089,0.00255056791861441,-0.0217402260120931,-0.0117419997711246,5.44098246724144e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,-0.0157844497229186,0.00240477288776542,-0.0204978045829388,-0.0110710948628984,5.48051606815571e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.02680680769162,0.00409549987750576,-0.0348339874515313,-0.0187796279317087,6.1952078530951e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.0579590963095088,0.00885906086770862,-0.0753228556102177,-0.0405953370087999,6.27384820870274e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.0413083417594153,0.00632435126315122,-0.0537040702351917,-0.0289126132836389,6.7387944763626e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,39929,-0.0464940025406955,0.00711925577436938,-0.0604477438584594,-0.0325402612229315,6.82464445898348e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.0306671406419323,0.00470215960883993,-0.0398833734752585,-0.021450907808606,7.24654939367263e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0259656037378738,0.00398292888311079,0.0181590631269766,0.0337721443487709,7.31905533821074e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRKL,Crk-like protein,42143,-0.064073310219988,0.0098318215194888,-0.083343680398186,-0.0448029400417899,7.42995380066839e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,42099,-0.0291564863760604,0.00447866953067043,-0.0379346786561745,-0.0203782940959464,7.77677578366014e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0557626200086573,0.00857537054923002,-0.0725703462851482,-0.0389548937321665,8.22289434903823e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDA,Cytidine deaminase,39946,-0.0290614516786984,0.00447151617839376,-0.0378256233883502,-0.0202972799690467,8.41107411156296e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0424518935018293,0.00654865183537416,-0.0552872510991626,-0.0296165359044959,9.33124226823499e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.0404919069448916,0.00625147507515648,-0.0527447980921983,-0.0282390157975849,9.73230910771649e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.0138126946042176,0.00213400480528512,-0.0179953440225765,-0.00963004518585878,9.95658920071349e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,41843,-0.0268518019784481,0.00414976934407293,-0.034985349892831,-0.0187182540640651,1.01000735710787e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.0203331341122115,0.00314259666492011,-0.0264926235754549,-0.014173644648968,1.0129174932492e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.0413544930724209,0.00639226496286048,-0.0538833323996275,-0.0288256537452144,1.0174178523947e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0208775763197711,0.00323086965134602,-0.0272100808364093,-0.0145450718031329,1.07700161933968e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.048140119656424,0.00745242678441344,-0.0627468761538744,-0.0335333631589737,1.09350494714025e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.0286286827719632,0.00443391678464671,-0.0373191596698708,-0.0199382058740557,1.10716148247291e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0483176179603629,0.00748623861844289,-0.062990645652511,-0.0336445902682149,1.12538765253759e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,42081,-0.0626051899143067,0.0097034976367919,-0.0816240452824188,-0.0435863345461945,1.14292682416464e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0214897668781466,0.00333914627027763,-0.0280344935678908,-0.0149450401884025,1.26986678911841e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.0368681607448127,0.00573702845946279,-0.0481127365253598,-0.0256235849642656,1.36088975121881e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPSE,Heparanase,39866,-0.057395625080285,0.00894166622847014,-0.0749212908880865,-0.0398699592724835,1.42780507196398e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0291159316275551,0.00453842007632766,-0.0380112349771573,-0.0202206282779529,1.46005458488446e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,39930,-0.0220720023423722,0.00344166506816451,-0.0288176658759747,-0.0153263388087698,1.48191498595797e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0222644360706874,0.00347256321616703,-0.0290706599743748,-0.0154582121670001,1.48956828871266e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,42107,-0.0545696656442836,0.00852283508151424,-0.0712744224040515,-0.0378649088845156,1.5764077493726e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCN2,Ficolin-2,42116,-0.0241822102880841,0.00377794339673667,-0.0315869793456879,-0.0167774412304802,1.59571462207234e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0240997817059557,0.00376770820480442,-0.0314844897873724,-0.016715073624539,1.64303147852876e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F12,Coagulation factor XII,39979,-0.0247146805492285,0.0038637715449984,-0.0322876727774254,-0.0171416883210317,1.65195181044209e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.0276003224269794,0.00431612827321264,-0.0360599338424761,-0.0191407110114826,1.66107404804496e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0465734943566556,0.0072823535657117,-0.0608469073454505,-0.0323000813678606,1.66610726585983e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,39925,-0.015339506303091,0.00239938615049704,-0.0200423031580652,-0.0106367094481168,1.68952513079679e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0218477321013954,0.0034175804970986,-0.0285461898757087,-0.0151492743270822,1.69333679043239e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,39929,-0.0412259198443787,0.00645504091181666,-0.0538778000315393,-0.028574039657218,1.76227492342976e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0197959983173365,0.00310071559466726,-0.0258734008828844,-0.0137185957517887,1.77760699757439e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.0467237150837379,0.00732378365115518,0.0323690991274737,0.061078331040002,1.83167520978288e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0501430702728818,0.00786236135261845,-0.065553298524014,-0.0347328420217496,1.85849715083366e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.034673017935341,0.00543834914296543,-0.0453321822555532,-0.0240138536151287,1.89277679506463e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTG,Protogenin,42262,-0.0145762739066884,0.00229216996826544,-0.0190689270444887,-0.0100836207688882,2.09316794464627e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0392207351850669,0.00616842805690626,-0.0513108541766031,-0.0271306161935306,2.10552676342451e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.0409226398113264,0.00643789391204309,-0.0535409118789308,-0.0283043677437219,2.14421138227147e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,39929,-0.0428578216767441,0.00676148615767276,-0.0561103345457827,-0.0296053088077055,2.40794757982518e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0318583860859097,0.0050357926783393,-0.0417285397354547,-0.0219882324363647,2.60421885891727e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.0323114723553966,0.00510846979630971,-0.0423240731561637,-0.0222988715546296,2.61198456488115e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CENPF,Centromere protein F,39757,-0.0320674752863162,0.00507055766746108,-0.04200576831454,-0.0221291822580925,2.64196736965563e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX8,Syntaxin-8,42119,-0.0281439711192521,0.00445589969863338,-0.0368775345285735,-0.0194104077099307,2.76620172856398e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.0448017235833687,0.00709703188978463,-0.0587119060873465,-0.0308915410793908,2.82671388043043e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0448820272126837,0.00711506569063158,-0.0588275559663216,-0.0309364984590458,2.93430309387842e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.0206747757277388,0.00327881569028457,-0.0271012544806966,-0.0142482969747811,2.96064070274143e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POF1B,Protein POF1B,39657,-0.0269026402757279,0.00426725005564538,-0.0352664503847928,-0.018538830166663,3.00254188217965e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0352072065830128,0.00558476473022976,-0.0461533454542631,-0.0242610677117624,3.0052164527356e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.0253714777395175,0.00402917541223221,-0.0332686615474926,-0.0174742939315424,3.15011489593426e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,42057,-0.0326346770596396,0.00518420039573255,-0.0427957098352754,-0.0224736442840038,3.16888972784473e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD226,CD226 antigen,39657,-0.0251230765188178,0.00400039978396402,-0.0329638600953873,-0.0172822929422483,3.50962277708085e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTD,Biotinidase,39979,-0.0120614487990493,0.00192163841257563,-0.0158278600876975,-0.00829503751040102,3.58533559062262e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,42145,-0.048578449671644,0.00774323049054475,-0.0637551814331118,-0.0334017179101763,3.63371793208012e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.0150088460808233,0.00239346701490449,-0.0197000414300361,-0.0103176507316105,3.7021363354165e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.015887764650997,0.0025377539203125,-0.0208617623348095,-0.0109137669671845,3.95134071143635e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.0264193958626828,0.00422181760251903,-0.0346941583636201,-0.0181446333617455,4.02414684337046e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0612094959884489,0.0097890240655627,-0.0803959831569518,-0.042023008819946,4.15196024704709e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0182794863969291,0.00292517302320784,-0.0240128255224165,-0.0125461472714418,4.25322370039466e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.0696168417884958,0.0111423847031448,-0.0914559158066596,-0.0477777677703319,4.30844551072638e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0273194555049229,0.00437311850172833,-0.0358907677683104,-0.0187481432415354,4.33420565839367e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.0162494956651483,0.0026071839132075,-0.021359576135035,-0.0111394151952616,4.72250335541231e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADA,Adenosine deaminase,42296,-0.0206234272310345,0.00330924468799782,-0.0271095468195103,-0.0141373076425588,4.73816620585066e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0237268372042776,0.0038081517394426,-0.0311908146135851,-0.0162628597949701,4.8132133700254e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.015615652712908,0.00250971905070239,0.0106966033735313,0.0205347020522847,5.05088221487887e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.0246187512451975,0.00395853874848352,-0.0323774871922252,-0.0168600152981697,5.14364316258449e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0444941557220226,0.00715711240999488,-0.0585220960456126,-0.0304662153984326,5.2264900423101e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,42262,0.00959928821916287,0.00155079159747497,0.00655973668811193,0.0126388397502138,6.1913228351896e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.0401449633268388,0.00648599251222481,-0.0528575086507994,-0.0274324180028782,6.25153591150514e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,42185,-0.0532607802689161,0.00863912479090336,-0.0701934648590867,-0.0363280956787456,7.24480096766028e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.0337901078507625,0.00548200231584329,-0.0445348323898154,-0.0230453833117096,7.34827844190842e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREG1,Protein CREG1,41960,-0.0232159791962159,0.00377181979718586,-0.0306087459987002,-0.0158232123937316,7.71701169649191e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,39575,-0.0282037883146646,0.00458307753744079,-0.0371866202880486,-0.0192209563412807,7.82396069809069e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.061063090561599,0.00992297576886127,-0.0805121230685671,-0.0416140580546309,7.82892867048029e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.0498005053340583,0.00809279129359617,-0.0656623762695068,-0.0339386343986098,7.83097748472059e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.0307310276720474,0.00500092286978699,-0.04053283649683,-0.0209292188472649,8.21808058232407e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0317950942376792,0.00517467328333766,-0.041937453873021,-0.0216527346023373,8.29697535538262e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0273442281316757,0.00445170615872257,-0.0360695722027719,-0.0186188840605794,8.35581734624257e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.0290757151702596,0.0047401464414921,-0.0383664021955841,-0.0197850281449351,8.81662495129508e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0450450380350507,0.00735294983730541,-0.0594568197161693,-0.0306332563539321,9.25670153423004e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0381660821465352,0.00623080967504015,-0.0503784691096139,-0.0259536951834565,9.35660115732375e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPBP,Platelet basic protein,39908,-0.0491417921488679,0.00802913995370031,-0.0648789064581205,-0.0334046778396152,9.64144385038017e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.0153026625291869,0.00250229954515112,-0.0202071696376831,-0.0103981554206907,9.89453357186422e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0283587964662824,0.0046406836659931,-0.0374545364516289,-0.0192630564809359,1.02320247428421e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP10,Stromelysin-2,42124,0.0327773010101649,0.00537120450543947,0.0222497401795035,0.0433048618408262,1.07333680419212e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0318994737820834,0.00522958863673772,-0.0421494675100893,-0.0216494800540775,1.09066600074526e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.0268176198978699,0.00440732327630369,-0.0354559735194252,-0.0181792662763147,1.19767650949052e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.0187165761009562,0.00308106023048789,-0.0247554541527124,-0.0126776980491999,1.27550510153985e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LXN,Latexin,41960,0.0387210187945575,0.00638330922126191,0.0262097327208841,0.0512323048682308,1.34694499424937e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP3,Stromelysin-1,42137,0.0280751767266438,0.00462893565990209,0.0190024628332357,0.0371478906200519,1.35344260318876e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPON1,Spondin-1,42144,-0.0184119804628029,0.00304031837206948,-0.0243710044720591,-0.0124529564535467,1.43295783761847e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0483376619856798,0.00799735406120181,-0.0640124759456354,-0.0326628480257243,1.54996959557946e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.034219985891216,0.00567084508341953,-0.0453348422547183,-0.0231051295277137,1.6384229686918e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0153547124388046,0.00254637345682156,-0.0203456044141749,-0.0103638204634344,1.68159697089001e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.0301566654680499,0.00500282514118407,-0.0399622027447706,-0.0203511281913291,1.7035340869969e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CR2,Complement receptor type 2,42217,-0.0262101948410085,0.00434902251642778,-0.0347342789732069,-0.01768611070881,1.71676654772079e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.0335715548681391,0.00557783911669848,-0.0445041195368681,-0.02263899019941,1.81218531124576e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0188948849960262,0.00314023469014224,0.0127400250033474,0.025049744988705,1.82189655179012e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,-0.013140418405349,0.00218403116754339,-0.017421119493734,-0.00885971731696397,1.82750030325855e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0239830243104305,0.00398566029357391,-0.0317949184858353,-0.0161711301350256,1.82948175203222e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA12,Serpin A12,41751,-0.0607451337522852,0.0101145297184279,-0.0805696120004039,-0.0409206555041665,1.9549808262875e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0202461178279705,0.00337135731402244,-0.0268539781634545,-0.0136382574924865,1.95943771841507e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.0741135264526771,0.0123517031316533,-0.0983228645907176,-0.0499041883146366,2.03169124314716e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0241527860617421,0.00402912291844802,-0.0320498669819002,-0.016255705141584,2.09246465614291e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,39934,-0.0143471426349769,0.00239331467888061,-0.0190380394055829,-0.0096562458643709,2.10100699484767e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.0821843908121767,0.0137142632814704,-0.109064346843859,-0.0553044347804947,2.12764892298733e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.0204246368515373,0.0034091557543227,0.0137426915730648,0.0271065821300098,2.13698665828771e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.0142468648758798,0.00237881855277424,-0.0189093492393173,-0.0095843805124423,2.17445790638035e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.0311821445976632,0.0052069913728396,-0.0413878476884289,-0.0209764415068976,2.18349834411593e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0229580166333111,0.00383872029369999,-0.0304819084089631,-0.0154341248576591,2.27867080919487e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.042487071535845,0.00711707037109552,-0.0564365294631922,-0.0285376136084978,2.4474838325066e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0521499705117064,0.00873620408383036,-0.0692729305160139,-0.0350270105073989,2.4524778171923e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.0191529345054312,0.00321080863672657,-0.0254461194334153,-0.0128597495774472,2.50546891259669e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0173533769144721,0.00291455139905004,-0.0230658976566101,-0.011640856172334,2.68072886822913e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0556212000985175,0.00934129274580041,-0.0739301338802863,-0.0373122663167487,2.68853170467882e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.0411785762599729,0.00692643254406435,-0.054754384046339,-0.0276027684736067,2.84498352119662e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0188720757258981,0.00317794286209068,-0.0251008437355958,-0.0126433077162003,2.96371319915663e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.0435657818963569,0.00734839659629084,-0.0579686392250869,-0.0291629245676268,3.14411350606736e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,39736,-0.03693967216682,0.00624315842591398,-0.0491762626816114,-0.0247030816520286,3.37877235857361e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0510170218982441,0.00864173236123288,-0.0679548173262606,-0.0340792264702277,3.64403060204883e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.023065660857332,0.00390670516898857,-0.0307228029885496,-0.0154085187261144,3.65011694838946e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,39636,-0.0248241911823579,0.00420567139130733,-0.0330673071093203,-0.0165810752553955,3.68453370246153e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0439982260195683,0.00745588542034107,-0.0586117614434368,-0.0293846905956998,3.69775213020187e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.0306936353286497,0.00520084341203344,-0.0408872884162353,-0.0204999822410642,3.70164702053534e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.039975606032215,0.00678077967651072,-0.053265934198176,-0.026685277866254,3.84552224986947e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.020005167690768,0.0033936620951661,-0.0266567453972935,-0.0133535899842424,3.86034109672228e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,42119,-0.0308413932013925,0.00523426350131025,-0.0411005496639606,-0.0205822367388244,3.90126978326728e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DENR,Density-regulated protein,39657,-0.0318288438027257,0.00540188412618354,-0.0424165366900454,-0.0212411509154059,3.92261308832798e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,39638,-0.0654358288250425,0.0111065025425341,-0.0872045738084092,-0.0436670838416757,3.93480687553772e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.00963419050418903,0.00163643152511648,-0.0128415962934173,-0.00642678471496072,4.01808874760026e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0237511016032802,0.00404340997464548,-0.0316761851535853,-0.015826018052975,4.35488622877753e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,39934,-0.0166246455311519,0.0028334018974991,-0.0221781132502502,-0.0110711778120537,4.55119258592688e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,39347,-0.0681670024300979,0.0116221599620536,-0.090946435955723,-0.0453875689044728,4.61644518808979e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOK1,Docking protein 1,39929,-0.0751264887421255,0.0128686431020465,-0.100349029222137,-0.0499039482621143,5.42970162677997e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.0368056352255151,0.00630920759269406,-0.0491716821071955,-0.0244395883438347,5.57635383501466e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0473074461596841,0.00811864569065073,-0.0632199917133595,-0.0313949006060087,5.77186402996183e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASPN,Asporin,39958,0.0152218966188326,0.00261199774389071,0.0101023810408068,0.0203414121968584,5.77292584892691e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.0281996409948879,0.00484071923713625,-0.037687450699675,-0.0187118312901009,5.82195992769701e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0378539779807937,0.00651130217196653,0.0250918257237393,0.0506161302378481,6.25691126385676e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,-0.0160719725514249,0.00276481554800163,-0.0214910110255081,-0.0106529340773417,6.27147082000352e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.0273315396724718,0.00471378772564229,-0.0365705636147306,-0.0180925157302129,6.88156309752383e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0434363304261751,0.00750940406510249,-0.0581547623937759,-0.0287178984585742,7.44416926408248e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.017538956164202,0.00303306343862551,-0.023483760503908,-0.011594151824496,7.51631794187625e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0527044294641704,0.00912336367367226,-0.0705862222645681,-0.0348226366637728,7.78167917734267e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEXN,Nexilin,39990,-0.0378120224810614,0.00654888663702137,-0.0506478402896233,-0.0249762046724995,7.95237848601936e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0628384412658014,0.0108954238095013,-0.0841934719324239,-0.0414834105991788,8.22636721606028e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0482491712859131,0.00839918981095325,-0.0647115833153814,-0.0317867592564447,9.41842135914423e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.0236091826894396,0.00411049956118798,-0.031665761829368,-0.0155526035495111,9.50531680537903e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NID1,Nidogen-1,42189,-0.0192738259732254,0.00335806402607399,-0.0258556314643304,-0.0126920204821204,9.69470454978927e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0442753935742713,0.00771343859294333,-0.0593937332164402,-0.0291570539321024,9.71498702859553e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,42103,-0.035417923128247,0.00617906282878208,-0.0475288862726599,-0.0233069599838342,1.01420162365077e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0332859442951969,0.00581896342085568,-0.0446911126000741,-0.0218807759903198,1.09130496704035e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0280273638901271,0.0049054385302942,-0.0376420234095037,-0.0184127043707504,1.13489705110161e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.0494542453081329,0.00865930856895603,-0.0664264901032867,-0.0324820005129791,1.14642704170005e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,42082,-0.0466347122346205,0.00816623094218548,-0.062640524881304,-0.030628899587937,1.14901812214209e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.0362251835292047,0.00634882061559227,-0.0486688719357655,-0.0237814951226438,1.18212861979236e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0168228724795061,0.00295116239522047,-0.0226071507741382,-0.011038594184874,1.22014906701978e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.0158358648509143,0.00277933417737213,-0.0212833598385637,-0.010388369863265,1.24006800661368e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,42070,-0.0294987419284374,0.00517832520084637,-0.0396482593220963,-0.0193492245347785,1.24791637802026e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.0217968384551063,0.00383079998063746,-0.0293052064171557,-0.0142884704930569,1.30254826240103e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0487251868384626,0.00858776762021564,-0.0655572113740852,-0.0318931623028399,1.43189005630498e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0467046086785036,0.00823510215049881,-0.0628454088934813,-0.030563808463526,1.45107523778188e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.0256295287449688,0.00453133961635388,-0.0345109543930225,-0.0167481030969152,1.58078345300994e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0443286780232165,0.00783851949736199,-0.059692176238046,-0.028965179808387,1.58784399995185e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.0327646459517252,0.00580405910570366,-0.0441406017989044,-0.021388690104546,1.68348021590766e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0354287951495057,0.0062790339466219,-0.0477357016848847,-0.0231218886141268,1.71786391502795e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0165006741436472,0.00292558927596723,-0.022234829124543,-0.0107665191627515,1.73984630433782e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0314315768915243,0.00557507246717068,-0.0423587189271789,-0.0205044348558698,1.7627607169977e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,42296,-0.03212472973893,0.00569897923889333,-0.0432947290471609,-0.020954730430699,1.76528278453962e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0335476319720278,0.00595165202418377,-0.045212869939428,-0.0218823940046276,1.76822166475119e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.0261180803142759,0.00463669914457109,-0.0352060106376352,-0.0170301499909166,1.80722764457049e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NID2,Nidogen-2,42137,-0.0382184249194018,0.0067925386378552,-0.051531800649598,-0.0249050491892056,1.8751608586157e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17D,Interleukin-17D,41913,-0.0178676395003287,0.00317919006673689,-0.024098852031133,-0.0116364269695244,1.94581287386575e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.0351367431855263,0.00626118488389803,-0.0474086655579665,-0.0228648208130862,2.0411748561333e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,42145,-0.0195997499519314,0.00349346181667364,-0.0264469351126118,-0.0127525647912511,2.05803900377835e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.0488945736840819,0.00871697502923139,-0.0659798447413754,-0.0318093026267884,2.07375569836578e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0348163720637441,0.00620661412170683,-0.0469813357422894,-0.0226514083851987,2.07720544757184e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,42224,-0.0374109577799182,0.00667525045441402,-0.0504944486705697,-0.0243274668892667,2.12997465392842e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPTC,Opticin,42070,0.0237252898671325,0.00423331305114038,0.0154279962868974,0.0320225834473677,2.13046088781263e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLVRB,Flavin reductase,42137,-0.0332596561573759,0.00593635200253305,-0.0448949060823407,-0.0216244062324112,2.15141769180209e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,39979,-0.0159694014791798,0.00285149324526094,-0.0215583282398913,-0.0103804747184684,2.18863329240095e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA10,Annexin A10,41839,-0.0426304074591024,0.00761714799912883,-0.0575600175373949,-0.0277007973808099,2.22890517248715e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.0163486624801069,0.00293104363535149,-0.0220935080053958,-0.010603816954818,2.48381139404291e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,41890,-0.029273823546252,0.00525280741903549,-0.0395693260875615,-0.0189783210049424,2.55281358910337e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.0300664969274898,0.00540082748368393,-0.0406521187955103,-0.0194808750594693,2.64110728244861e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.0190502116269392,0.00342720197196732,-0.0257675274919951,-0.0123328957618832,2.77222186675305e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0139980634773863,0.00251885978078418,0.00906109830704932,0.0189350286477233,2.79149159685362e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFLAM,Pikachurin,39930,-0.0161218479004436,0.0029029378400857,-0.0218116060670116,-0.0104320897338757,2.86102329135884e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPL,Periplakin,39657,-0.0168459987009332,0.00303339137721365,-0.022791445800272,-0.0109005516015945,2.86442817484723e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,42137,-0.0233027760042698,0.00420336528951771,-0.0315413719717245,-0.0150641800368151,3.01449348818022e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,39876,-0.0245492937252558,0.00443324731832665,-0.0332384584691761,-0.0158601289813356,3.13616202183353e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,39649,-0.0355909767696912,0.00643497055791074,-0.0482035190631962,-0.0229784344761861,3.25899419700342e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSTB,Cystatin-B,41959,-0.0223451096728495,0.00404257389613505,-0.0302685545092742,-0.0144216648364248,3.31015982009964e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0234552673189574,0.00425641165987185,-0.0317978341723063,-0.0151127004656086,3.64127257670214e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0458756940519078,0.00832550320907077,-0.0621936803416865,-0.0295577077621291,3.66116207714369e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,41843,-0.0198772899306213,0.00360845871750418,-0.0269498690169295,-0.0128047108443131,3.68600996827982e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.0122341912424079,0.00222257293790474,-0.0165904342007012,-0.0078779482841146,3.76929117424221e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0334658251259699,0.0060880782296119,-0.0453984584560092,-0.0215331917959306,3.93579703514329e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPP1,Osteopontin,42286,0.0224922868734476,0.00409967309986173,0.0144569275977186,0.0305276461491765,4.17587163181582e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.0113302758047732,0.00206570797634732,-0.0153790634384139,-0.0072814881711324,4.21017455553037e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0336831826863293,0.00614905583492919,-0.0457353321227905,-0.0216310332498681,4.38511785958541e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX4,Syntaxin-4,42070,-0.0301250997609116,0.00550211129703611,-0.0409092379031024,-0.0193409616187209,4.44871982588887e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0202981936119448,0.00371037793714923,0.0130258528551324,0.0275705343687573,4.5634251472008e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0658399970430711,0.0120358490797881,-0.0894302612394558,-0.0422497328466863,4.57185598380701e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,42169,0.0139387678770169,0.00254855395816731,0.00894360211900901,0.0189339336350249,4.59854003115951e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPART,Spartin,39736,-0.0399732570615139,0.00731050597455572,-0.0543018487716431,-0.0256446653513847,4.65177461952077e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,42016,-0.0219442249907413,0.00401536523716466,-0.029814340855584,-0.0140741091258986,4.71002931218284e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0330585774132668,0.00606111887687056,-0.0449383704119331,-0.0211787844146005,5.02277715253862e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.0363519334881218,0.00666747557633262,0.0232836813585098,0.0494201856177337,5.08143999866035e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0518456367956579,0.00951274495970603,-0.0704906169166818,-0.0332006566746341,5.12245769467338e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,39586,-0.0279029535183844,0.00512439926467913,-0.0379467760771555,-0.0178591309596133,5.28858181867785e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.0174242426968548,0.00320060517508392,-0.0236974288400193,-0.0111510565536904,5.2993464495078e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,-0.0115954932630989,0.0021333149698052,-0.0157767906039171,-0.00741419592228066,5.56083580447383e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.0348839612729246,0.00641800987747223,-0.0474632606327701,-0.022304661913079,5.56412272375208e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,42264,-0.0104383278244479,0.00192084381913703,-0.0142031817099565,-0.00667347393893935,5.59736234601593e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.0118029702480521,0.0021744265352933,-0.0160648462572269,-0.00754109423887721,5.79321612349525e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.0341639985555623,0.00629597119286487,-0.0465041020935774,-0.0218238950175471,5.87401976433177e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,42145,0.0356695660352988,0.00658117438947379,0.0227704642319301,0.0485686678386674,6.06398075176223e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0269724080390549,0.00497623050969187,-0.0367258198380509,-0.0172189962400588,6.07360205326332e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0348920462743141,0.00643822611096766,-0.0475109694518107,-0.0222731230968175,6.07864586627324e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0281577565527563,0.00519625274885321,-0.0383424119405086,-0.017973101165004,6.10074329235284e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0215739857617573,0.00399737750575476,-0.0294088456730367,-0.013739125850478,6.89030024763418e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0349131875904042,0.0064707136331067,-0.0475957863112933,-0.022230588869515,6.97058872826148e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKD2,Polycystin-2,39575,-0.0296340871936092,0.0054927301981236,-0.0403998383819315,-0.018868336005287,6.98905558668605e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,-0.0231144926021729,0.00429312125275768,-0.031529010257578,-0.0146999749467679,7.40321737335989e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.0188695776037789,0.00351111131597516,-0.0257513557830902,-0.0119877994244675,7.8466206174688e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,-0.0161164236532792,0.00300095944184757,-0.0219983041593005,-0.010234543147258,8.01462943011266e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0299562827128774,0.00558523324766819,0.0190092255474477,0.040903339878307,8.29947664768604e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,42110,-0.0147581882241166,0.0027529603423227,-0.020153990495069,-0.00936238595316407,8.41965615810867e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0316035769783947,0.00589555304465711,-0.0431588609459227,-0.0200482930108668,8.45924981735794e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0149336225194551,0.00279326907538396,0.00945881513170251,0.0204084299072077,9.1228144057874e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,42146,-0.0272718177980938,0.00510136004381355,-0.0372704834839684,-0.0172731521122193,9.13831984434782e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.0315951437690429,0.0059191402544814,-0.0431966586678265,-0.0199936288702594,9.55854244871319e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.0218079462172783,0.00409232008821562,-0.0298288935901809,-0.0137869988443757,1.00703477452529e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,39919,-0.0240593606902772,0.00451603898526039,-0.0329107971013876,-0.0152079242791668,1.01463392177987e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0235545173201254,0.00442442591636422,-0.0322263921161993,-0.0148826425240516,1.03311996210081e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.0116207294833415,0.00218599275519955,-0.0159052752835326,-0.00733618368315036,1.08144362411237e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,42239,-0.0300149811603478,0.00565537647771125,-0.0410995190566618,-0.0189304432640337,1.12981463273733e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.0320000888847707,0.0060301832163221,-0.043819247988762,-0.0201809297807794,1.13763403202679e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.0173643062736939,0.00327447836119789,-0.0237822838616417,-0.010946328685746,1.15787826239824e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0260503122323198,0.00491516987748249,-0.0356840451921855,-0.0164165792724541,1.17990788395209e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,42296,-0.0210139758221617,0.00397612771093084,-0.0288071861355861,-0.0132207655087372,1.27608696602919e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.0368947484788338,0.00698340942797763,-0.05058223095767,-0.0232072659999977,1.29337800677123e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB8,Serpin B8,42296,-0.028716168898394,0.00544984639202761,-0.0393978678267681,-0.0180344699700198,1.39119852978577e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0232263942706544,0.00441696647702561,-0.0318836485656246,-0.0145691399756842,1.47920796798448e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.0304385323910255,0.00579013555526075,-0.0417871980793366,-0.0190898667027145,1.48730504580526e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.0164429177190867,0.00312918970258381,-0.022576129536151,-0.0103097059020225,1.50505099330275e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASC3,Protein CASC3,39649,-0.0213052039912094,0.00405511498771623,-0.0292532293671332,-0.0133571786152856,1.51676253483482e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.0161839344592757,0.00308469976719615,-0.0222299460029801,-0.0101379229155712,1.57872368301594e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0262763686527724,0.00501306093945375,-0.0361019680941018,-0.0164507692114431,1.62068834980146e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IST1,IST1 homolog,39850,-0.0484184594714816,0.00924842832075889,-0.066545378980169,-0.0302915399627941,1.67670484417094e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0222385395227927,0.00425118935105677,0.0139062083947215,0.030570870650864,1.71047320939194e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.0192933645751452,0.00368902878622163,-0.0265238609961396,-0.0120628681541508,1.72674135172937e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0602031104881895,0.0115274239370665,-0.0827968614048398,-0.0376093595715392,1.79126345968481e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0147628077266704,0.00283144463763218,-0.0203124392164294,-0.00921317623691132,1.8763860635877e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,39638,-0.0252371179035299,0.00484780418729736,-0.0347388141106327,-0.0157354216964271,1.96543487797477e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPOCK1,Testican-1,42016,0.0126521591967903,0.00243337596376736,0.00788274230780626,0.0174215760857743,2.0284301277336e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.0103690157917671,0.00199976385904022,-0.0142885529554859,-0.00644947862804828,2.19002512859838e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FETUB,Fetuin-B,42199,-0.0155336818429976,0.00299879846414741,-0.0214113268327265,-0.00965603685326867,2.25094721330437e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNR,Tenascin-R,42016,0.0201454053724706,0.00390143960583195,0.01249858374504,0.0277922269999012,2.45734408382157e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.0144013740524813,0.00278997068214056,-0.0198697165894768,-0.00893303151548585,2.48670249954613e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.0129879192564287,0.00251783871736043,-0.0179228831424551,-0.00805295537040225,2.52628259707333e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,42119,-0.0192454441028126,0.00373091988918997,-0.0265580470856249,-0.0119328411200002,2.52640026505139e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0433691570755202,0.00841215684732252,-0.0598569844962724,-0.0268813296547681,2.57163042223651e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.025900740493483,0.00502445462905679,-0.0357486715664344,-0.0160528094205317,2.57993972316297e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,39586,-0.0202703836205898,0.00393598048070783,-0.0279849053627772,-0.0125558618784025,2.64967557889324e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.00956405262453923,0.00185912106813178,-0.0132079299180775,-0.00592017533100094,2.72154675706968e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB9,Serpin B9,42016,-0.0157336964386918,0.00305841479876227,-0.0217281894442659,-0.00973920343311778,2.72168296710407e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH5,Cadherin-5,42310,0.0145628487587731,0.00283210933859632,0.00901191445512429,0.0201137830624219,2.75499793049566e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0425358978447356,0.00827238396190259,-0.0587497704100646,-0.0263220252794065,2.76602496686462e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NADK,NAD kinase,42145,-0.0261937992097501,0.00509790410622935,-0.0361856912579596,-0.0162019071615406,2.81312883434066e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.0237027400888895,0.00461347739531089,-0.0327451557836988,-0.0146603243940801,2.82837421387168e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0323819944447703,0.00631094704547253,-0.0447514506538965,-0.0200125382356442,2.93009402212731e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0230369561639637,0.00449160726778293,-0.0318405064088182,-0.0142334059191092,2.96246916848187e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.0111472309691555,0.00217646307269409,-0.0154130985916359,-0.00688136334667511,3.06870720782241e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,42119,-0.0184602383251542,0.00360545934488682,-0.0255269386411324,-0.011393538009176,3.09603358749796e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,-0.0193379847467661,0.00377832762709149,-0.0267435068958654,-0.0119324625976668,3.12848404757197e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.013604818250242,0.00266473450133439,-0.0188276978728574,-0.00838193862762656,3.35248294030057e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.0215895717817547,0.00423480416276083,-0.0298897879407659,-0.0132893556227435,3.47684730097048e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0308394084275063,0.0060509845609485,-0.0426993381669654,-0.0189794786880473,3.51395094257217e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.0252884960528344,0.00496371317756798,-0.0350173738808676,-0.0155596182248012,3.55117073774145e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.0226170294894811,0.00444047912128722,-0.0313203685672041,-0.0139136904117582,3.57400598581476e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.014525802381146,0.00285412236210045,-0.0201198822108629,-0.00893172255142912,3.63955701508378e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.015614845859526,0.0030704400675117,0.00959678332720305,0.0216329083918489,3.7147866835131e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00435450647360163,0.000857761491162711,0.00267329395092271,0.00603571899628054,3.89303088799041e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.0232798253576821,0.00458546935290898,-0.0322673452893837,-0.0142923054259805,3.89825617384698e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.0177448625155996,0.00350325205484931,-0.0246112365431042,-0.0108784884880949,4.14272845999201e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.0201217090502837,0.00397526902235522,-0.0279132363340999,-0.0123301817664675,4.21030559951652e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0136568530991773,0.00269936027165662,-0.0189475992316243,-0.0083661069667303,4.27391968468688e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.0297634424525585,0.00590128697563492,-0.041329964924803,-0.0181969199803141,4.63018886175975e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.0265585298704216,0.00526638458598737,-0.0368806436589568,-0.0162364160818863,4.65540875397247e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTN,Pleiotrophin,41900,-0.0233716931938026,0.00463766060485767,-0.0324615079793236,-0.0142818784082816,4.72771972875084e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.0127071720014012,0.00252242990437551,-0.0176511346139772,-0.0077632093888252,4.78683860490305e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0269570422099926,0.00535353570060377,-0.037449972183176,-0.0164641122368092,4.84461422024358e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.010169418470978,0.00202002762191583,-0.014128672609933,-0.00621016433202293,4.86977531271981e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMS,Spermine synthase,39586,-0.0304084029087733,0.00604114956433601,-0.0422490560548719,-0.0185677497626747,4.89118752555815e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.0107604761131959,0.00213804442142287,-0.0149510431791848,-0.00656990904720711,4.90637753819948e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.0491814433054046,0.00977249301376915,-0.0683355296123921,-0.0300273569984171,4.91195793877898e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,0.0524213403695723,0.0104214356103019,0.0319953265733806,0.072847354165764,4.98074832877575e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0279351319100548,0.00556583788805597,-0.0388441741706445,-0.0170260896494651,5.26025502195472e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0237821809756931,0.00474038154819269,-0.0330733288101508,-0.0144910331412355,5.32987974114076e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.017250349663948,0.00344134781008573,-0.023995391371716,-0.01050530795618,5.43576004595926e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.014523899290326,0.00289831674918763,-0.0202046001187337,-0.00884319846191823,5.47801050661571e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMH,Granzyme H,41900,-0.0367283249241187,0.00733032946315312,-0.0510957706718988,-0.0223608791763385,5.49973310806927e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0354597546155818,0.00709575818962592,-0.0493674406672486,-0.021552068563915,5.90016590872254e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.023918557855841,0.00479133154099059,-0.0333095676761826,-0.0145275480354995,6.04987049176636e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BGN,Biglycan,41820,0.0549638588447966,0.0110224812765746,0.0333597955427105,0.0765679221468828,6.22551978126695e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.0348225846780368,0.0069873659694557,-0.04851782197817,-0.0211273473779037,6.33324418700438e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSB,Cathepsin B,42153,0.0235604014979842,0.0047308813718403,0.0142878740091772,0.0328329289867912,6.43238513360931e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGA4,Pepsin A-4,39990,-0.035052561937223,0.00703892656042508,-0.0488488579956561,-0.0212562658787898,6.4577378731345e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.050849332886435,0.0102141267988538,-0.0708690214121885,-0.0308296443606815,6.49249433866172e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.0209942480613949,0.0042193358269268,-0.0292641462821714,-0.0127243498406184,6.59600540200229e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.0489280044749566,0.00984808699245155,-0.0682302549801617,-0.0296257539697516,6.85547666337065e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMTN,Smoothelin,39897,-0.0431451247974749,0.00868518201641118,-0.0601680815496408,-0.0261221680453089,6.87537602743964e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0333607673423341,0.0067248538798036,-0.0465414809467492,-0.0201800537379191,7.12174599113449e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.0261415730136058,0.00527010286449734,-0.0364709746280205,-0.015812171399191,7.13974087996775e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0200282649723802,0.00403877101346003,0.0121122737859985,0.0279442561587618,7.1911509023974e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.0126892969993386,0.00256120530358454,0.00766933460431296,0.0177092593943643,7.35965685689357e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD40LG,CD40 ligand,42296,-0.0365704531412715,0.0073891183867529,-0.0510531251793072,-0.0220877811032359,7.53931191614629e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.0179067452327466,0.00361964191885121,-0.0250012433936949,-0.0108122470717982,7.64427339599806e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,41900,-0.0335583426069545,0.00678452892499493,-0.0468560192999446,-0.0202606659139644,7.65598181267133e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,39701,-0.030238210080416,0.00611908131857701,-0.0422316094648269,-0.018244810696005,7.86046944065123e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0338936745241049,0.00686390465828649,-0.0473469276543464,-0.0204404213938634,7.98854790362503e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.0169751711724157,0.00343840439235473,-0.023714443781431,-0.0102358985634005,8.03277104463224e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,41900,-0.038848537155963,0.00787291161410067,-0.0542794439196003,-0.0234176303923257,8.13472213876061e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.0131638203145746,0.00266831399118966,-0.0183937157373063,-0.00793392489184284,8.19587872878555e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS27,Serine protease 27,42107,-0.0184858945020279,0.00374772604597261,-0.0258314375521342,-0.0111403514519216,8.21233678603539e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0165681788646483,0.00336163459267678,-0.0231569826662948,-0.00997937506300184,8.37978357513631e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.0132060495094815,0.00267952444055187,-0.0184579174129631,-0.00795418160599981,8.3841334496145e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.0186855187186908,0.0037918137517158,0.0112535637653279,0.0261174736720538,8.41244696251274e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.026190078615783,0.00532027429128139,-0.0366178162266945,-0.0157623410048715,8.65937082578647e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.0186890662612695,0.00379718938159478,-0.0261315574491952,-0.0112465750733437,8.6745165311308e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.018567120733051,0.00377395936768634,-0.0259640810937163,-0.0111701603723858,8.78480142015844e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.04097899967631,0.00833036879298341,-0.0573065225105575,-0.0246514768420625,8.81364685275152e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA11,Annexin A11,42087,-0.0303419597747373,0.00617181766375663,-0.0424387223957003,-0.0182451971537743,8.92732502185235e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,41843,-0.0282298392490849,0.00575594945713731,-0.039511500185074,-0.0169481783130957,9.47956809974403e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,42145,-0.0118199218011162,0.00241009023658477,-0.0165436986648224,-0.00709614493741009,9.48259314759352e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0136611386295807,0.00278620905764054,-0.0191221083825561,-0.00820016887660521,9.5631227440627e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCT,Secretin,39649,-0.0221674946190622,0.0045223219912458,-0.031031245721904,-0.0133037435162205,9.63147431082153e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSPN,Persephin,42119,-0.039424875054861,0.00805638290584311,-0.0552153855503135,-0.0236343645594085,1.00139413143334e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP7,Caspase-7,39929,-0.038797441235008,0.00792953069379522,-0.0543393213948467,-0.0232555610751694,1.00790228205775e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.0189928307673828,0.00388583834464539,-0.0266090739228878,-0.0113765876118779,1.0345122833914e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,39657,-0.0122705033125058,0.00251477628733109,-0.0171994648356747,-0.00734154178933682,1.07914664422047e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,42262,-0.0100713856342543,0.00206619768647187,-0.0141211330997392,-0.00602163816876944,1.10389826615104e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN5,Contactin-5,42170,0.0168203265147665,0.00345135384235165,0.0100556729837572,0.0235849800457757,1.10852741961215e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.052305380017821,0.0107336035034944,-0.07334324288467,-0.031267517150972,1.11376833790793e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0360087049714044,0.00739249669027805,-0.0504979984843494,-0.0215194114584594,1.123132336188e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.0195379139005564,0.00401328115955435,-0.0274039449732829,-0.0116718828278298,1.1385321420237e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0374171682313533,0.00769289581487414,-0.0524952440285067,-0.0223390924342,1.16412181301746e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0359794996189445,0.00741196773163239,-0.050506956372944,-0.021452042864945,1.22502537600177e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,-0.0233916372371244,0.00481895516895984,-0.0328367893682857,-0.0139464851059631,1.22550095885476e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.0189949100667704,0.00391415208624762,0.011323171977725,0.0266666481558157,1.23313051678171e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.0158770793158478,0.00327295580498053,-0.0222920726936096,-0.00946208593808596,1.24534453892083e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.0224706915800228,0.00463431316230491,0.0133874377819052,0.0315539453781405,1.25615263147084e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0338166449615268,0.00698431584245371,-0.047505904012736,-0.0201273859103175,1.30396347492887e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.0121830416878372,0.00251878891803515,-0.0171198679671861,-0.00724621540848834,1.33634754452608e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPC5,Glypican-5,42016,-0.025378876714982,0.00524849206914186,-0.0356659211705,-0.0150918322594639,1.3431132127575e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.0112102322850007,0.00231988036228683,-0.0157571977950828,-0.00666326677491847,1.36476531406753e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0227492644392606,0.00471763630938649,-0.0319958316056581,-0.0135026972728631,1.43546452942956e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.0197719850177074,0.00410370694212761,-0.0278152506242775,-0.0117287194111372,1.46887162526859e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0188690273610506,0.00391833211854866,-0.026548958313406,-0.0111890964086952,1.48451722978969e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0401606768951435,0.00833984462670078,-0.056506772363477,-0.02381458142681,1.48717650838885e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.0300041840564325,0.00623670737175789,-0.042228130505078,-0.0177802376077871,1.52187244184304e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0305749285827913,0.00636053325362688,-0.0430415737598999,-0.0181082834056826,1.54914451251757e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.0146658870676909,0.0030518975028858,-0.0206476061733471,-0.00868416796203472,1.56020130718509e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.0316971244144603,0.00660383785751633,-0.0446406466151923,-0.0187536022137282,1.60916366313449e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.0302214523505227,0.00630419795885796,-0.0425776803498843,-0.0178652243511611,1.65339732306885e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLGN,Calmegin,39649,-0.0205620962482827,0.00429039606102085,-0.0289712725278835,-0.0121529199686818,1.6678906567019e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.0173543526769861,0.00362621916414449,-0.0244617422387093,-0.0102469631152629,1.7246079247211e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,41839,-0.0173112873490924,0.00361800662366242,-0.0244025803314707,-0.010219994366714,1.7304102517635e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.0341864742842245,0.00715808256250093,-0.0482163161067263,-0.0201566324617226,1.80756693482975e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX3,Syntaxin-3,39929,-0.0170748846074178,0.00357563568365128,-0.0240831305473743,-0.0100666386674612,1.81649125381242e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.0131274188672384,0.00274913874586025,-0.0185157308091245,-0.00773910692535228,1.81864494616921e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLIN3,Perilipin-3,42145,-0.0190769124679863,0.00399582402687464,-0.0269087275606606,-0.011245097375312,1.82298958576266e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAT,Catalase,39827,-0.0234310396242063,0.00491284266116625,-0.0330602112400921,-0.0138018680083204,1.87151390210528e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNC,Tenascin,42217,0.0214430706146189,0.00450372523104907,0.0126157691617628,0.0302703720674751,1.94440519402293e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DMD,Dystrophin,39638,-0.0230373366065858,0.00484012028847663,-0.032523972372,-0.0135507008411717,1.96379500157896e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.0175204475333057,0.00368657396285992,-0.0247461325005112,-0.0102947625661003,2.0338156053004e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0374104586514908,0.00787289163587993,-0.0528413262578154,-0.0219795910451661,2.0408711254216e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,39736,-0.0486114772383378,0.0102343496915049,-0.0686708026336874,-0.0285521518429882,2.06123758445412e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.0380966077130488,0.00802116620021573,-0.0538180934654716,-0.0223751219606259,2.0647353076915e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.0112243941655744,0.00236506755998654,-0.015859926583148,-0.00658886174800076,2.09668783594421e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.0262108345341519,0.00553142695908848,-0.0370524313739653,-0.0153692376943385,2.17975932917573e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.033671137774663,0.00711325335933455,-0.0476131143589587,-0.0197291611903673,2.2335143420134e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TWF2,Twinfilin-2,39966,-0.0377709433231138,0.00798467565576728,-0.0534209076084177,-0.0221209790378099,2.26742761588519e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.0146199821445992,0.0030917413169913,0.0085601691632963,0.0206797951259022,2.28654753675285e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0230606640655777,0.00487939523663627,-0.0326242787293848,-0.0134970494017706,2.31191912686937e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0208735787434463,0.00441868104293731,-0.0295341935876035,-0.0122129638992892,2.33690342483849e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.0439703777255867,0.0093198057543885,-0.0622371970041881,-0.0257035584469852,2.40636375328126e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0168481877014106,0.00357579135771889,-0.0238567387625396,-0.00983963664028156,2.48065274700308e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.0255589566043207,0.00542481156319328,-0.0361915872681795,-0.0149263259404618,2.48367497503018e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.0192696950258306,0.00410337625837409,-0.0273123124922438,-0.0112270775594174,2.67846009691492e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.0115761425598889,0.00246513435908714,0.00674447921607811,0.0164078059036997,2.68543351644421e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.0102754647002243,0.00218940761793822,0.0059842257690654,0.0145667036313832,2.71483125365772e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.0268043068061797,0.0057108281926699,-0.0379975300638126,-0.0156110835485467,2.71694933961483e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.027286908399294,0.00581460478343671,-0.0386835337748299,-0.015890283023758,2.72099165791817e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0326875390811688,0.0069710714621214,-0.0463508391469268,-0.0190242390154109,2.77768500186355e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0356230639484972,0.00759786813078794,-0.0505148854848416,-0.0207312424121529,2.78423997333144e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.0233218498016443,0.00498283495994678,-0.03308820632314,-0.0135554932801486,2.89051879124672e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.0249426633934747,0.00533812726996027,-0.0354053928425968,-0.0144799339443526,3.00910250255393e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0317402282495449,0.00681052424129814,-0.0450888557624893,-0.0183916007366006,3.19205875618945e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.0208580715448641,0.00448269703002903,-0.029644157723721,-0.0120719853660072,3.30818325890695e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.0403527577325075,0.0086791472604367,-0.0573638863629634,-0.0233416291020515,3.36065494995975e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,42070,-0.00829490025815735,0.0017842282526662,-0.0117919876333831,-0.0047978128829316,3.36693647050187e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS3,Galectin-3,42196,-0.0128284313453568,0.00275973619340745,-0.0182375142844354,-0.00741934840627817,3.37620802086851e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.0236690410110879,0.0051064379297104,-0.0336776593533203,-0.0136604226688556,3.60673400789342e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.015066697500105,0.0032516181201531,-0.0214398690156051,-0.00869352598460496,3.63372304666258e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,42137,-0.0385169616429973,0.0083161918308258,-0.0548166976314159,-0.0222172256545787,3.66295517927155e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,-0.0143915461468004,0.00310830920507327,-0.020483832188744,-0.00829926010485683,3.69028281828863e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A13,Protein S100-A13,39657,-0.0154808272155306,0.00334676620059732,-0.0220404889687013,-0.00892116546235982,3.7774171952894e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX16,Syntaxin-16,41843,-0.024635768646854,0.00532852400444586,-0.0350796756955679,-0.0141918615981401,3.8111405237733e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,42145,-0.0292409143547756,0.00633872383844392,-0.0416648130781257,-0.0168170156314255,4.00419083219406e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0164968905341979,0.00357622222394971,-0.0235062860931393,-0.00948749497525643,4.0061758099883e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST1,Cystatin-SN,38503,-0.0461883281085266,0.0100149479064034,-0.0658176260050773,-0.0265590302119759,4.03931695429634e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0431183262712958,0.00935025037155514,-0.0614448169995439,-0.0247918355430477,4.04223915575008e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH3,Cadherin-3,42249,-0.0158356924299608,0.00343494551942426,-0.0225681856480324,-0.00910319921188926,4.05983937178053e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.0348912048586195,0.00757677351112613,-0.0497416809404268,-0.0200407287768123,4.16242613589856e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.019641251649854,0.00427360415055587,-0.0280175157849435,-0.0112649875147645,4.34682584916588e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK10,Kallikrein-10,42138,-0.0175224723293309,0.0038157937161809,-0.0250014280130455,-0.0100435166456163,4.42779832040996e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.0154496022597407,0.00336923979320451,-0.0220533122544215,-0.00884589226505985,4.5705783585806e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.0207203534840568,0.00452028590379996,0.0118605931126089,0.0295801138555048,4.60561808722071e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.0109885093936836,0.00239830254614058,-0.0156891823841191,-0.00628783640324803,4.65183547701309e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0162397200533602,0.0035497357047004,-0.023197202034573,-0.00928223807214746,4.80656268183658e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.0185807327502362,0.00406213327267441,-0.0265425139646781,-0.0106189515357944,4.83272532442972e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0216511575183356,0.00473712366687577,-0.0309359199054121,-0.0123663951312591,4.90765123168163e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.0189100093846533,0.00414504178127746,-0.0270342912759571,-0.0107857274933495,5.11987422040239e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.0387727407329193,0.00850098850696049,-0.0554346782065619,-0.0221108032592768,5.14525023814423e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0155656265911537,0.00341383573327904,-0.0222567446283806,-0.00887450855392675,5.18136376141226e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0232993297159415,0.00511586621247729,-0.033326427492397,-0.013272231939486,5.31018074759435e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CETN3,Centrin-3,39930,-0.0336081299687438,0.00739283476892623,-0.0480980861158392,-0.0191181738216483,5.52307937699296e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0329339847624044,0.00725211554563511,-0.0471481312318492,-0.0187198382929596,5.63946215707484e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.0152494901851414,0.00336037749292214,-0.0218358300712688,-0.00866315029901405,5.73770710672564e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,41997,0.0193983268538561,0.00427813652324884,0.0110131792682883,0.0277834744394238,5.82977426019928e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,39930,-0.0265532431876775,0.00585947566727703,-0.0380378154955405,-0.0150686708798145,5.91166441643709e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHAD,Chondroadherin,39736,0.0199777449835022,0.00440893270052912,0.0113362368904651,0.0286192530765392,5.92608673845477e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,42299,0.0188196370112836,0.00415452536766016,0.0106767672906697,0.0269625067318975,5.9506553722217e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.0145575601392852,0.00321611513187041,-0.0208611457977512,-0.00825397448081921,6.05025128030843e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.0174979904208336,0.0038717810518312,-0.0250866812824228,-0.00990929955924446,6.25628827865724e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0185923328324661,0.00413672826982356,0.010484345423612,0.0267003202413203,7.03281736570549e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AZU1,Azurocidin,41751,-0.0314861505757667,0.00700764690891531,-0.0452211385172407,-0.0177511626342927,7.07881321887966e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0382603062457042,0.00854440948805922,-0.0550073488423002,-0.0215132636491081,7.61668517258879e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.011507075423062,0.00257000758895344,-0.0165442902974107,-0.00646986054871327,7.62789623157143e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0136746921676565,0.00305441881692906,0.00768803128647557,0.0196613530488375,7.64502173136166e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,41976,-0.0271310256448526,0.00607119464380479,-0.03903056714671,-0.0152314841429952,7.93013051998568e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,-0.015274586739335,0.00341950226124347,-0.0219768111713722,-0.00857236230729781,8.00036795064365e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0224256360352873,0.00502127719816664,-0.0322673393436939,-0.0125839327268807,8.04192522069743e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX7,Syntaxin-7,39657,-0.0205518287537297,0.00461310676566617,-0.0295935180144353,-0.011510139493024,8.46799523339392e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0354355034741772,0.00795591129948025,-0.0510290896211585,-0.0198419173271959,8.49816678023996e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,41913,-0.0200215191951438,0.00449567098921944,-0.028833034334014,-0.0112100040562737,8.5165435320561e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0248071210433277,0.00557765957295519,-0.0357393338063199,-0.0138749082803355,8.75332159544994e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0212890178615999,0.00478705603194605,-0.0306716476842141,-0.0119063880389856,8.76865523516841e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0111419050065743,0.00250725000483606,-0.0160561150160529,-0.00622769499709561,8.90581804700704e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,39990,0.0222756702840681,0.00501639623913423,0.012443533655365,0.0321078069127712,9.05649271887726e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.00970109379992878,0.00218714116701487,0.00541429711257964,0.0139878904872779,9.25750796104103e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.0129638135844959,0.00292500324522666,-0.0186968199451402,-0.00723080722385166,9.42324735140878e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0143075720194139,0.0032291326932714,-0.0206366720982259,-0.007978471940602,9.46344820917088e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0431479346699773,0.00975900215549113,-0.0622755788947399,-0.0240202904452147,9.90187831851193e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0275892975921233,0.00624174486802994,-0.039823117533462,-0.0153554776507847,9.9412815258686e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.0172357662185093,0.00390070654997408,-0.0248811510564585,-0.00959038138056008,1.000965099423e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,39657,-0.0181477668026012,0.00410956628173682,-0.0262025167148054,-0.010093016890397,1.01507962518294e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0459825538884009,0.0104270382651332,-0.066419548888062,-0.0255455588887399,1.04213705435459e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.0209830831895444,0.00476031628793466,-0.0303133031138963,-0.0116528632651925,1.05360880542876e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.034694412279975,0.0078717011316542,-0.0501229464980173,-0.0192658780619328,1.05536459892514e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,39560,-0.0230843487247776,0.00523757510849133,-0.0333499959374206,-0.0128187015121346,1.05589768058716e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.123019207936486,0.0279243655096444,-0.177750964335389,-0.0682874515375831,1.0637963039753e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0194867195890201,0.00442373815159473,-0.0281572463661457,-0.0108161928118944,1.06762796512572e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.0246806867847052,0.005606703349192,-0.0356698253491215,-0.0136915482202889,1.0807343829001e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,42143,-0.0147984246178114,0.00336342487325807,-0.0213907373693972,-0.0082061118662256,1.09174471503084e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.0112589746725512,0.00255950508484264,-0.0162756046388428,-0.00624234470625968,1.09800500261859e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0194074443610249,0.00441323627053328,-0.0280573874512702,-0.0107575012707797,1.10317159942981e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.0304717287367117,0.00693181335977073,-0.0440580829218623,-0.016885374551561,1.11161328257026e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,39966,0.0211271813041757,0.00480612759881766,0.0117071712104931,0.0305471913978583,1.11324247523616e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFH,Complement factor H,39418,-0.00968839481857214,0.0022073826179613,-0.0140148647497763,-0.00536192488736799,1.14906957479651e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.00990716375509648,0.00225772013521328,0.00548203229007846,0.0143322952201145,1.1520025322235e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.0132621679107342,0.00302530477444213,0.00733257055282762,0.0191917652686408,1.17725401007933e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.0253336640331664,0.00578162384640256,-0.0366656467721154,-0.0140016812942174,1.1878316523033e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0293791923715194,0.00670747109094662,-0.0425258357097748,-0.016232549033264,1.19529835909709e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBN1,Drebrin,39657,-0.020997780023375,0.00479762107006233,-0.0304011173206972,-0.0115944427260529,1.21591827165629e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.0201459961016356,0.00460679324231586,-0.0291753108565747,-0.0111166813466965,1.23584734717193e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.0362263994407322,0.008286475680758,-0.0524678917750178,-0.0199849071064465,1.24190530816775e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,39930,-0.0179333049981725,0.00410986730967059,-0.0259886449251268,-0.00987796507121809,1.29145648860159e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FN1,Fibronectin,39979,-0.0111456278390199,0.00255482464866593,-0.0161530841504051,-0.00613817152763468,1.2966951051916e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0211393439860869,0.0048461518338841,-0.0306378015804998,-0.0116408863916741,1.29800760778984e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRELP,Prolargin,42123,-0.00950662767390877,0.00218312047122793,-0.0137855437975155,-0.00522771155030203,1.34287580914784e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0170477291359143,0.00391630599690127,-0.0247236888898408,-0.00937176938198777,1.35257933523604e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN5,CCN family member 5,42137,-0.0153993893420142,0.00353854695400143,-0.022334941371857,-0.00846383731217137,1.35954523898207e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.0166496088995503,0.00382676525118631,-0.0241500687918755,-0.00914914900722515,1.36619105327068e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.0441105509088874,0.0101378356870841,-0.0639807088555722,-0.0242403929622027,1.3665507360913e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,42185,-0.0138536695859999,0.0031907973596977,-0.0201076324110073,-0.00759970676099238,1.42370604939607e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.0403629722171013,0.00930933529804876,-0.0586092694012769,-0.0221166750329258,1.46556894503022e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.0142478806325764,0.0032980868263496,-0.0207121308122216,-0.00778363045293117,1.57114965828934e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,-0.017945688749058,0.00415472338375782,-0.0260889465812233,-0.00980243091689268,1.5786006031406e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,-0.00930124514733573,0.00215342959751104,-0.0135219671584574,-0.00508052313621409,1.57876451209432e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0104710231010228,0.00242537634698812,0.00571728546092613,0.0152247607411196,1.59092596466058e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD160,CD160 antigen,42296,-0.0194931719024568,0.00451869606900034,-0.0283498161976974,-0.0106365276072161,1.61528391762028e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAX,Protein max,41839,-0.0426037689823951,0.00988962536773383,-0.0619874347031534,-0.0232201032616368,1.65981177051328e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLNK,B-cell linker protein,39657,-0.0169071403492568,0.00393359976838689,-0.0246169958952951,-0.00919728480321853,1.73716729358816e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.039899870218154,0.00928407110685662,-0.058096649587593,-0.021703090848715,1.74045068538726e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.0312314276471094,0.00726913777943643,-0.0454789376948048,-0.016983917599414,1.74774566609635e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0232676802270343,0.00541690254430562,-0.0338848092138733,-0.0126505512401953,1.75633848942753e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.0131374436928679,0.00305887974227593,-0.0191328479877287,-0.00714203939800707,1.76032397746636e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0366182016189591,0.00852916891391533,-0.0533353726902331,-0.019901030547685,1.77260073313945e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.0188298790075692,0.00439149994438,-0.027437218898554,-0.0102225391165844,1.81728149417022e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0287820052920323,0.00671589038633228,-0.0419451504492436,-0.0156188601348211,1.83487629801759e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.0214705454642862,0.00501595599468628,-0.0313018192138713,-0.0116392717147011,1.87831280560919e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.0171687188647981,0.00401612099997466,-0.0250403160247484,-0.00929712170484779,1.92510884199676e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL34,Interleukin-34,41814,-0.0145504889056633,0.00340421430896775,-0.0212227489512401,-0.00787822886008656,1.93119754027226e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0148876092729477,0.00348625616216689,-0.0217206713507948,-0.00805454719510056,1.96466175964331e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0210861122206794,0.00493865937657509,-0.0307658845987665,-0.0114063398425922,1.97459253734475e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.0130270943526482,0.00305318841534911,-0.0190113436467325,-0.00704284505856394,1.99700866791793e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0167812717871386,0.00393880232059417,0.009061219238774,0.0245013243355032,2.05616578146186e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.0225531739618134,0.00529962202050499,-0.0329404331220032,-0.0121659148016236,2.09881154997595e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.0282236714750517,0.00663304917691565,-0.0412244478618064,-0.015222895088297,2.10443895494099e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.014475794154089,0.00341178016585462,-0.021162883279164,-0.00778870502901391,2.22145052412463e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0196972898937641,0.00464366266765961,-0.0287988687223769,-0.0105957110651512,2.23583501750475e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.0112061867391956,0.00264333538592593,0.0060252493827808,0.0163871240956104,2.25592850180864e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,41839,-0.02421333900453,0.00571861957591522,-0.0354218333733238,-0.0130048446357361,2.30994085635789e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALCAM,CD166 antigen,42310,-0.00776293757972024,0.00183557717393719,-0.0113606688406371,-0.00416520631880334,2.36094334773542e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0210177714476827,0.00498073669074365,-0.0307800153615402,-0.0112555275338251,2.46135135564169e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.0347656074067134,0.00823975240725293,-0.0509155221249291,-0.0186156926884976,2.47023001783061e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFP,Properdin,39979,-0.00935906355547598,0.00221981999259892,-0.0137099107409699,-0.0050082163699821,2.50444749737132e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.0118409782069959,0.00281270849841859,-0.0173538868638963,-0.00632806955009544,2.57246995913276e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.0159271270980721,0.00378357236649613,-0.0233429289364045,-0.00851132525973968,2.57909947793602e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGMN,Legumain,42185,-0.0142459803419518,0.00338753467676166,-0.0208855483084046,-0.00760641237549892,2.62276825808911e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.0115353388282005,0.00274643420623267,-0.0169183498724166,-0.00615232778398451,2.68856709620678e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,41839,-0.0281982641357908,0.00672878020154174,-0.0413866733308126,-0.015009854940769,2.79906396073929e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.0342159315392222,0.00817776360116032,-0.0502443481974964,-0.0181875148809479,2.88595411503722e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.020748010131979,0.00496039488751543,-0.0304703841115092,-0.0110256361524487,2.89839688913198e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0326768624958251,0.00781619259305654,-0.047996599978216,-0.0173571250134343,2.92884318449655e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.0153696032908805,0.00368008179361653,-0.0225825636063689,-0.00815664297539206,2.98336749265182e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0236442187477657,0.00566594313108352,-0.0347494672846894,-0.012538970210842,3.02825510036418e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARG1,Arginase-1,42015,-0.0196673942470697,0.00471591047355564,-0.0289105787752387,-0.0104242097189006,3.05931329532041e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.0117932630181431,0.00283544615848938,-0.0173507374887823,-0.00623578854750395,3.21322462354654e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.018644247421554,0.0045061156161932,-0.0274762340292926,-0.00981226081381527,3.53214025202589e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.0269549275283943,0.00653333221996106,-0.039760258679518,-0.0141495963772707,3.71761608148948e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0145026854722887,0.00351591968194323,-0.0213938880488974,-0.00761148289567993,3.73671232307266e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,39929,-0.0116988216360047,0.00283781237600975,-0.0172609338929838,-0.00613670937902561,3.7748832177973e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELL,L-selectin,39979,0.0089961612167118,0.00218338768632938,0.00471672135150621,0.0132756010819174,3.81097501709059e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK11,Kallikrein-11,42062,-0.0123824704811212,0.00300928984841254,-0.0182806785840098,-0.00648426237823266,3.89909313265382e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0321024077160442,0.0078095686105165,-0.0474091621926565,-0.0167956532394318,3.96865083633132e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0146554996954937,0.00356793890625465,-0.0216486599517528,-0.00766233943923463,4.02276747433325e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM17,Splicing factor 45,39934,-0.0296599308411209,0.00722519481606847,-0.0438213126806151,-0.0154985490016267,4.07025823396364e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.025698729978632,0.00627344474622254,-0.0379946816812282,-0.0134027782760358,4.22065744838387e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0463763201148064,0.0113225662975335,-0.068568550057972,-0.0241840901716408,4.2351469585302e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0185864591724686,0.00454126542367715,-0.0274873394028758,-0.00968557894206135,4.2868373595898e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0414328301695073,0.0101260119177076,-0.0612798135282142,-0.0215858468108004,4.30719444070862e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0263415616955954,0.0064599753434357,-0.0390031133687294,-0.0136800100224614,4.57533495648882e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,39736,-0.0150724424279059,0.00369939126109807,-0.0223232492996581,-0.00782163555615367,4.64722899547283e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.0202755617177449,0.00497748481969104,-0.0300314319643393,-0.0105196914711504,4.65905103246017e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,42070,-0.03603970838385,0.00885431716159472,-0.0533941700205756,-0.0186852467471243,4.72210931175188e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.0121328862713647,0.00298361894288801,-0.0179807793994252,-0.0062849931433042,4.80575005534415e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0283734755563107,0.00701202595980648,-0.0421170464375315,-0.01462990467509,5.23012294706747e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,39575,-0.0239488926931846,0.00592334554049196,-0.0355586499525489,-0.0123391354338204,5.31013632314612e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,42070,-0.0311373009991836,0.00770336733144256,-0.046235900968811,-0.0160387010295562,5.32832995999476e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.0239739749084169,0.00593610229229865,-0.0356087354013223,-0.0123392144155116,5.41142880382609e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNG,Interferon gamma,41913,-0.0430022712423849,0.0106562264508501,-0.0638884750860512,-0.0221160673987186,5.48111089722788e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP2,Caspase-2,42119,-0.0257039905737877,0.00636995827708316,-0.0381891087968707,-0.0132188723507047,5.48584480047145e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.0144762221762952,0.00358928827222079,0.00744121716274247,0.021511227189848,5.53348398899238e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,39638,-0.0118179085406045,0.00293048789550742,-0.017561664815799,-0.00607415226540993,5.55001580418454e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.0187217313464329,0.00464935682245103,-0.0278344707184369,-0.00960899197442887,5.68656496054838e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0180812664585625,0.00450085199579617,-0.026902936370323,-0.00925959654680202,5.92492397228794e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0169025905041243,0.00421434575203675,-0.0251627081781164,-0.00864247283013232,6.09210211160941e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.0235279726274883,0.00586865074187028,-0.0350305280815541,-0.0120254171734226,6.13428225133014e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0273449523276217,0.00682453795005489,-0.0407210467097293,-0.0139688579455141,6.18616015380513e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.00915053096150484,0.00228592132112343,0.00467012517210291,0.0136309367509068,6.28749607691197e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0334019230565979,0.00834835272561397,-0.0497646943988013,-0.0170391517143945,6.34068670624138e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0129637539993996,0.00324047287114429,-0.0193150808268425,-0.00661242717195682,6.35247770935297e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.0162285905404181,0.00406429993285062,-0.0241946184088053,-0.00826256267203088,6.56761598308847e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.0109193248296271,0.00273562176957242,-0.016281143497989,-0.00555750616126514,6.60611993848867e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0323343905117861,0.00810883641405814,-0.0482277098833401,-0.0164410711402321,6.71933992156184e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0119356501311073,0.00299464357206764,-0.0178051515323599,-0.00606614872985472,6.76439341094555e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RP2,Protein XRP2,42070,-0.015833552416981,0.00397455617253333,-0.0236236825151463,-0.00804342231881569,6.81993253119779e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.0149376606035486,0.00375334210221151,-0.0222942111238832,-0.00758111008321408,6.94056655672116e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,39960,-0.0139211565505279,0.00350936023671682,-0.0207995026144929,-0.00704281048656295,7.32715730589722e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,42181,-0.0226369047189546,0.0057222159068213,-0.0338524478963244,-0.0114213615415849,7.66126144290931e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELOB,Elongin-B,39575,-0.0145384266496539,0.00368337086492407,-0.021757833544905,-0.00731901975440269,7.96155436407463e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.0211916153696341,0.00539405394414749,-0.0317639611001632,-0.010619269639105,8.59214179537106e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0267677272477984,0.00682429257081499,-0.0401433406865958,-0.013392113809001,8.81807059926024e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0286581583198361,0.00730701468283394,-0.0429799070981906,-0.0143364095414816,8.83325486979029e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.0115574146067663,0.00295095777303909,-0.0173412918419229,-0.0057735373716097,9.03721329672148e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0332659136640955,0.00850169698953473,-0.0499292397635836,-0.0166025875646074,9.17574107865731e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0224904485431482,0.00575168421383791,-0.0337637496022705,-0.0112171474840259,9.27569318849367e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00993203204197025,0.00254157544578144,-0.0149135199157019,-0.00495054416823863,9.35813406594641e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK7,Kallikrein-7,39475,-0.0145453090503171,0.00373357443286373,-0.02186311493873,-0.00722750316190415,9.84560723469327e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.0106919577608164,0.00274552542460134,-0.0160731875930351,-0.0053107279285978,9.8947657443056e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.0235355375923585,0.00604973677207272,-0.035393021665621,-0.0116780535190959,0.000100690235412974
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0276075608727821,0.00710878077778183,-0.0415407711972345,-0.0136743505483297,0.000103427335256592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED8,Protein TMED8,39930,-0.0376024927296419,0.00971382535318857,-0.0566415904218915,-0.0185633950373923,0.000108985498943065
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0401323498669339,0.010392326787016,-0.0605013103694852,-0.0197633893643826,0.00011312316073765
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.0169347826077047,0.00438774124765893,-0.0255347554531162,-0.00833480976229323,0.000114120778124657
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.0226358758119797,0.00586656000624671,-0.0341343334242233,-0.0111374181997362,0.00011463721241324
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.0143138671920726,0.00373873588794943,-0.0216417895324535,-0.00698594485169172,0.000129614385236244
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0234210301604514,0.00614825466787239,-0.0354716093094813,-0.0113704510114215,0.000139931854903886
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.0133760250786543,0.00351387682433339,-0.0202632236543477,-0.00648882650296084,0.000141616735752192
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0217466913594678,0.00571665379803269,0.0105420499153237,0.0329513328036119,0.000142950441729603
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,39919,-0.0305100602068494,0.00802384701054749,-0.0462368003475225,-0.0147833200661763,0.000144040259561678
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.0144551371567534,0.00380195709841956,-0.0219069730696557,-0.00700330124385104,0.00014416290790563
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.0143749490933159,0.00378390518176021,-0.0217914032495659,-0.00695849493706588,0.000146058539223609
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,-0.0107942465751414,0.0028447836954708,-0.0163700226182641,-0.0052184705320186,0.000148790378088187
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.0140243616203949,0.00369751157048726,-0.0212714842985499,-0.00677723894223983,0.000149660582817597
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0183797160268383,0.00485236414485516,-0.0278903497507544,-0.00886908230292221,0.000152802493218016
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.017112874358608,0.00452051957923251,-0.0259730927339038,-0.00825265598331233,0.000154130637082548
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,42122,0.0230618051576011,0.00609901629325797,0.0111077332228155,0.0350158770923868,0.000156724637847962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0201865142494564,0.00534025281442108,0.00971961873319105,0.0306534097657217,0.000157467112802048
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.020588779813956,0.00545035095074733,-0.0312714676774208,-0.00990609195049123,0.000159211923744595
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIM,Vimentin,41900,-0.0403988219622901,0.0107014876244608,-0.0613737377062333,-0.019423906218347,0.000160660822088567
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.0128345009839864,0.00340445649649291,-0.0195072357171124,-0.00616176625086026,0.000164156366458058
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,-0.0129105238215761,0.0034345078170166,-0.0196421591429286,-0.00617888850022355,0.000171261003671518
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.025309889857709,0.00673314470458673,-0.038506853478699,-0.012112926236719,0.000171323133013057
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,42119,-0.0178336486695659,0.00474768915432326,-0.0271391194120395,-0.00852817792709228,0.000173181830817958
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.0133961190106899,0.0035664505185151,0.00640587599440033,0.0203863620269795,0.000173268991396037
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0244730949559469,0.00651806689121185,-0.0372485060627221,-0.0116976838491716,0.000174476504058407
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.00944374408671578,0.00251776766558929,-0.0143785687112708,-0.00450891946216076,0.000176976045864801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VNN1,Pantetheinase,39990,-0.0257822783224666,0.00687660014433572,-0.0392604146053646,-0.0123041420395686,0.000178222796144638
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,42137,-0.00858606035046982,0.00229266580696695,-0.013079685332125,-0.00409243536881461,0.000181133033597445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.0151852154124163,0.00405954221657055,-0.0231419181568946,-0.00722851266793804,0.000184339327607646
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,39649,-0.0229812792173705,0.00614856457693845,-0.0350324657881699,-0.0109300926465711,0.000186673218537982
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0431859534082145,0.011555895120007,-0.0658355078434282,-0.0205363989730009,0.000187065516845258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.0186745218741474,0.00499744918591997,-0.0284695222785505,-0.00887952146974421,0.000187148132743653
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.0258510807258654,0.00692060242684486,-0.0394154614824814,-0.0122866999692495,0.000188375741605732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MILR1,Allergin-1,41913,-0.0177978098777675,0.00477335955219772,-0.027153594600075,-0.00844202515545994,0.000193366982247113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.00647022605980904,0.00173533562617118,0.00306896823251353,0.00987148388710456,0.000193546951058668
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.0123150441070806,0.00330299799648196,-0.0187889201801853,-0.00584116803397601,0.000193604990143885
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.0113350071393646,0.00304245587279284,-0.0172982206500385,-0.00537179362869061,0.000195786834687022
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0145703849055414,0.00391209193071713,-0.022238085089747,-0.00690268472133583,0.000196530900106249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMNB2,Lamin-B2,39929,-0.0100041927438853,0.00269037380433015,-0.0152773254003724,-0.00473106008739815,0.000201364776608418
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0165860112971528,0.00446562481150927,-0.025338635927711,-0.00783338666659464,0.000204862986344384
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0107237804903767,0.00288807839289478,0.00506314684030291,0.0163844141404504,0.000205531378707682
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.0113222096069716,0.00305364137302161,-0.017307346698094,-0.00533707251584927,0.000209933218212858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.00283490775286531,0.000765268612675771,0.0013349812720208,0.00433483423370982,0.000212860102829459
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0199737765714286,0.00539225696025808,-0.0305426002135344,-0.00940495292932273,0.000212955619089551
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0202674152792244,0.00547249233573054,-0.0309935002572563,-0.00954133030119259,0.000213491820287379
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.00924624804790268,0.00249729717790701,0.00435154557920494,0.0141409505166004,0.000214335491293273
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0275921294031074,0.00745927412984423,-0.0422123066976021,-0.0129719521086127,0.000217294585209147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,-0.00840266940115103,0.00227406588426542,-0.0128598385343112,-0.00394550026799081,0.000220759115186284
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.0169933594985068,0.00460337564907369,-0.0260159757706912,-0.00797074322632234,0.000224009582028033
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEPR,Leptin receptor,42145,0.0108246514663851,0.00293290494511383,0.00507615777396201,0.0165731451588082,0.000224460785735228
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGT,Angiotensinogen,39990,-0.00754621534761434,0.0020456483770384,-0.0115556861666096,-0.00353674452861907,0.000226264237556311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.025922842082114,0.00703406901590505,-0.0397096173532879,-0.0121360668109401,0.000229322883439884
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.0125654605560504,0.00341025504165016,-0.0192495604376847,-0.00588136067441607,0.000230122302018161
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0194814466772976,0.00529201248625231,-0.0298537911503521,-0.00910910220424309,0.000232976243010849
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.0167265494752514,0.00454561085534629,-0.0256359467517302,-0.0078171521987727,0.000234579013285001
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.0250186262762403,0.00680912119512935,-0.0383645038186938,-0.0116727487337867,0.000239462663955498
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.0156649761763374,0.0042654858053596,-0.0240253283548423,-0.00730462399783264,0.000241302852762237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSR,Insulin receptor,39657,-0.00591478384817895,0.00161112100896966,-0.00907258102575949,-0.0027569866705984,0.000242529969758452
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0108626477596478,0.00295931880993038,-0.0166629126271113,-0.00506238289218423,0.00024286127416763
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL7,Interleukin-7,42119,-0.0220737761767951,0.00602071418831904,-0.0338743759859004,-0.0102731763676898,0.00024702309228293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.013359616634158,0.003647606944521,-0.0205089262454192,-0.00621030702289684,0.00025086498206386
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB6,Serpin B6,42216,-0.0199958250790325,0.00546242019939758,-0.0307021686698517,-0.00928948148821323,0.000252560888983686
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.0158576172756456,0.00433536281784225,-0.0243549283986164,-0.00736030615267477,0.000255642755895493
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0281888213715889,0.00770949853104975,-0.0432994384924464,-0.0130782042507314,0.000256776873232572
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0325339510844576,0.00889796185484791,-0.0499739563199595,-0.0150939458489557,0.000257003811204801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSC2,Desmocollin-2,41984,-0.0119562754915964,0.00327852670616998,-0.0183821878356896,-0.00553036314750324,0.000266488210023748
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,39649,-0.00946670988297992,0.0025966941164259,-0.0145562303511747,-0.00437718941478515,0.000267912530231908
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0301104162640676,0.00826426489899351,-0.0463083754660948,-0.0139124570620403,0.000270212135837388
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.0189722955871496,0.00520737133126196,-0.029178743396423,-0.00876584777787613,0.00027034040531775
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0145985266425514,0.004016171609363,-0.0224702229969029,-0.00672683028819994,0.000279320813240249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.0177852648868191,0.00489622932319772,-0.0273818743602867,-0.0081886554133516,0.000281993833507225
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD84,SLAM family member 5,42119,-0.0107438599122135,0.00297093471834236,-0.0165668919601645,-0.00492082786426245,0.000299904884458619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,42185,-0.0140247758906106,0.00387967165680977,-0.0216289323379577,-0.00642061944326343,0.000301504991274407
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.0136280242721331,0.00377691237188759,-0.0210307725210328,-0.00622527602323342,0.000309603460190886
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.0281513750416529,0.00780599651098537,-0.0434511282031842,-0.0128516218801215,0.000311611404871407
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10,Interleukin-10,41913,-0.0257780645716865,0.00717754185345108,-0.0398460466044507,-0.0117100825389224,0.00032997791771735
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP3,Caspase-3,42310,-0.0294626214052758,0.00820977592966588,-0.0455537822274209,-0.0133714605831306,0.000333458966861318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.0126404650529553,0.00353014036269755,-0.0195595401638425,-0.00572138994206808,0.000344116034385143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.0221410396963027,0.00618379958836249,-0.0342612868894932,-0.0100207925031123,0.00034438354011034
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,42020,-0.0233074519751771,0.00654590354371056,-0.0361374229208498,-0.0104774810295044,0.000371265036073977
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,39649,-0.0104831639455881,0.00295615540749006,-0.0162772285442686,-0.00468909934690758,0.000392424251836268
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0258438696114411,0.00728955686837303,-0.0401314010734523,-0.01155633814943,0.000393707795378757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.0189395958299626,0.00534807508033013,-0.0294218229874096,-0.00845736867251549,0.000399366241629487
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.0279580553748994,0.0079030144574775,-0.0434479637115553,-0.0124681470382435,0.000405356362275599
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,42015,-0.0194140765906962,0.0054976950162226,-0.0301895588224925,-0.00863859435889994,0.000414891035669304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,-0.0106036914731351,0.00300463360836612,-0.0164927733455327,-0.00471460960073747,0.000418330084856778
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSL,Cathepsin L1,42145,-0.00804128964343627,0.00228344902841273,-0.0125168497391252,-0.00356572954774731,0.000430435850303731
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.0134861744904355,0.00383165104034451,-0.0209962105295107,-0.00597613845136026,0.000433482491977742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.0171044642020303,0.00485970644626002,-0.0266294888366999,-0.00757943956736063,0.000433521320042349
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,-0.00727294043465304,0.00207182781081649,-0.0113337229438534,-0.00321215792545272,0.000448892486446939
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDC1,Syndecan-1,42145,-0.0132544587480096,0.00377737801686649,-0.0206581196610679,-0.0058507978349513,0.000451416491964327
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,42145,-0.0115604509608685,0.003297372330506,-0.0180233007286603,-0.00509760119307677,0.000456437634623703
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.0147088837778883,0.00419738858949817,-0.0229357654133047,-0.00648200214247188,0.000459306109226592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCN15,Lipocalin-15,39934,-0.0199606116047364,0.00569837141708113,-0.0311294195822154,-0.00879180362725741,0.000462060837093701
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.00780245150933499,0.00222950059049504,0.00343263035196472,0.0121722726667053,0.000467382281531422
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0389365576536146,0.0111475303912712,-0.0607857172205062,-0.017087398086723,0.000479432008779567
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,41839,-0.0114960435805328,0.00329334403871464,-0.0179509978964135,-0.00504108926465211,0.000483343351431557
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0391735018410559,0.0112638606403542,-0.0612506686961501,-0.0170963349859617,0.000507469544204451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.0413000394234888,0.0118779062815624,-0.064580735735351,-0.0180193431116266,0.000508903150730966
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.019896358698362,0.00573948822548817,-0.0311457556203188,-0.00864696177640519,0.000528772037808845
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST7,Cystatin-F,42148,-0.0303939499034917,0.00881094694712757,-0.0476634059198617,-0.0131244938871217,0.000563196102138074
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0153706459451517,0.00445571924364186,-0.0241038556626897,-0.00663743622761363,0.000563423876670011
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0223317040672179,0.00648155012361965,-0.0350355423095124,-0.0096278658249234,0.000572225910677482
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2,Complement C2,42199,-0.00726136723458737,0.00210788691241341,-0.0113928255829177,-0.00312990888625708,0.000573087339839974
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,39925,-0.0154830537702606,0.00450142060179291,-0.0243058381497747,-0.00666026939074645,0.000584689331043335
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00965935897448076,0.0028200076535827,-0.0151865739755028,-0.00413214397345867,0.000616308620751155
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.0072926909023254,0.00213144180976931,-0.0114703168494732,-0.00311506495517756,0.000624624608807121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN1,Contactin-1,42310,0.00851987941956442,0.00249125188225234,0.00363702573034983,0.013402733108779,0.000628222755567056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,39966,0.0159437093797211,0.00466521347719764,0.00679989096441367,0.0250875277950284,0.000634035414220626
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSD1,Tryptase delta,39934,-0.011733964573571,0.00343580759394122,-0.0184681474576958,-0.00499978168944623,0.00063959044911229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.0216003531604245,0.00632653920971338,-0.0340003700114628,-0.00920033630938633,0.000641847157534913
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.0161728787440773,0.00473875479728571,-0.0254608381467573,-0.00688491934139731,0.000645070047373595
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPO,Lactoperoxidase,41647,-0.0195990808586435,0.00574506120864027,-0.0308594008275785,-0.00833876088970859,0.000648105473687409
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A12,Protein S100-A12,41910,-0.0233452924964379,0.00685311200007112,-0.0367773920165773,-0.00991319297629852,0.000659902618559035
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.0150234061383363,0.00441592823475572,-0.0236786254784575,-0.00636818679821505,0.000670699356323641
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.0214895566087922,0.00631671883132702,-0.0338703255181931,-0.0091087876993912,0.00067083540371984
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,39638,-0.023498236743298,0.00691140168165589,-0.0370445840393436,-0.0099518894472525,0.000676433865412569
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0280645321709024,0.00826250437864253,-0.0442590407530418,-0.0118700235887631,0.000684660102247591
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,39930,-0.0208453705699271,0.00617064592174273,-0.0329398365765429,-0.00875090456331138,0.000732209153073492
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.0234726197474764,0.00695474512110982,-0.0371039201848516,-0.00984131931010113,0.000740114704102795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,-0.0113882636987934,0.00338253643532892,-0.0180180351120381,-0.00475849228554871,0.000763035714632133
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MATN3,Matrilin-3,41992,0.0103230217270151,0.0030748158955107,0.00429638257181413,0.0163496608822161,0.000789321537212687
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0113204774442592,0.0033720319708091,-0.017929660107045,-0.00471129478147332,0.000790044310126153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.0321929645726468,0.00959196542467995,-0.0509932168050195,-0.0133927123402741,0.000792758112452936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRTN,Neurturin,41913,-0.0155005144848637,0.00462500809079607,-0.024565530342824,-0.00643549862690338,0.000806112964797174
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,42189,-0.0141789209594654,0.00423939016082599,-0.0224881256746843,-0.00586971624424642,0.000826343208945372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.0229318155800208,0.00685982021270564,-0.0363770631969239,-0.00948656796311777,0.000831322299817478
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.0124304988341021,0.00372362080163616,-0.019728795605309,-0.00513220206289526,0.000845738315301717
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,42096,-0.0136576368906702,0.00409380293477962,-0.0216814906428382,-0.00563378313850214,0.000851693688031099
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,42137,-0.0236137243333692,0.00708527502943888,-0.0375008633910694,-0.00972658527566902,0.000862106931498627
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17C,Interleukin-17C,41913,-0.0220302326800322,0.00661625300092693,-0.034998088561849,-0.00906237679821546,0.000871712581008239
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0224498444030611,0.00674359963996347,-0.0356672996973895,-0.00923238910873266,0.000874220659649328
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.0101555563385917,0.0030534027677723,0.00417088691375799,0.0161402257634254,0.000883412815351672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPO,Myeloperoxidase,42137,-0.0139461704434074,0.00419414607993655,-0.0221666967600831,-0.00572564412673181,0.0008860542253423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.00904033115487464,0.00271930169013235,-0.0143701624675341,-0.00371049984221524,0.000888571376935745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.0173471173334228,0.00522130625793786,-0.027580877598981,-0.00711335706786455,0.000895385028442368
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BGLAP,Osteocalcin,39966,-0.0262214882864095,0.00789677909564624,-0.0416991753138761,-0.0107438012589429,0.000901298335798844
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.00842658604773813,0.00253859621391543,-0.0134022346270124,-0.00345093746846389,0.000904981382591745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0259246283197146,0.00781061310413645,-0.0412334300038221,-0.0106158266356072,0.000905870738239787
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0165862144366914,0.00499872100090926,-0.0263837075984736,-0.00678872127490927,0.000908783819984621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.0229349156359971,0.00693298371538974,-0.036523563718161,-0.00934626755383324,0.000941858954445158
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,42166,-0.0254268151133982,0.00768656413202637,-0.0404924808121699,-0.0103611494146265,0.000942241079756262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.0191688258037258,0.00580964280093188,-0.0305557256935523,-0.00778192591389933,0.000971104706883016
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.00642876887563584,0.00194881707399519,-0.0102484503406664,-0.00260908741060527,0.000973489051945128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIT,Vitrin,39958,-0.0119101864115738,0.00361181193693659,-0.0189893378079695,-0.00483103501517805,0.000978265114439873
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.0147416049136405,0.00448046161296589,-0.0235233096750536,-0.00595990015222733,0.00100377159455143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0155373234064352,0.00472534986005153,0.00627563768073418,0.0247990091321362,0.00101180881280128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DRAXIN,Draxin,42016,-0.0130214263042311,0.00396483474044512,-0.0207925023955036,-0.00525035021295871,0.00102523639327013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.0148683110780645,0.00452727937683741,-0.0237417786566658,-0.00599484349946313,0.00102597001556044
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.00972053582336658,0.00296061722866881,0.00391772605517572,0.0155233455915574,0.00102925480328758
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0234390967911807,0.00714472327989215,-0.0374427544197693,-0.00943543916259206,0.00103904004519504
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,39575,0.0106618924845272,0.00325283542248015,0.00428633505646614,0.0170374499125883,0.00104973482039236
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.0137465643720481,0.00420627334534709,-0.0219908601289284,-0.00550226861516778,0.00108591064894066
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0346421130061684,0.0106005860939707,-0.055419261750351,-0.0138649642619858,0.00108600820129662
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0299735489703497,0.00917295862787014,-0.0479525478809752,-0.0119945500597242,0.00108797345363635
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,41900,-0.0142380689926055,0.00436045995578356,-0.0227845705059412,-0.00569156747926971,0.00109637255534779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN2,Ataxin-2,39586,-0.0325565177929413,0.00997139193891342,-0.0521004459932115,-0.013012589592671,0.00109802170892061
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.00620792494105608,0.00190145879685589,0.00248106569921853,0.00993478418289363,0.00109803864666594
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0295632135707282,0.00906068200183133,-0.0473221502943176,-0.0118042768471388,0.0011059267565451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,-0.00879454347492937,0.0027022803234266,-0.0140910129088455,-0.00349807404101324,0.00113874126042765
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0127759126882486,0.00393471610999919,0.00506386911265016,0.020487956263847,0.00116922846080441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGN,Mimecan,42137,-0.0130667358945019,0.00403265988626824,-0.0209707492715877,-0.00516272251741617,0.00119722764955528
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.0141700313779612,0.00437330638050153,0.0055983508721782,0.0227417118837442,0.00119835915932545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.0298642010307712,0.00925858019446168,-0.0480110182119161,-0.0117173838496263,0.00126077883013182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.0178765549485066,0.00554235405807553,-0.0287395689023347,-0.00701354099467861,0.00126143241648935
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0215222696826719,0.00667748032476212,-0.0346101311192056,-0.00843440824613812,0.00127170209797558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.011966379385673,0.00371725773434374,-0.0192522045449868,-0.0046805542263593,0.00128884878939005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRGN,Neurogranin,39990,-0.0279543064293571,0.00868349265580409,-0.0449739520347331,-0.0109346608239811,0.001288880027062
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.0136788913069836,0.00425360461338863,-0.0220159563492253,-0.00534182626474189,0.00130430572012269
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,41900,0.0155698493548581,0.00484767805824919,0.00606840036068971,0.0250712983490265,0.00132212730886376
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.0103220831244399,0.00321385617646323,-0.0166212412303079,-0.00402292501857201,0.00132240310134292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.0132199766618206,0.00412218597127153,-0.0212994611655128,-0.00514049215812837,0.00134485673752261
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0120843005814605,0.00377636220644134,0.00468263065683546,0.0194859705060855,0.00137757258277578
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RETN,Resistin,42105,-0.0127896053495981,0.00400068076392639,-0.0206309396468939,-0.0049482710523024,0.00139253669075704
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.00989474918568533,0.00310397049584346,-0.0159785313575385,-0.00381096701383215,0.00143770071970872
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOC,Brother of CDO,41900,0.00690569985093274,0.00216685604208452,0.00265866200844709,0.0111527376934184,0.00144105358806623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.0254568330126484,0.00800768890847197,-0.0411519032732534,-0.00976176275204332,0.00148156577572835
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,39736,-0.0103286826851911,0.00325545554240815,-0.016709375548311,-0.0039479898220711,0.00151422966074516
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.00568533313159101,0.00179424347065909,0.0021686159290992,0.00920205033408282,0.00153485937158707
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0181678404955436,0.00573521087901093,-0.029408853818405,-0.00692682717268215,0.00153956305517217
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.0104045485526654,0.00328545148149319,-0.0168440334563921,-0.00396506364893874,0.00154435148969741
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.0177332515157779,0.00560058819672649,-0.0287104043813618,-0.00675609865019398,0.0015479744129892
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,41900,-0.013163715081585,0.00415998286430218,-0.0213172814956173,-0.00501014866755277,0.00155770424521722
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FZD8,Frizzled-8,39586,-0.0128196613743262,0.00405110345447597,-0.0207598241450991,-0.0048794986035533,0.00155780735498265
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,42249,-0.0088765569094086,0.00280605716550039,-0.0143764289537894,-0.00337668486502784,0.00156303557312605
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.00925532659878983,0.00292901410821707,0.00351445894668437,0.0149961942508953,0.0015826456412356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.00873158845086651,0.00276505460591671,-0.0141510954784633,-0.00331208142326976,0.00159298336960762
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.0351287883728301,0.0111948682547835,-0.0570707301522057,-0.0131868465934545,0.00170507160345504
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.0211280030509686,0.00673671442415132,-0.0343319633223051,-0.00792404277963196,0.00171563109112346
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0282499630455334,0.00906810238025009,-0.0460234437108236,-0.0104764823802432,0.00184209563592231
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,42129,-0.0276788562490314,0.00890035298436914,-0.0451235480983949,-0.0102341643996679,0.00187564528325128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,-0.00951494471748813,0.00306533074817095,-0.0155229929839032,-0.00350689645107307,0.00191375580899744
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD70,CD70 antigen,42119,0.0127909195608577,0.00412186042399326,0.00471207312983088,0.0208697659918845,0.00191840988460285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.0167048415311397,0.00539316577550152,-0.0272754464511227,-0.00613423661115672,0.00195709996997461
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.033881864557994,0.0109540977733545,-0.0553518961937689,-0.0124118329222191,0.00198501342974027
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,39638,-0.00866613859328829,0.00280391957302483,-0.014161820956417,-0.00317045623015962,0.00200166879438688
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,39929,-0.0141148772107366,0.00458603320579442,-0.0231035022940937,-0.00512625212737952,0.00209035285640637
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,41814,-0.026293448384142,0.00855216232450715,-0.043055686540176,-0.00953121022810802,0.00211300201270438
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.0205444301582013,0.00668233104890723,-0.0336417990140595,-0.00744706130234317,0.00211326819205802
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP1,Caspase-1,41839,-0.019731595606221,0.00642444830863409,-0.0323235142911439,-0.0071396769212982,0.00213540214428941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.0176802324895709,0.00575766156802902,0.00639521581623404,0.0289652491629078,0.00214040914080682
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.0175205497422918,0.00570669336173172,0.00633543075329762,0.028705668731286,0.00214436678133311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,0.0100965840768757,0.00329395502390238,0.003640432230027,0.0165527359237243,0.00217960357479928
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.00833550954530354,0.00271949492765104,-0.0136657196034996,-0.00300529948710749,0.00218120851126372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,39966,0.00733343379435218,0.00239358070525674,0.00264201561204898,0.0120248519766554,0.00219062335729415
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,39929,-0.00793226147226669,0.00258905112963064,-0.0130068016863427,-0.00285772125819064,0.00219079005989172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.0138075798175009,0.00450812103293168,-0.022643497042047,-0.00497166259295483,0.00219699981879242
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,41913,-0.0174603306963736,0.00572071482491957,-0.028672931753216,-0.00624772963953126,0.00227676071088417
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGMB,RGM domain family member B,42249,-0.00795123868204455,0.00261567061391166,-0.0130779530853114,-0.00282452427877769,0.00237146623700719
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,39575,-0.0160510514092947,0.00528154400264129,-0.0264028776544716,-0.00569922516411775,0.00237857877355275
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,39919,-0.0113672417263296,0.0037514193187523,-0.0187200235910841,-0.00401445986157511,0.00245010415218559
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0150280389165596,0.00495985568978918,0.00530672176457279,0.0247493560685464,0.00245063977661807
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.013255506740149,0.00437829257209621,-0.0218369601814576,-0.00467405329884044,0.00247018649501748
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,41839,-0.0186339963040436,0.00615626720055637,-0.0307002800171341,-0.00656771259095316,0.00247605049380247
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.0161318728573127,0.00533524479176584,-0.0265889526491737,-0.00567479306545161,0.00250329162034915
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0264037725911349,0.00875345890166712,-0.0435605520384024,-0.00924699314386731,0.00256288330996711
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,41654,0.0088448886949363,0.00294260134762402,0.00307739005359321,0.0146123873362794,0.00265381381173241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0177635246406073,0.00591600363143451,-0.0293588917582189,-0.00616815752299563,0.002682671735141
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,39575,0.00876596409939975,0.00292460945001306,0.00303372957737416,0.0144981986214253,0.00272982137832633
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.0286433393878043,0.00957462949109636,-0.0474096131903531,-0.00987706558525542,0.00278148188850732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.01617957484361,0.00541097022896305,-0.0267850764923775,-0.00557407319484241,0.0027946194453508
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.00774767315667498,0.00259350795069943,-0.0128309487400459,-0.00266439757330409,0.00281932421449386
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TF,Serotransferrin,39979,-0.00599155044930775,0.00201008164073451,-0.00993131046514739,-0.00205179043346811,0.00288151735684124
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GKN1,Gastrokine-1,41538,-0.00788203101361837,0.00264468540431359,-0.013065614406073,-0.00269844762116374,0.00288474782556123
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,41714,-0.00730951642368276,0.00246197139501411,-0.0121349803579104,-0.00248405248945512,0.00299341289140528
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBLN2,Fibulin-2,39966,0.00893264232763073,0.00301292244740014,0.00302731433072646,0.014837970324535,0.00303531579431674
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.0264779552531387,0.00894254581017533,-0.0440053450410824,-0.00895056546519509,0.00307276137011948
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.0157274329581649,0.00533596480988195,-0.0261859239855336,-0.00526894193079631,0.0032097345298095
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.0128241948009872,0.0043510158276896,-0.0213521858232588,-0.00429620377871554,0.00321014714576532
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBD,Thrombomodulin,42145,-0.00812967646553085,0.00275845468423551,-0.0135362476466325,-0.00272310528442925,0.00321227878237913
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.0165518738578562,0.00561661646179672,-0.0275604421229777,-0.00554330559273458,0.00321468692369234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.0343800504712641,0.0116710449754294,-0.0572552986231057,-0.0115048023194226,0.00322843130340632
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.0169270483018714,0.00575596283596145,-0.0282087354603559,-0.005645361143387,0.00328061350042511
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.0117504200787781,0.00399724229159644,-0.0195850149703072,-0.00391582518724913,0.00329287590057776
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO1,Alpha-enolase,42119,0.0215391088539114,0.0073387616744585,0.00715513597197272,0.03592308173585,0.00334131824642294
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.0104282729473398,0.00355773377788483,-0.0174014311519941,-0.00345511474268557,0.00338290257791674
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.0170810492367218,0.00582875469629822,-0.0285054084414663,-0.00565669003197725,0.00339024775320513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00603742036234198,0.00206275070823873,0.00199442897419408,0.0100804117504899,0.00343061114860991
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA3,Annexin A3,42224,-0.0189693538792476,0.00648358368367186,-0.0316771778992445,-0.00626152985925079,0.00344192550881792
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.0124666876659968,0.00426280188087216,-0.0208217793525063,-0.00411159597948741,0.00345683007613434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-0.00675735220132514,0.0023118609776653,-0.0112885997175491,-0.00222610468510116,0.00347479031379042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.0192281480647607,0.0065878182097254,-0.0321402717558224,-0.00631602437369889,0.00352149388915666
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFB,Complement factor B,39794,0.0089355134145371,0.0030736419858636,0.00291117512224446,0.0149598517068298,0.00365463610361423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0170327490776292,0.0058663168166368,-0.0285307300382373,-0.00553476811702104,0.00369767918719155
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,39919,-0.00938395452722613,0.00323209174182682,-0.0157188543412067,-0.00304905471324557,0.00369884762593756
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.0164806163000318,0.00568077961790565,-0.0276149443511269,-0.00534628824893672,0.00372442532876643
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,-0.0124907807058827,0.00430778729079386,-0.0209340437958387,-0.00404751761592674,0.00374258267379479
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGN,Cingulin,39649,-0.0101993733905927,0.00351775416329742,-0.0170941715506556,-0.00330457523052971,0.00374614919418425
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.00986430462174079,0.00340718029271933,0.00318623124801092,0.0165423779954707,0.00379586400534682
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.0267868148651822,0.00926180369885654,-0.0449399501149411,-0.0086336796154234,0.0038318736244283
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0173526269221145,0.0060115489507304,-0.029135262865546,-0.00556999097868286,0.00390248391104519
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.0115092563995193,0.00400273436633362,-0.0193546157575332,-0.0036638970415054,0.00404211915938546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.0325936260499272,0.0113384848990351,-0.054817056452036,-0.0103701956478184,0.00405168767898962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.01322861309085,0.00460463765618276,-0.0222537028969682,-0.00420352328473181,0.00407368867620285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.0236108320180217,0.00823111734116421,-0.0397438220067036,-0.00747784202933989,0.00413078852290093
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0227370075813157,0.00793872035032757,-0.0382968994679578,-0.00717711569467372,0.00418886601494389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.0150291332871327,0.00524837870922109,-0.0253159555572061,-0.0047423110170594,0.00419681407803687
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,41900,-0.0374224294797799,0.0130724144753944,-0.063044361851553,-0.0118004971080069,0.00420701304914103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.030406125122298,0.0106228648580908,-0.0512269402441561,-0.00958531000043994,0.00421325497272312
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,39759,-0.00656784425165211,0.00229612868328704,-0.0110682564708947,-0.00206743203240951,0.00423893753944883
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNXB,Tenascin-X,42137,0.00696762056954814,0.00243787473546048,0.0021893860880456,0.0117458550510507,0.00426874491066288
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.00689614608822054,0.00241316250581785,0.00216634757681755,0.0116259445996235,0.00427472140493522
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.00900632296357132,0.00315165611187464,-0.0151835689428456,-0.00282907698429702,0.00427569633191271
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0172079795685793,0.00603074067759551,-0.0290282312966665,-0.00538772784049209,0.00433353497920041
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,39958,-0.0192954670494512,0.00676785820574093,-0.0325604691327034,-0.00603046496619896,0.00436543690096475
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL19,Interleukin-19,41756,-0.0195369559081611,0.00685862530775752,-0.0329798615113659,-0.0060940503049564,0.00439907230491567
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RSPO3,R-spondin-3,42262,-0.00747303093310276,0.0026247176111894,-0.012617477451034,-0.00232858441517154,0.00441748434232943
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.00984923399391739,0.00346233913531418,-0.0166354186991332,-0.00306304928870159,0.00445360067488514
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,-0.00657462345988334,0.00231275471314687,-0.0111076226976512,-0.00204162422211548,0.00448036753118509
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,42137,-0.0322688081244495,0.0113613296225802,-0.0545370141847067,-0.0100006020641922,0.00451480213519786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.0124791590933205,0.00439801285461976,0.00385905389826581,0.0210992642883753,0.0045558387180235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN3,CCN family member 3,42299,-0.0089815221127805,0.00316931521037907,-0.0151933799251235,-0.00276966430043752,0.00460509602686565
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.0121634169929861,0.00429881075345008,-0.0205890860697482,-0.00373774791622394,0.0046705036101462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-0.00892658982957844,0.00315733084595895,-0.015114958287658,-0.00273822137149888,0.00470175978646791
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSTN,Osteocrin,39649,-0.0107498769398051,0.00380282679145994,-0.0182034174510666,-0.00329633642854361,0.00470983595453752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES2,Cocaine esterase,42070,-0.0146769411023394,0.00519616945233863,-0.0248614332289231,-0.00449244897575564,0.00474137588636629
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00725818299343706,0.00257017040208282,-0.0122957169815194,-0.00222064900535472,0.0047497654265763
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.00699119719593948,0.00248029476878747,-0.0118525749427629,-0.00212981944911605,0.00483023083833461
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.0128682658044596,0.0045730068606985,-0.0218313592514286,-0.0039051723574905,0.0049007235510146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.0198198166548788,0.00704504553470697,-0.0336281059029044,-0.00601152740685311,0.00491219979885656
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.0172249106738375,0.00612700840269955,-0.0292338471431286,-0.00521597420454636,0.00494252768392508
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRNN,Cornulin,41749,0.0176920943004759,0.00629467462980066,0.0053545320260666,0.0300296565748852,0.00495154415642419
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.0187284283007971,0.00667559987557335,-0.0318126040569208,-0.00564425254467328,0.00503232416348113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,42137,-0.010919298968895,0.00389431080155914,-0.0185521481399509,-0.00328644979783911,0.00505587961104578
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,39575,-0.0102278178117349,0.00365522996888309,-0.0173920685507458,-0.00306356707272406,0.00514886191757526
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.00536710379936768,0.00191887208062694,-0.00912809307739647,-0.00160611452133888,0.00516671005021988
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRN,Progranulin,42077,-0.00654921573424003,0.00234185977554249,-0.0111392608943033,-0.00195917057417675,0.0051718589480635
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEO1,Neogenin,39934,-0.00591409644044209,0.00212303997495189,-0.0100752547913478,-0.00175293808953639,0.00535053508200223
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,42137,0.0081848924116511,0.00294509561483897,0.00241250500656671,0.0139572798167355,0.00545747958455695
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00813531555003769,0.00292938854772988,-0.0138769171035883,-0.00239371399648712,0.00549170260199383
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.0122336457425363,0.00440593174682955,-0.0208692719663222,-0.00359801951875043,0.00550156993210488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.0311793444003802,0.0112353040243338,-0.0532005402880745,-0.00915814851268586,0.00552563518283845
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.0146217674717677,0.00527090670728282,-0.024952744618042,-0.0042907903254934,0.00554545280486583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.0217018485188829,0.00782606246258724,-0.0370409309455539,-0.00636276609221193,0.00556155823412266
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.0213830210199314,0.00771732500565012,-0.0365089780310056,-0.00625706400885718,0.00559983244303179
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,-0.0102659404052312,0.00371109439242889,-0.0175396854143918,-0.00299219539607057,0.00567761272373435
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A11,Protein S100-A11,42027,-0.0118867886340301,0.00431758131532759,-0.0203492480120722,-0.00342432925598803,0.00591108718032404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MELTF,Melanotransferrin,39958,-0.00777910585117838,0.00282642986707378,-0.013318908390643,-0.00223930331171377,0.00592771326565053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.0124582667103638,0.00452963864649538,-0.0213363584574948,-0.00358017496323289,0.00596220431553756
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00872851559363956,0.00317413973048147,-0.0149498294653832,-0.00250720172189589,0.00597134425086309
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0276289850406515,0.0100534784132178,-0.0473338027305584,-0.00792416735074458,0.00600179940067234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.0090793421131923,0.00330834794880648,0.0025949801335316,0.015563704092853,0.00607064250765398
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00722272927234945,0.00263174500525674,-0.0123809494826527,-0.00206450906204624,0.00607076141653516
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.0274021994540999,0.00999492692817817,-0.0469922562333291,-0.00781214267487069,0.00612370264301116
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,41839,-0.0127959303207261,0.00466864560378571,-0.0219464757041461,-0.00364538493730615,0.00613677437911741
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0223349031114842,0.00815613898323156,-0.038320935518618,-0.00634887070435033,0.00618165642329003
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,42287,-0.0149728035091695,0.00548336668882059,-0.0257202022192579,-0.00422540479908115,0.00633027833269696
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.0114414414964065,0.00420147668032641,-0.0196763357898462,-0.00320654720296671,0.00647543678519831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.0244918620309772,0.00901153967649776,-0.0421544797969128,-0.00682924426504157,0.00658126035754573
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.0222940462784779,0.00820370921246418,-0.0383733163349077,-0.00621477622204809,0.00658673649383785
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,39649,-0.0157258567004822,0.00578913690093876,-0.0270725650263221,-0.0043791483746422,0.00660903829363654
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0072978827980693,0.00269118841065039,-0.0125726120829441,-0.00202315351319454,0.00670103488925119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.00665825954786541,0.0024554128158127,0.00184565042887251,0.0114708686668583,0.00670494617329447
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0197134231801375,0.00727447847548559,-0.0339714009920893,-0.00545544536818577,0.00673986790787289
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.0179810866084916,0.00663630605354071,-0.0309882464734314,-0.0049739267435518,0.00674871422575181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0145577356845127,0.00540028057748711,-0.0251422856163875,-0.003973185752638,0.00703199602013287
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,39990,-0.00577610202394372,0.0021428528942379,-0.00997609369665001,-0.00157611035123744,0.00703821368587231
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWF,von Willebrand factor,42310,0.0186156485214123,0.00690817412129279,0.00507562724367844,0.0321556697991462,0.00705320082813344
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0195066193151398,0.0072429974200686,-0.0337028942584742,-0.0053103443718053,0.00708801859687079
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0100405323007981,0.00372845512615108,-0.0173483043480542,-0.00273276025354201,0.00709278051853197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.010092949520064,0.00375154853705986,-0.0174459846527014,-0.00273991438742672,0.00714682982159216
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.0076423032526492,0.00285586449151898,0.002044808849272,0.0132397976560264,0.00746130352669568
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,39934,-0.017415815681665,0.00650916416809222,-0.0301737774511258,-0.00465785391220429,0.00747063651610297
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRN1,Secernin-1,42119,-0.0137680984762779,0.0051620167371452,-0.0238856512810825,-0.00365054567147328,0.00765786863124931
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.0318735642155239,0.0119923105866139,0.00836863546576059,0.0553784929652871,0.0078736375482846
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,39649,-0.0144466049361646,0.00543744896721745,-0.0251040049119108,-0.00378920496041841,0.00789827966889719
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.0164718954119064,0.00621805200561611,-0.0286592773429139,-0.0042845134808988,0.00808156978518786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.0152273409693366,0.00574872597541031,-0.0264948438811408,-0.00395983805753237,0.00808849656019944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.00776052724633615,0.00293031652663803,-0.0135039476385467,-0.0020171068541256,0.00809793018366367
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,-0.00657783983753789,0.00248394184152577,-0.0114463658469284,-0.00170931382814738,0.0081046179699944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.0109487025526942,0.00413801209875728,-0.0190592062662585,-0.00283819883912995,0.00815717879768229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLC,Galectin-10,42119,0.0165740911449106,0.00626930789983016,0.00428624766124351,0.0288619346285777,0.00821029658385619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTC,Probetacellulin,41843,-0.0181031130564493,0.00685332281853896,-0.0315356257807857,-0.00467060033211294,0.00826345984762267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CX3CL1,Fractalkine,42016,0.00817687403411833,0.00311578698496464,0.00206993154358763,0.014283816524649,0.00869162719554503
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.0123077988520281,0.00469011010706898,-0.0215004146618833,-0.00311518304217286,0.00869518073372031
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.0192275379415955,0.00733182578016504,-0.033597916470719,-0.004857159412472,0.00874101519742744
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.00823341509648424,0.0031430717814985,-0.0143938357882213,-0.00207299440474718,0.00881647467519881
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0121046217544803,0.00462150076587163,0.00304648025337194,0.0211627632555887,0.00882566893331535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',39575,-0.0105818305079486,0.0040420826954302,-0.0185043125909918,-0.00265934842490538,0.00885901894232621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.0265932749936635,0.010170205722861,-0.046526878210471,-0.00665967177685598,0.0089373385813519
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,-0.012726703316286,0.00487394578041364,-0.0222796370458967,-0.00317376958667528,0.00903558093570899
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH6,Cadherin-6,42145,-0.00947233428528055,0.00363306106541093,-0.016593133973486,-0.00235153459707513,0.00913701188676198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0100547798782787,0.00385715478113056,-0.0176148032492947,-0.00249475650726284,0.00914987101404577
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0166763035108325,0.0063993607349195,-0.0292190505512747,-0.00413355647039028,0.00917241365370474
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.018324086127684,0.00703358128708327,-0.0321099054503672,-0.00453826680500082,0.00919327193583932
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,39959,0.0035307092013341,0.00135679219615692,0.000871396496866534,0.00619002190580167,0.00927352119695703
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.0123459727968278,0.00474703252582477,-0.0216501565474444,-0.00304178904621124,0.00931368077305329
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,-0.0128283707047983,0.00493283200781354,-0.0224967214401128,-0.00316001996948374,0.00931812292383467
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CORO6,Coronin-6,39586,-0.00954701264716174,0.00367351123417264,-0.0167470946661401,-0.00234693062818336,0.00936536053832331
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0144392351558504,0.00555944218606492,-0.0253357418405377,-0.00354272847116318,0.00941002012530736
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.00928646085267827,0.00357925319863495,-0.0163017971220028,-0.00227112458335377,0.00948468162971585
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC2,Mucin-2,39966,-0.022542662863161,0.00869951816639674,-0.0395937184692986,-0.00549160725702341,0.0095749054113246
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.00663521927490336,0.00256407747558636,-0.0116608111270526,-0.00160962742275409,0.00967038919085459
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.0111592972895023,0.00432108201808352,-0.019628618044946,-0.00268997653405858,0.00981868919920211
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.0130685617137295,0.00507282757877075,-0.0230113037681202,-0.00312581965933888,0.0100024725510288
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.012688478209696,0.00494390175963317,0.00299843076081501,0.0223785256585771,0.0102839920759033
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.0134473756565972,0.0052414753383154,-0.0237206673196954,-0.00317408399349902,0.0103114813972615
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.0121789061925369,0.00474892816012229,0.00287100699869718,0.0214868053863765,0.0103436939263725
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,-0.00758470836628435,0.00296191765892969,-0.0133900669777865,-0.00177934975478216,0.0104580547346416
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS1,Galectin-1,42145,-0.00836122304419577,0.00326676478667468,-0.0147640820260781,-0.00195836406231339,0.0104936129818593
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,42113,-0.00570241166643259,0.00223811008534623,-0.0100891074337112,-0.00131571589915397,0.0108492842690075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,-0.0140317213522964,0.00551074384431437,-0.0248327792871526,-0.00323066341744023,0.010902218149143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.0104326133090509,0.00409820368018017,-0.018465092522204,-0.00240013409589777,0.0109208620602949
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.00705608288251942,0.00277749321474725,-0.012499969583424,-0.00161219618161482,0.0110845474876708
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,-0.0056847550869277,0.0022435734581769,-0.0100821590649544,-0.00128735110890098,0.0112948242501924
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLG,Plasminogen,39742,-0.00519010279523644,0.00205152138107658,-0.00921108470214654,-0.00116912088832633,0.0114238196657984
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.0112619049125556,0.00446536297964155,-0.020014016352653,-0.00250979347245816,0.0116809784923795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,39575,-0.0141266268484933,0.00563750183085225,-0.0251761304369637,-0.00307712326002291,0.0122307576730598
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.0177510505268704,0.00709360944512771,-0.0316545250393207,-0.00384757601442012,0.0123498493624198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL5,Interleukin-5,41913,-0.0322507078885596,0.0128958841447648,-0.0575266408122986,-0.00697477496482068,0.0124013862626922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.0146395676776645,0.00585919598830013,-0.0261235918147328,-0.00315554354059629,0.0124838787766676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0311394199497864,0.0124864568638061,-0.0556128754028464,-0.0066659644967264,0.0126482925128555
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,42115,-0.0204650804175599,0.00821413863979869,-0.0365647921515653,-0.00436536868355444,0.0127343389192336
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.0189289842330122,0.00760959538975983,-0.0338437911969414,-0.00401417726908293,0.0128785293296025
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM3,Myomesin-3,39736,0.0226928826760341,0.00912354026282322,0.00481074376090063,0.0405750215911677,0.012886597280891
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0090806491800872,0.00365839812105401,-0.0162511094973531,-0.00191018886282134,0.0130720572668967
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,42310,-0.00637122673408282,0.00256750297362594,-0.0114035325623897,-0.00133892090577599,0.0130954192656379
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.00517337464637966,0.00208687052264405,-0.00926364087076198,-0.00108310842199733,0.0131867332786149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,39649,-0.00934686786061406,0.00377424374059643,-0.0167443855921831,-0.00194935012904505,0.0132830821546041
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0297383280246855,0.012014244018904,-0.0532862463017374,-0.00619040974763364,0.0133285851746517
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC16,Mucin-16,42070,-0.0440617640709625,0.0178240390263646,-0.0789968805626371,-0.00912664757928798,0.0134466549341172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALB2,Calretinin,41839,-0.00677717828843294,0.00274257807781928,-0.0121526313209587,-0.00140172525590715,0.0134823954555613
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.0149769237767797,0.00606470718047946,-0.0268637498505194,-0.00309009770303994,0.0135443861258862
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.0136021619361485,0.00551497507964442,-0.0244115130922516,-0.00279281078004547,0.0136599902401814
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.00923010344104846,0.00374323785260428,-0.0165668496321528,-0.00189335724994408,0.0136852019140904
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENG,Endoglin,42310,-0.00396971151429157,0.00161220414264305,-0.00712963163387194,-0.000809791394711187,0.0138175713261335
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK8,Kallikrein-8,41668,-0.00843387450568923,0.0034254326246338,-0.0151477224499715,-0.00172002656140699,0.013824113426874
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,42070,-0.0195626478094347,0.00794711399065071,-0.0351389912311101,-0.00398630438775929,0.0138441665982967
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX6,Syntaxin-6,41843,-0.0150824349403341,0.00612851901171522,-0.0270943322032959,-0.00307053767737226,0.0138667554988193
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0180595985575758,0.00733864510859728,-0.0324433429704265,-0.00367585414472515,0.0138719482371729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.0102272301885309,0.00415836505509055,0.0020768346805534,0.0183776256965083,0.0139280042552583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,42262,-0.00725452397484597,0.00296468158089482,-0.0130652998733998,-0.00144374807629211,0.0144182908233317
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.0123607205439889,0.00506671210996569,-0.0222914762795216,-0.00242996480845614,0.0147190228669054
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.00685106357350668,0.00281398705647107,0.00133564894282338,0.01236647820419,0.0149219460018977
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,42016,0.00275550406762557,0.00113573713805698,0.000529459277033895,0.00498154885821724,0.0152717433413109
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.00778155707366094,0.00321023895240238,0.00148948872695228,0.0140736254203696,0.015366922913709
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.0104841048034852,0.00433583174342685,-0.0189823350206018,-0.00198587458636858,0.0156211320624437
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.0253855362130618,0.0105089149953283,0.00478806282221825,0.0459830096039053,0.015721756470007
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0124680655470675,0.00516630056757981,-0.022594014659524,-0.00234211643461111,0.0158231086270961
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.0092265070647072,0.00382744985849219,-0.0167283087873519,-0.0017247053420625,0.0159418717216811
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00854564757464863,0.00354742916497266,-0.015498608737995,-0.00159268641130222,0.0160140372938198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.0128774896798022,0.00535035432720194,-0.023364184161118,-0.00239079519848637,0.0161067983917642
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.0142278353722954,0.00591673049373374,-0.0258246271400135,-0.00263104360457728,0.0162030562631562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN9,Septin-9,42070,-0.00645288680351941,0.00268489079643455,-0.0117152727645311,-0.00119050084250768,0.0162565036984941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.0197073459115376,0.00820041397699193,-0.0357801573064418,-0.00363453451663341,0.0162681819697058
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.0184890527211996,0.00771291937093506,-0.0336063746882323,-0.0033717307541669,0.0165395928413028
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.00912694104875292,0.00381148103179712,-0.0165974438710753,-0.00165643822643057,0.0166554256115123
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_A,,39934,-0.00737085105321985,0.00308460303727191,-0.0134166730062728,-0.00132502910016691,0.0168847079265654
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0224128454470001,0.00940991106104399,-0.0408562711266463,-0.00396941976735387,0.0172430664183244
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,-0.0113598585407886,0.00479352272362468,-0.020755163079093,-0.00196455400248424,0.0178102667689411
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM3,Paralemmin-3,39575,-0.0168541831546523,0.00712420244633259,-0.0308176199494642,-0.00289074635984042,0.018010178613621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0104947049286242,0.00444396278638749,-0.0192048719899437,-0.00178453786730469,0.0182150884222812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0193378163600221,0.00822749494714796,-0.0354637064564321,-0.00321192626361213,0.0187711334543749
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP9,Caspase-9,39657,-0.0140716118817112,0.00600610678885784,-0.0258435811878726,-0.00229964257554983,0.0191529600217356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.01808201357895,0.00771916910646748,-0.0332115850276263,-0.00295244213027374,0.0191736184527069
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00748709154095616,0.00319647034947584,-0.0137521734259288,-0.00122200965598351,0.0191798011829043
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,-0.0114926463931983,0.00490947873079139,-0.0211152247055494,-0.00187006808084718,0.0192515748129187
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,41638,-0.00514550775092659,0.00220245819287994,-0.00946232580897126,-0.000828689692881915,0.0194929366358039
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00615353692519399,0.00263412671987648,-0.0113164252961519,-0.000990648554236083,0.0195042984582666
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWC2,Brorin,41973,-0.00889761162286072,0.0038129482187961,-0.0163709901317011,-0.00142423311402037,0.0196353261497846
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,42187,-0.00592912906636045,0.00254555140495843,-0.010918409820079,-0.000939848312641925,0.0198624160823239
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMI,N-myc-interactor,39875,0.0158971317382893,0.00684083820554593,0.00248908885541925,0.0293051746211593,0.0201508275789372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00971222690835865,0.00420337872015737,-0.0179508491998671,-0.00147360461685021,0.0208745857825344
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.00728213630461541,0.00315735864330091,-0.0134705592454852,-0.00109371336374563,0.0211066282432548
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0185162042279549,0.00805246576911523,-0.0342990371354207,-0.002733371320489,0.0214982275828015
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,39870,-0.00702662389491282,0.00305621433861522,-0.0130168039985987,-0.00103644379122699,0.0215159491410378
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.00608552066883839,0.00264722578837768,-0.0112740832140586,-0.000896958123618136,0.02153003773906
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,-0.0196249620893367,0.00854078143946089,-0.03636489371068,-0.00288503046799334,0.0215886743722177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,39649,-0.00482221387819032,0.00210142446358402,-0.00894100582681499,-0.000703421929565652,0.0217669297909084
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.0099030043085763,0.00431973026916329,-0.0183696756361363,-0.00143633298101625,0.0218919095567221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,-0.0109362941635579,0.0047751994357232,-0.0202956850575754,-0.0015769032695404,0.0220269979589576
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0123978860745554,0.00542494499935312,-0.0230307782732875,-0.00176499387582329,0.0223082357948112
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.00471529590369492,0.00206737340814097,-0.00876734778365122,-0.00066324402373861,0.0225783437321526
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0256922378291955,0.0112839748123944,-0.0478088284614885,-0.00357564719690251,0.0228120524244496
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00731410447010005,0.00322813047027825,-0.0136412401918454,-0.000986968748354685,0.0234829010537244
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNLY,Granulysin,42137,-0.0113764169128658,0.00503195357890875,-0.021239045927527,-0.00151378789820465,0.0237852829436691
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,0.00415652169191416,0.00184946796051683,0.000531564489301163,0.00778147889452716,0.0246326428035368
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.012611481737081,0.00563144862285662,0.00157384243628205,0.02364912103788,0.02514163865937
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.0241345070991863,0.0108123089288959,-0.0453266325998223,-0.00294238159855041,0.0256227712183343
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.00804857535042598,0.00361249500924053,-0.0151290655685374,-0.000968085132314546,0.0258980439553131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0119914063393717,0.00539685389798585,-0.022569239979424,-0.00141357269931942,0.0263047698473021
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.0055097876175571,0.00249098425600305,-0.0103921167593231,-0.000627458475791109,0.026990848744629
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANK2,Ankyrin-2,39575,0.0145166931567155,0.00656620330659799,0.00164693467578343,0.0273864516376476,0.0270688519184873
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0300952371074353,0.0136239907064901,0.00339221532271478,0.0567982588921559,0.0271952803594168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,39690,-0.0176892318272409,0.00801707828949471,-0.0334027052746506,-0.00197575837983131,0.0273733681068531
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,39966,0.0236658613900798,0.0107391916879239,0.00261704568174904,0.0447146770984106,0.0275660523382124
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHGB,Secretogranin-1,42210,-0.00868488725271966,0.00394383895496424,-0.0164148116044496,-0.000954962900989749,0.0276720996029112
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.0109628335806937,0.00497910811646949,0.00120378167241348,0.0207218854889739,0.0277022312998149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.0115490837974478,0.00525209591950013,-0.021843191799668,-0.00125497579522751,0.0279017857558672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.00638487408657198,0.00290777044753727,0.000685644009398934,0.012084104163745,0.0281233523657151
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.00571655044957915,0.00260681905535092,-0.0108259157980669,-0.000607185101091353,0.0283338031318327
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.00583770355524758,0.00266354825079514,0.000617148983689105,0.0110582581268061,0.0284180181976088
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.0133177570460653,0.00607726795535833,-0.0252292022385676,-0.00140631185356298,0.0284397425924608
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.0136415542758426,0.00623439503481084,-0.0258609685440719,-0.00142214000761336,0.028678865899986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,39575,-0.0097530599701441,0.00447125215020236,-0.0185167141845407,-0.00098940575574747,0.0291837458809736
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOSB,Protein fosB,41839,-0.00780171127047027,0.003587448248459,-0.0148331098374499,-0.000770312703490628,0.0296684183741609
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00562096280494889,0.00259069033866492,-0.0106987158687321,-0.000543209741165641,0.0300490065756536
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,39657,-0.00889854885754296,0.00412133462255757,-0.0169763647177558,-0.000820732997330119,0.0308605501154004
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.00919407732916303,0.00426065661863582,0.000843190356636828,0.0175449643016892,0.0309569542836168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.0186843602279728,0.00867360076981463,-0.0356846177368094,-0.00168410271913611,0.0312489969583834
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN2,Contactin-2,42262,-0.00885637216425747,0.00411175051322367,-0.0169154031701759,-0.00079734115833908,0.0312640627587907
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.00724731036483187,0.00337605537846516,-0.0138643789066236,-0.000630241823040152,0.0318368778460399
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00661175500847247,0.00308135314629512,-0.0126512071752109,-0.000572302841734033,0.0319163136856194
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,39560,0.00804357917659437,0.00375343237288124,0.000686851725747141,0.0154003066274416,0.0321356160948481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,39638,-0.0177776330064449,0.00830045658539683,-0.0340465279138227,-0.00150873809906715,0.0322341649594975
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALB1,Calbindin,42070,-0.00904889506785058,0.00422510002866377,-0.0173300911240316,-0.000767699011669598,0.0322355454327683
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,39586,0.00976144461918302,0.00455814333890983,0.000827483674919745,0.0186954055634463,0.0322524757913578
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,42249,-0.00452253095867731,0.002111973819431,-0.00866199964476207,-0.000383062272592562,0.0322613477055142
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.00664096872847154,0.00310925158448008,0.000546835622890592,0.0127351018340525,0.0327077235490089
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,-0.0111259341079016,0.00521237233955738,-0.021342183893434,-0.000909684322369118,0.0328218506514303
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0112748041596207,0.00528277386458748,0.000920567385029205,0.0216290409342121,0.0328396432489109
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,-0.0217495402973419,0.0102534273886861,-0.0418462579791668,-0.00165282261551709,0.0339232849676812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA11,Serpin A11,42310,0.00825906462612782,0.00389736692140216,0.000620225460179581,0.0158979037920761,0.0340965967970742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.0143958700871197,0.00679670145082853,0.00107433524349582,0.0277174049307437,0.034191094184185
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.00726619196194821,0.00343687658322741,-0.0140024700650739,-0.000529913858822493,0.0345219848380212
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.0042852487949861,0.00203006513583201,0.000306321128755364,0.00826417646121683,0.0347999888437416
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.0141717931271776,0.00672271111169132,-0.0273483069060926,-0.000995279348262644,0.0350454197356283
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,-0.00749128852924974,0.00356512276102431,-0.0144789291408574,-0.000503647917642102,0.0356356282706535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.00800292169006865,0.00382453569231869,-0.0154990116470133,-0.000506831733124014,0.0364105916704257
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00728210564940845,0.00349968003584019,-0.0141414785196552,-0.000422732779161684,0.0374757203802579
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.00605886252380966,0.00291897002264584,-0.0117800437681955,-0.000337681279423801,0.0379455994170356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH23,Cadherin-23,39929,-0.00520726419461495,0.00251112922553469,-0.010129077476663,-0.000285450912566958,0.038132108913466
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTN3,Myeloblastin,41800,0.0092909990966688,0.00449335428448296,0.000484024699082196,0.0180979734942554,0.0386857870906708
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.0123647102205348,0.0059812388563737,0.000641482062042377,0.0240879383790273,0.038729975679977
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00584710614089906,0.00282881767828316,-0.0113915887903341,-0.000302623491464057,0.0387587577531735
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.00834022797066914,0.00406575788781117,-0.016309113430779,-0.000371342510559241,0.0402539612682637
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00907378602842258,0.00442837981145705,-0.0177534104588784,-0.000394161597966765,0.040484330096204
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,39575,0.00649126494893897,0.00317168035519049,0.000274771452765607,0.0127077584451123,0.0407179250073347
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN4,Contactin-4,42137,0.00448450821973,0.00219208490438862,0.000188021807128304,0.0087809946323317,0.0407979887466641
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLPS,Colipase,42115,0.0140570561841533,0.00687807429498949,0.000576030565973884,0.0275380818023327,0.0409977135047408
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,42185,-0.00412610285347808,0.00201902732613832,-0.00808339641270919,-0.000168809294246969,0.0410114157015923
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,39560,-0.0136262669332167,0.00668717290257082,-0.0267331258222555,-0.00051940804417785,0.0416066828321964
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F3,Tissue factor,42174,0.00496937562865365,0.00244234438832954,0.000182380627527754,0.00975637062977955,0.0419030388610961
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.00800122753850722,0.00393439347054224,0.000289816336244427,0.01571263874077,0.0420093175657177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO2,Gamma-enolase,42249,-0.0123393403668216,0.00607476936459822,-0.0242458883214341,-0.000432792412209046,0.0422495604448254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.00992418912327103,0.00488572085947953,-0.0195002020078509,-0.000348176238691142,0.0422515340948388
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.0143226913335442,0.00705846937555699,-0.0281572913096359,-0.000488091357452489,0.0424671598372243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.00949210710027215,0.00468020753537205,-0.0186653138696014,-0.00031890033094294,0.0425661341058837
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,39586,-0.0108709692331289,0.00536229978555616,-0.021381076812819,-0.000360861653438857,0.0426562395150434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,42119,-0.011264125526965,0.00556708739922043,-0.022175616829437,-0.000352634224492927,0.0430574673902567
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.0031322491797053,0.00155064300280908,-0.0061715094652111,-9.29888941995074e-05,0.0434101000776023
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THPO,Thrombopoietin,41900,0.0073168209022758,0.00363354335670553,0.000195075923132958,0.0144385658814186,0.0440624531375318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,39958,-0.0186267848078358,0.00928994802206104,-0.0368350829310755,-0.000418486684596209,0.0449816796679103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,41843,0.0166152493364555,0.00830648598181828,0.000334536812091699,0.0328959618608194,0.0454910483570014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.0086419758843724,0.00432051556227039,0.000173765382322433,0.0171101863864224,0.0455004723278004
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.0157412925287187,0.00787095232367668,0.000314225974312458,0.031168359083125,0.045533261885394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMB,Granzyme B,42119,-0.0126384770533694,0.00632674982451092,-0.0250389067094108,-0.000238047397327983,0.0457772742657844
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,42296,-0.00744343417400855,0.00373635189246757,-0.014766683883245,-0.000120184464772122,0.0463726375240834
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXN,Thioredoxin,39854,-0.00805635195263977,0.00404750111838237,-0.0159894541446692,-0.000123249760610322,0.0465654432081938
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,39575,0.00835713116036554,0.00420063128461957,0.000123893842511177,0.0165903684782199,0.046671470091959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.0127363941773695,0.0064026176835963,-0.0252855248372182,-0.00018726351752075,0.0466943842427959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00644390750980757,0.00323992904429744,-0.0127941684366306,-9.36465829845775e-05,0.0467322457625922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0110249586008669,0.00555187935612631,-0.0219066421388744,-0.000143275062859284,0.047074708929837
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,39638,-0.00340974496169395,0.00171719366054852,-0.00677544453636904,-4.40453870188509e-05,0.0470969422241293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,39560,-0.0136068036574266,0.00686643180005109,-0.0270650099855267,-0.000148597329326443,0.0475443648051283
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,39649,-0.00911365180915153,0.0046372288262655,-0.0182026203086319,-2.46833096711457e-05,0.0494018929096112
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,-0.0120790633691934,0.00614635836353416,-0.0241259257617204,-3.22009766664834e-05,0.0494117594577392
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0141032673377612,0.00720615607168381,-2.07985627390956e-05,0.0282273332382614,0.0503592612779587
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.00803967239561534,0.00411601625925776,-2.77194725298701e-05,0.0161070642637605,0.0508127274634247
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.0120928812766578,0.00621778940345278,-0.0242797485074252,9.3985954109652e-05,0.0518135469277145
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,39934,-0.00958587765704455,0.00493017512082491,-0.0192490208938614,7.72655797722805e-05,0.0518806152454805
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00481831562541696,0.00248137261973042,-4.51747092546535e-05,0.00968180596008857,0.0521875429743602
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,41913,-0.00556748761213145,0.0028683935639301,-0.0111895389974344,5.45637731715412e-05,0.052282074671194
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLB,Beta-klotho,41839,0.0134993793332435,0.00696741451684508,-0.000156753119772904,0.0271555117862598,0.0527052542480618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.0066114158131531,0.00341399421601039,-0.0133028444765334,8.00128502272601e-05,0.0528241985272909
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.0125599574905324,0.0064974408907126,-0.0252949416363291,0.000175026655264284,0.0532540534601008
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.0144901067728995,0.0074969850308332,-0.000203983887533605,0.0291841974333325,0.0532876545645668
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,39649,-0.0127122471894722,0.00660299406901601,-0.0256541155647435,0.000229621185799226,0.0542268934834973
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.00964553204092261,0.00502143826490337,-0.0194875510401332,0.000196486958288,0.05477377998091
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00602997891874428,0.0031441863520006,-0.0121925841686654,0.0001326263311769,0.0551552666967987
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,-0.00697746112043963,0.00364379464615749,-0.0141192986269083,0.000164376386029047,0.0555325200998185
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_DRA,,42060,0.00647289222774869,0.00339309727859965,-0.000177578438306635,0.013123362893804,0.0564558138195905
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK13,Kallikrein-13,41839,-0.00798518128739899,0.00418836473040013,-0.0161943761589832,0.00022401358418526,0.0566050153885955
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.0177199306724506,0.0093032470391473,-0.0359542948691793,0.000514433524278088,0.0568438730631514
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.0113217200389554,0.00594619756484871,-0.000332827188148066,0.0229762672660589,0.0569328109732005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0138575820484697,0.00727930524842329,-0.0281250203353793,0.000409856238439971,0.0569757835102955
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,39929,-0.0175151780249609,0.00920066003225906,-0.0355484716881887,0.000518115638266883,0.0569762589008456
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,39560,0.00543336332072766,0.00285983946685307,-0.000171922034304351,0.0110386486757597,0.0574745624112179
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRXN3,Neurexin-3,39649,-0.00641963537228164,0.003380672426311,-0.0130457533278512,0.000206482583287915,0.057600673707547
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.014920728267038,0.00786623334975982,-0.0303385456325672,0.000497089098491272,0.0578796509792886
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,41843,-0.00954488244676656,0.00503347324688206,-0.0194104900106554,0.000320725117122273,0.0579445686249536
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLU,Clusterin,39979,0.00534215267345778,0.00282334839195659,-0.000191610174777132,0.0108759155216927,0.0584985302713301
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.00678791036468971,0.00359533395450287,-0.0138347649155153,0.000258944186135913,0.059054526102119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00684493246209734,0.0036421356494387,-0.0139835183349972,0.000293653410802521,0.0602200145118536
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.00918967901966038,0.00489609670561553,-0.0187860285626668,0.000406670523346047,0.0605528816645499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00646454281692389,0.00345012881542047,-0.013226795295148,0.000297709661300233,0.0609967019130417
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00672498231495309,0.00359002777252094,-0.0137614367490941,0.000311472119187951,0.0610618587394235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,42119,-0.0156595631491851,0.00837475263717374,-0.0320740783180457,0.000754952019675407,0.061525717834158
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK15,Kallikrein-15,39900,-0.00923671105068342,0.00494265569004588,-0.0189243162031733,0.000450894101806492,0.0616799856192071
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00643188925437688,0.00345077515907165,-0.0131954085661573,0.000331630057403557,0.0623626820391111
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.0064870838935886,0.00349172079701222,-0.000356688868555341,0.0133308566557325,0.0632174696454966
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,39757,-0.00699026215631587,0.00376498999567046,-0.01436964254783,0.000389118235198241,0.0633875517356013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.00970778516240811,0.00523216049999307,-0.0199628197423945,0.00054724941757831,0.063560271897558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.0168218578665463,0.00906788506601464,-0.000951196862842389,0.034594912595935,0.0636083352547562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00361877773181617,0.00195597020068824,-0.000214923861532778,0.00745247932516512,0.064323252974227
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00771819719719192,0.00418668705441343,-0.0159241038238422,0.000487709429458408,0.0652815780812388
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0173636986032454,0.00942116892545106,-0.0358291896971294,0.00110179249063871,0.0653476359519908
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.00680938070089341,0.00371303350472589,-0.0140869263701562,0.00046816496836934,0.0666889945232945
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,-0.0187182746600822,0.0102205183092574,-0.0387504905462267,0.00131394122606223,0.0670622391867941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA1,Annexin A1,39699,-0.00763833493285816,0.00417953576553436,-0.0158302250333055,0.000553555167589175,0.0676430753471781
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,42181,-0.0135048830380261,0.00742186847097454,-0.0280517452411362,0.00104197916508398,0.0688408968128632
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,41839,-0.00768534320356947,0.00424001689924185,-0.0159957763260835,0.000625089918944549,0.0699202352605954
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPLX2,Complexin-2,39560,0.00521762037139995,0.00287976353567555,-0.000426716158524137,0.010861956901324,0.0700409847876898
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,39575,0.00670997776741043,0.00370836323175268,-0.000558414166824829,0.0139783697016457,0.070413495309907
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.012049975552625,0.00667178767164904,-0.0251266793890571,0.00102672828380711,0.0709286768735207
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.00752761048678789,0.00416812179405987,-0.0156971292031452,0.000641908229569443,0.0709461766911005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,41913,-0.00490201956561739,0.00272092016870888,-0.0102350230962868,0.00043098396505201,0.0716304106198215
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.00509863661842791,0.00284042866364219,-0.0106658767991666,0.000468603562310789,0.0726722811135371
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XG,Glycoprotein Xg,42261,-0.00580002930231596,0.0032311902904258,-0.0121331622715505,0.000533103666918612,0.0726736897541409
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,-0.0063616449581656,0.00354877737984549,-0.0133172486226628,0.000593958706331573,0.0730587685912632
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TG,Thyroglobulin,39919,0.0175517067433646,0.00984244809487759,-0.00173949152259549,0.0368429050093246,0.0745697397461089
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.00521563448605825,0.00293088673898204,-0.010960172494463,0.000528903522346549,0.0751787357094957
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0114303845592119,0.00642754566524986,-0.0011676049446778,0.0240283740631016,0.0753699936440773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.00638742325064229,0.0036046086083069,-0.0134524561229238,0.000677609621639237,0.0764188144079615
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.00605051946736079,0.00341636285481252,-0.0127465906627933,0.000645551728071746,0.0765813892159389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.00967971143801794,0.00549543158381362,-0.0204507573422926,0.00109133446625677,0.0781915289716106
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.00785987401839523,0.0044669032387149,-0.0166150043662764,0.000895256329485981,0.078505928500622
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERC2,ERC protein 2,39649,-0.0121874364017733,0.00693100989940797,-0.025772215804613,0.0013973430010663,0.0787084161760301
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0171794961393407,0.00978030734092857,-0.00198990624887928,0.0363488985275607,0.0790233453065862
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.00808350117609948,0.00460332136738178,-0.0171060110561678,0.000939008703968808,0.0791137449485653
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.0082014116311362,0.00467139225567319,-0.0173573404522556,0.000954517189983248,0.0791728834255481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.00745173055735521,0.00425083526896259,-0.0157833676845219,0.000879906569811463,0.0796288098155277
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,42310,0.00482160371015212,0.00275091481040706,-0.00057018931824572,0.01021339673855,0.0796711637581177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.00794856754218598,0.00454199749909378,-0.0168508826404098,0.000953747556037823,0.0801426764767487
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,39575,-0.0064887642461879,0.00371795269434041,-0.0137759515270951,0.000798423034719301,0.0809690052552324
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPT,Dermatopontin,42310,-0.004120606532968,0.00236918027773637,-0.00876419987733129,0.000522986811395288,0.0820125196072392
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,39713,0.00473645717706781,0.00272461532484446,-0.000603788859627326,0.0100767032137629,0.0821689642839315
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,-0.00943687950734061,0.00543760936291668,-0.0200945938586573,0.00122083484397609,0.08267842267632
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,42262,-0.00745364645396352,0.00430993440691967,-0.0159011178915261,0.000993824983599033,0.0837582134640853
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,42247,-0.00493815216558512,0.00286150618786012,-0.010546704293791,0.00067039996262072,0.0844208300989819
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP13,Collagenase 3,41839,0.00518336518501904,0.00300962585725918,-0.000715501495208953,0.011082231865247,0.0850453676560435
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.00622774261945814,0.00362058718948472,-0.000868608271931911,0.0133240935108482,0.0854430756384003
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00461309161975752,0.00268193688555293,-0.00986968791544127,0.000643504675926223,0.0854488260370291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.0144277064504158,0.00839548578486976,-0.0308828585887606,0.00202744568792889,0.0857318572127143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.00618609300966387,0.00360147528017648,-0.000872798539482038,0.0132449845588098,0.0858821512650797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FST,Follistatin,42166,0.00777931827210528,0.00454904236474921,-0.00113680476280318,0.0166954413070137,0.0872702113533074
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,-0.00448814605699061,0.00262981749013172,-0.00964258833764878,0.000666296223667555,0.0879167212313726
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,-0.00942440596040069,0.00552837475037445,-0.0202600204711346,0.00141120855033324,0.0882724019711692
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.00542711438714116,0.00318525820564948,-0.0116702204702141,0.00081599169593182,0.0884372555525261
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.00454486980887256,0.00267940851359785,-0.00979651049552434,0.000706770877779221,0.0898668881080224
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.00579552030669215,0.00342748006747234,-0.0125133812389379,0.000922340625553635,0.0908846561126868
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,39560,0.00676295828406295,0.00400317742339974,-0.00108326946580055,0.0146091860339264,0.0911717052941706
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,39919,-0.00839956930332902,0.00498091910091534,-0.0181621707411231,0.00136303213446505,0.0917561044808281
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.004893692905048,0.00290800909306004,-0.0105933907274457,0.000806004917349672,0.0924303483901479
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.00520304120869531,0.00309525030726861,-0.0112697318109418,0.000863649393551169,0.0927960481729821
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.00834070470849563,0.00498178003981178,-0.00142358416953546,0.0181049935865267,0.0941105298654987
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.0149335088690497,0.00894081511323925,-0.0324575064909986,0.00259048875289921,0.0948959787694297
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.0054176775931722,0.00324838763182272,-0.000949162165200324,0.0117845173515447,0.0953829149308833
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.0184073855428156,0.0110577696405368,-0.0400806140382678,0.0032658429526366,0.0960098689697292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.00461301879791442,0.00277249450377592,-0.0100471080253152,0.000821070429486393,0.0961654070802947
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.00535606745399664,0.0032376234215857,-0.000989674452311338,0.0117018093603046,0.0980906554453766
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,39638,-0.0122252903825593,0.00739704920118935,-0.0267235068168905,0.00227292605177179,0.0984152225164542
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.00952672864701713,0.00579024097283299,-0.0208756009537698,0.00182214365973553,0.0999350274668825
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,-0.0113299676536396,0.00688962374191721,-0.0248336301877974,0.00217369488051809,0.100101117675578
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.00874806350847697,0.00532356849487144,-0.019182257758425,0.00168613074147105,0.100350576297058
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP4,Caspase-4,39757,0.0256717640667544,0.0156344889717582,-0.00497183431789178,0.0563153624514005,0.100619072987198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMBN,Ameloblastin,41913,0.00418868366101435,0.00255415977422704,-0.000817469496470657,0.00919483681849935,0.101040057287301
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.0038554185946379,0.00235213090052536,-0.000754757970391814,0.0084655951596676,0.101211888970234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL22,Interleukin-22,39919,-0.0108175686330505,0.0066154058516685,-0.0237837641023208,0.00214862683621971,0.102033128984566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-0.0040033920034354,0.00246007774603492,-0.00882514438566385,0.000818360378793041,0.103691929852456
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0055951618819323,0.00344167666830433,-0.00115052438794418,0.0123408481518088,0.104035420497915
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,39575,-0.00789349489969645,0.0048558864196802,-0.0174110322822696,0.00162404248287674,0.104073748651526
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,42145,-0.0173441532299963,0.0107003289064816,-0.0383167978867003,0.00362849142670767,0.105062562081719
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00613892085109275,0.00378896121489045,-0.013565284832278,0.00128744313009253,0.105214981598877
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.0120542274710437,0.00744056767628703,-0.0025292851744789,0.0266377401165663,0.105245877781019
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.00735172170782111,0.00454126298915939,-0.0162525971665735,0.00154915375093131,0.105503714445915
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.00926932832189528,0.00574380247314014,-0.0019885245254594,0.02052718116925,0.106594668858283
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP6,Gastrotropin,41881,0.0085325814937567,0.0052979169530598,-0.0018513357342405,0.0189164987217539,0.107300724991499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.00986604036653704,0.00612642041608909,-0.0218738243820717,0.00214174364899757,0.107332383528006
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,42070,0.00418030550540825,0.00260030953483668,-0.000916301182871642,0.00927691219368815,0.107942212888505
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.0158061699635162,0.0098421431665064,-0.0350967705698687,0.00348443064283638,0.108309430667047
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00536243370289541,0.00334277958997795,-0.0119142816992522,0.00118941429346137,0.108701388745213
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00260140007769211,0.00162558213600815,-0.000584740908883869,0.00578754106426808,0.109558039990691
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.005916443163163,0.00370064769754784,-0.0131697126503568,0.00133682632403077,0.109902987497072
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,39560,0.00512844686113372,0.00321579586895322,-0.00117451304201459,0.011431406764282,0.110793062410201
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBN2,Fibrillin-2,39649,-0.00900523813961235,0.00564790996685431,-0.0200751416746468,0.00206466539542209,0.110866732803793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,39575,-0.0167623935808868,0.0105241769641296,-0.0373897804305808,0.00386499326880728,0.111244855394619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.0069650657724598,0.00437383340419746,-0.0155377792446868,0.00160764769976721,0.11131453635828
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.0102007069048401,0.0064114548640949,-0.00236574462878595,0.0227671584384661,0.111635530583409
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00396973480777986,0.00249744523966402,-0.000925257861961621,0.00886472747752135,0.111972328597339
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.00885826659248496,0.00558964848881042,-0.0198139776305534,0.00209744444558348,0.113049104333115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00719047807181787,0.00454502867727931,-0.00171777813564956,0.0160987342792853,0.113666235129173
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.0039552079800764,0.00250546573573716,-0.00886592082212123,0.000955504861968427,0.114449386399038
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.0111862909277203,0.00710319773886047,-0.00273597664044625,0.0251085584958868,0.115324871515107
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,42249,-0.00425865238938216,0.00271117253895308,-0.00957255056573019,0.00105524578696587,0.116257214215917
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,41839,-0.0042269076158125,0.00270823517333549,-0.00953504855555005,0.00108123332392506,0.118604074175343
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.00784913963465471,0.00505925020026402,-0.00206699075786277,0.0177652700271722,0.120819390395037
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.00835678211016605,0.00539404387490893,-0.0189291081049876,0.00221554388465546,0.121347850591473
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.0061271285865411,0.00396253766677063,-0.00163944524032933,0.0138937024134115,0.122068825145596
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,39919,-0.0038512549210297,0.00249492695613721,-0.00874131175505864,0.00103880191299923,0.122704896938929
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.00632344453803016,0.0041037153320785,-0.0017198375128437,0.014366726588904,0.123367297998067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.0037147692487023,0.00241121210787124,-0.00844074498012994,0.00101120648272534,0.12343719016713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BEX3,Protein BEX3,39560,0.00676008089827647,0.00439426009310373,-0.00185266888420684,0.0153728306807598,0.123982425515442
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CENPJ,Centromere protein J,39757,-0.0101620295280709,0.00661914961958819,-0.0231355627824638,0.00281150372632193,0.12475152564897
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,39586,-0.00888091718601198,0.00578643394096454,-0.0202223277103025,0.00246049333827852,0.12486607493975
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,39575,0.00835441312490271,0.00545683267964329,-0.00234097892719815,0.0190498051770036,0.12579811056036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.00901325785170108,0.005910871274573,-0.0205985655498642,0.002572049846462,0.127321561618737
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.00554996784637019,0.00364943814033116,-0.0127028666014193,0.00160293090867888,0.128340627686178
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN10,Ataxin-10,41839,-0.0104017846007563,0.00684147810817,-0.0238110816927695,0.0030075124912569,0.128434308471621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.0110231615201023,0.00725154609611984,-0.0252361918684972,0.0031898688282926,0.12851146813863
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,39575,0.00921153309513976,0.00606969829392673,-0.00268507556095663,0.0211081417512362,0.129137463527196
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.00585581461259371,0.00387757510478011,-0.0134558618179627,0.0017442325927753,0.131022058644758
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,41865,-0.0104968372687914,0.00695984795007621,-0.0241381392509408,0.00314446471335797,0.13152736140246
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NENF,Neudesin,39919,-0.0158882270196716,0.0105613436408843,-0.0365884605558048,0.0048120065164616,0.132512600327892
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,-0.00968710356464699,0.00644670188101927,-0.0223226392514448,0.00294843212215079,0.132958946080876
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13,Interleukin-13,41913,0.00679365386837059,0.00453727905200668,-0.0020994130735625,0.0156867208103037,0.134339727965071
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.00832888840979256,0.00556770200978407,-0.00258380752938422,0.0192415843489693,0.134699942908431
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.00187815688912405,0.00125593980638535,-0.000583485131391232,0.00433979890963933,0.134833202162073
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00440138252168249,0.0029496887536334,-0.010182772478804,0.00138000743543898,0.135687981943841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00414510831459425,0.00277911669155537,-0.00959217703004278,0.00130196040085428,0.135853534664187
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A3,Protein S100-A3,39919,-0.00596703141274308,0.00401115055934574,-0.0138288865090607,0.00189482368357456,0.136881385350182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAEP,Glycodelin,42016,0.0145003989107176,0.00976629446322565,-0.00464153823720469,0.0336423360586399,0.137636453455757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMP,Olfactory marker protein,39586,-0.00667731068543913,0.00451218099228977,-0.0155211854303271,0.00216656405944883,0.138944343275324
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.00856082933589184,0.0057901936072799,-0.00278795013437677,0.0199096088061604,0.139301369076965
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,42075,-0.00810339386932843,0.00549439585464881,-0.0188724097444401,0.00266562200578324,0.140277014230809
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,39649,-0.00431182580032985,0.00294384864715452,-0.0100817691487527,0.00145811754809301,0.143033954612072
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MB,Myoglobin,42310,0.0076668096290301,0.00523461069978736,-0.00259302734255312,0.0179266466006133,0.143042644171831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,-0.00724479480283045,0.00496628429184965,-0.0169787120148558,0.00248912240919487,0.144644628283677
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,39733,-0.00525895256748376,0.00361264635415064,-0.012339739421619,0.00182183428665149,0.145501985797476
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,39649,-0.0106046064637204,0.00730494523937401,-0.0249222991328935,0.00371308620545265,0.146612766976459
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.0041406012271572,0.00286085058164321,-0.00146666591286349,0.00974786836717789,0.147832500026331
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00706452894059856,0.00489390011233134,-0.016656573160768,0.00252751527957087,0.148892743153382
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM2,Myomesin-2,39575,0.00755556603737056,0.005236608535285,-0.00270818669178805,0.0178193187665292,0.149095282569155
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.00482582196714228,0.00334709581065547,-0.00173448582174243,0.011386129756027,0.149383551284693
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0134499627753043,0.00937568507290799,-0.031826305518204,0.00492637996759533,0.151441621133701
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PI3,Elafin,41966,-0.00749662527584483,0.00524064010277108,-0.0177682798772761,0.00277502932558648,0.152602983755304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTPN,Myotrophin,41900,0.00432384632083944,0.00302924660070505,-0.00161347701654246,0.0102611696582213,0.153497644375621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVPL,Envoplakin,39757,0.0044894276149665,0.00314558315299908,-0.00167591536491169,0.0106547705948447,0.153545537032709
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,0.005091051087543,0.00357185639488375,-0.00190978744642916,0.0120918896215152,0.154091228865933
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,39657,-0.00452430320199137,0.00318468420758126,-0.0107662842488506,0.0017176778448679,0.155448415083948
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00641545726609106,0.00452028851228369,-0.0152752227501671,0.00244430821798498,0.155851643290074
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERVV_1,,39575,0.00580862222571588,0.00409441867431683,-0.0022164383759451,0.0138336828273769,0.156024121715176
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00709044957245457,0.00500948952904345,-0.00272814990447059,0.0169090490493797,0.156977703520712
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.00813819445402763,0.00576193114494468,-0.00315519059006394,0.0194315794981192,0.157857917171754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCP1,Plastin-2,39966,0.00634100648985533,0.00449281757325606,-0.00246491595372655,0.0151469289334372,0.158164323169583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.00946087357395388,0.00671967226844723,-0.0037096840722027,0.0226314312201105,0.159177960157484
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK6,Kallikrein-6,42158,-0.00406252653601058,0.00288628943275518,-0.00971965382421073,0.00159460075218958,0.159294489284245
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.00409154597623208,0.0029166416659081,-0.00162507168894779,0.00980816364141196,0.160694247824567
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.00913494822204492,0.00651757017888401,-0.0219093857726576,0.00363948932856774,0.161066126403531
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.00527788641547544,0.00377513333002316,-0.0126771477423208,0.00212137491136995,0.162121432712328
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00704140549054554,0.00504378318244891,-0.00284440954705433,0.0169272205281454,0.162720938512012
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.00278804621408988,0.00199965402385037,-0.00113127567265685,0.0067073681008366,0.163265623605472
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.003345114051085,0.00239986796645016,-0.00804885526532732,0.00135862716315731,0.163382852612565
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00690254348304766,0.00495834674420544,-0.002815816135595,0.0166209031016903,0.163918594514864
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00543948044886858,0.00391484508220986,-0.0131125768099999,0.00223361591226276,0.164723330468214
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.00304540478057068,0.00219446010039928,-0.00125573701621191,0.00734654657735326,0.165230112270859
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,39979,0.00294017833655325,0.00212124545769602,-0.00121746276053094,0.00709781943363745,0.16575504393455
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F11,Coagulation factor XI,39822,0.00407760631843806,0.00295048244105512,-0.00170533926602998,0.0098605519029061,0.166995089538107
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.00973992682827078,0.00705709037338368,-0.0235718239601028,0.00409197030356123,0.167560125091317
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.00199460753895288,0.0014460322763203,-0.00083961572263491,0.00482883080054066,0.167809090354389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,42145,-0.0098129889793562,0.0071220298470166,-0.0237721674795087,0.00414618952079635,0.168276696511641
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0120057180966614,0.00873042733679655,-0.0291173556767826,0.00510591948345989,0.16910520456071
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,39930,-0.0335877453587016,0.0244312457888593,-0.0814729871048659,0.0142974963874626,0.169224851179507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,42070,0.00385874410685899,0.00280912130556382,-0.0016471336520461,0.00936462186576408,0.169573820623921
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,-0.00540942208665458,0.0039500950850851,-0.0131516084534214,0.0023327642801122,0.170889304191319
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.00378014442719033,0.00276814854148207,-0.00920571556849519,0.00164542671411453,0.172091552422028
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,39657,-0.00384918635265759,0.00282244654974147,-0.00938118159015088,0.0016828088848357,0.172665672485596
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00441325317381251,0.00324727225158831,-0.00195140043930057,0.0107779067869256,0.174153980342508
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.00807826659202668,0.00594800606706328,-0.0197363584834707,0.00357982529941734,0.174439535898611
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6,Interleukin-6,42070,-0.0094320569912699,0.00697374397804077,-0.0231005951882298,0.00423648120569,0.176234993377791
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,41843,-0.00478516648429452,0.00353881510197962,-0.0117212440841746,0.00215091111558555,0.176336178015794
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0122474652439337,0.00906151394099712,-0.030008032568288,0.00551310208042066,0.176533727312874
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,39649,-0.0115842347291026,0.00857901954438733,-0.0283991130361018,0.00523064357789657,0.176948003746515
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.0105468216660427,0.00783381029510596,-0.00480744651236495,0.0259010898444504,0.17822686093184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20,Interleukin-20,41913,0.0058459435113164,0.00435606151551684,-0.0026919370590966,0.0143838240817294,0.179610772463037
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,39657,-0.00358164419464252,0.00267008007430024,-0.00881500114027099,0.00165171275098595,0.179818315650841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,-0.00364931611414778,0.00272454309079991,-0.00898942057211561,0.00169078834382005,0.180456011597057
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.00462504880477732,0.00345624907923759,-0.011399297000083,0.00214919939052836,0.180863883234995
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.00984804039739844,0.00736186072671202,-0.00458120662695711,0.024277287421754,0.181017578690503
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.00511630123178318,0.00383617638787404,-0.00240260448844994,0.0126352069520163,0.182329647616827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,42167,0.00262443825016491,0.00196875518137031,-0.0012343219053209,0.00648319840565071,0.182539587536306
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,-0.00873648979971391,0.00656851681602413,-0.0216107827591212,0.00413780315969338,0.183527545964598
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,39638,-0.00783316072509362,0.00590803867832622,-0.019412916534613,0.00374659508442577,0.184917516970048
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,39657,-0.00823870951362508,0.0062143456436398,-0.0204188269751591,0.00394140794790893,0.184947733986923
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.00637927178474534,0.00481415823847615,-0.0158150219321586,0.00305647836266791,0.185163272488832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CORO1A,Coronin-1A,41883,-0.0109787258486198,0.00828780452995821,-0.0272228227273379,0.00526537103009823,0.185298619454595
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.00388005058727905,0.0029427744035133,-0.00188778724360702,0.00964788841816513,0.187363550572116
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,39915,0.00303271300737729,0.00230769721465636,-0.00149037353334917,0.00755579954810374,0.188814685679521
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRAS,GTPase Hras,39750,-0.0122344266330038,0.00933808262079186,-0.0305370685697559,0.00606821530374821,0.190167099080902
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.00762486293891918,0.00585945456375645,-0.0191093938838818,0.00385966800604346,0.193185545603929
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,39649,0.00718577188397611,0.00553756388018985,-0.003667853321196,0.0180393970891482,0.194437695576209
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,-0.00840853277986595,0.00649445339147583,-0.0211376614271586,0.00432059586742668,0.195437308973053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,42070,-0.00395688430194915,0.00305657573463424,-0.00994777274183225,0.00203400413793395,0.195498358018013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN7,Septin-7,39757,0.00648153190035395,0.00501233203264104,-0.00334263888362249,0.0163057026843304,0.195997361017223
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX5,Syntaxin-5,39657,-0.00483640294146236,0.00374129970361972,-0.012169350360557,0.00249654447763228,0.196139554407578
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00586196612757917,0.00454474389459,-0.0147696641609756,0.00304573190581723,0.197135407099773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,39657,0.00662014767710634,0.0051437794251263,-0.00346165999614121,0.0167019553503539,0.198114212922752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00359799612660141,0.002802131867748,-0.00909017458738749,0.00189418233418468,0.199156310654946
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,42310,0.00290514397609889,0.0022637949095473,-0.00153189404661383,0.0073421819988116,0.199406213549939
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0142194642637444,0.0110831009378293,-0.0359423421018898,0.00750341357440106,0.199523186160708
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.00841933648115339,0.00660004888977512,-0.0213554323051126,0.00451675934280584,0.202106318682254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00582154389274837,0.00456440361882931,-0.0147677749856538,0.00312468720015708,0.20218664437279
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,39575,0.006085923094073,0.00478445774087611,-0.00329161407804417,0.0154634602661902,0.203393175770754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00464508078089435,0.00365183668594471,-0.00251251912355729,0.011802680685346,0.203405468585575
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,-0.00501800894697982,0.00395055716462047,-0.012761100989636,0.00272508309567631,0.204039349231952
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00418067726555872,0.00329671471739125,-0.0106422381116456,0.00228088358052812,0.204776840100402
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-0.00503575007955232,0.00397352083235789,-0.0128238509109738,0.00275235075186914,0.205064855086108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.00283536274320734,0.00223758714189638,-0.00155030805490957,0.00722103354132425,0.205122669835167
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG4,Desmoglein-4,42018,0.0056688489589571,0.00447540547445443,-0.00310294577097359,0.0144406436888878,0.205296328558653
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00783727533669717,0.00618973285971094,-0.0199691517417306,0.00429460106833626,0.205477430718131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.00378710242575719,0.00301018748989544,-0.00968706990595225,0.00211286505443788,0.208379511194342
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,-0.00288408715494916,0.00231079857208461,-0.007413252356235,0.00164507804633668,0.21201921061948
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,39649,0.00788009531928397,0.00631531161128616,-0.00449791543883689,0.0202581060774048,0.21213948219201
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.00631516878667451,0.00506579807402547,-0.0162441330117644,0.00361379543841541,0.212559879645367
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,-0.00362452361623879,0.0029100072195408,-0.00932813776653877,0.00207909053406118,0.212959870504862
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00796969533802521,0.00641080762180291,-0.0205348782767589,0.00459548760070849,0.213833382056399
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.00725734189874272,0.00584655461192024,-0.0187165889381064,0.00420190514062095,0.214520433923429
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.00495859237353557,0.00400084575144299,-0.0028830652992927,0.0128002500463638,0.215228874179202
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00496295053992937,0.00401543264695296,-0.00290729744809843,0.0128331985279572,0.216496318507092
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.00633856248787864,0.00513660472400728,-0.0164063077469329,0.00372918277117562,0.217229712523444
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,39649,-0.00748194129174388,0.0060967869100672,-0.0194316436354756,0.00446776105198782,0.219775770538804
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0046676738372936,0.00380470119697084,-0.0121248881833564,0.00278954050876925,0.219912698052945
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH4,Myosin-4,39575,0.00527846659079016,0.00430519449051047,-0.00315971461061036,0.0137166477921907,0.220198921580738
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,41948,-0.00319099497906299,0.00260462215749543,-0.00829605440775403,0.00191406444962806,0.220548695244888
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,39934,-0.00506819830289739,0.00416595346615966,-0.0132334670965703,0.00309707049077555,0.223790976395011
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.00325970644112598,0.00267977329376478,-0.00851206209690494,0.00199264921465299,0.223853498761459
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.00337459126526251,0.00278235394380732,-0.00882800499512486,0.00207882246459984,0.225211489820268
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00341952692453123,0.00283213193645028,-0.00897050551997378,0.00213145167091132,0.227302509998954
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00696459791923827,0.00577291378957705,-0.00435031310833274,0.0182795089468093,0.22767818132136
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,41843,-0.00949111294645332,0.00787316709792589,-0.0249225204583881,0.00594029456548143,0.228031386520489
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK12,Kallikrein-12,41843,-0.0150280304907236,0.0124674818127881,-0.0394642948437883,0.00940823386234108,0.22807887985507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00343261476104801,0.0028521337011549,-0.00902279681531161,0.00215756729321558,0.22879466173166
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.00988826864971241,0.00821834100389726,-0.00621967971792622,0.025996217017351,0.228926543480188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,39958,-0.0121414685482442,0.0100933390856255,-0.0319244131560702,0.00764147605958182,0.229032772256742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.00788932746751633,0.00656344986229978,-0.0207536891976239,0.00497503426259123,0.229385067337188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,39586,0.010457354170507,0.0087193142206401,-0.0066325017019476,0.0275472100429616,0.23042467136765
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM,Paralemmin-1,39859,-0.00342751780163529,0.00287678992761969,-0.00906602605976989,0.00221099045649931,0.233506665696241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,-0.00378437337865993,0.00317723997472082,-0.0100117637291127,0.00244301697179287,0.233640176075407
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,39757,0.00375898514828915,0.00316106787712851,-0.00243670789088274,0.00995467818746104,0.234405793661158
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,-0.0063127152628455,0.00531663069445196,-0.0167333114239713,0.00410788089828034,0.235109866134178
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0164709755121719,0.0138738580825782,-0.0436637373540253,0.0107217863296814,0.235171997501659
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,-0.00613426481891579,0.00517951814456734,-0.0162861203822678,0.00401759074443619,0.23630761410253
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,39757,0.0042932482248661,0.0036332626857532,-0.00282794663921018,0.0114144430889424,0.237369422383656
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.00651815548739395,0.00553618934233637,-0.0173690865983732,0.00433277562358535,0.239072482240723
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,39586,-0.00515747118896816,0.00438420473419723,-0.0137505124679947,0.00343557009005841,0.239470332837213
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.00405669218045292,0.00344926893124591,-0.0108172592856949,0.00270387492478906,0.239579447404684
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARTN,Artemin,41913,-0.00494321915661822,0.00422059318892561,-0.0132155818069124,0.00332914349367598,0.241533604905999
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,41825,-0.00616688836733877,0.00526548022508274,-0.0164872296085009,0.0041534528738234,0.241542707270238
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCG3,Secretogranin-3,42144,0.00363315729557396,0.00310635050878296,-0.00245528970164064,0.00972160429278857,0.242186481168751
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.00309185691902321,0.00264394923482198,-0.00827399741927429,0.00209028358122788,0.242259632628279
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.00389246542725685,0.0033286440532595,-0.0104166077716455,0.00263167691713177,0.242273653110848
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,-0.0059450938824025,0.00508936563439285,-0.0159202505258125,0.00403006276100749,0.242775524147066
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.00821507469607368,0.00703522384446059,-0.00557396403906908,0.0220041134312164,0.242950625702857
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,42310,-0.00335907175448367,0.00288362873341652,-0.00901098407198005,0.00229284056301271,0.244089197654324
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,39736,0.00569806979197351,0.00491348004161871,-0.00393235108959916,0.0153284906735462,0.246203543733811
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.0075622963930086,0.0065287806702861,-0.00523411372075216,0.0203587065067694,0.24676622680962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.00543930934661447,0.00471177400968241,-0.014674386405592,0.00379576771236304,0.248358070474743
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,39736,-0.00396179809252466,0.00344210654234833,-0.0107083269155274,0.00278473073047807,0.249764900800856
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00491364907904575,0.00427122307781894,-0.0132852463115709,0.00345794815347937,0.250000775306775
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,0.00460774920708221,0.00400813704296648,-0.0032481993971321,0.0124636978112965,0.250329752715347
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,39657,-0.00278646164070511,0.00242733650904986,-0.00754404119844284,0.00197111791703262,0.251013922817539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CR1,Complement receptor type 1,39970,-0.00382354697790527,0.00333475858569944,-0.0103596738058762,0.00271257985006563,0.251581918984185
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0126984328822126,0.0110806212155347,-0.0344164504646606,0.00901958470023548,0.251813879753547
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,-0.00817100587098297,0.00714373255678165,-0.022172721682275,0.00583070994030907,0.252731246137546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCN,Decorin,41900,-0.00244866639930896,0.0021446598980422,-0.00665219979947168,0.00175486700085375,0.253578320104415
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.00513254000205981,0.0045002446874229,-0.00368793958528908,0.0139530195894087,0.25409766597793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,-0.00355347571075904,0.00311980843012901,-0.00966830023381191,0.00256134881229382,0.254721476707797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.00621749231275315,0.00546838373592702,-0.00450053980966381,0.0169355244351701,0.255567670654639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.013094913348764,0.0115671633198481,-0.0357665534556662,0.00957672675813834,0.257622353275254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.00806735118197902,0.00712692292011271,-0.0220361201053999,0.00590141774144189,0.257678346419528
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL3,Insulin-like 3,39929,0.00955817559511313,0.00845365999590917,-0.00701099799686885,0.0261273491870951,0.25822413167795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.00376876562180129,0.00333717127305198,-0.0103096213169832,0.00277209007338058,0.258778915673522
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,-0.00490148861612884,0.00435775050827659,-0.013442679612351,0.00363970238009328,0.26070419070794
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,-0.003665783350582,0.00325950481541264,-0.0100544127887908,0.00272284608762678,0.260763631194534
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,-0.00759014120635936,0.00676217856276537,-0.0208440111893795,0.00566372877666076,0.261695317443323
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.0053553344045154,0.00477647955515218,-0.0147172343326137,0.00400656552358286,0.262231960030231
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,39652,0.00748339121264855,0.00668371845438844,-0.00561669695795279,0.0205834793832499,0.262889449775492
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.00431136993390956,0.00386854439140923,-0.0118937169410716,0.00327097707325253,0.265102360441432
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00274979880712262,0.00247418896119473,-0.00209961155681906,0.00759920917106429,0.266423166149036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN1,Nectin-1,39657,-0.00344710289704324,0.00310419976448654,-0.00953133443543686,0.00263712864135038,0.266823168391129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.00881222293389492,0.0079553763833767,-0.0244047606453132,0.00678031477752341,0.268012062617979
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH7B,Myosin-7B,39560,-0.00446155967796088,0.00402946076442295,-0.0123593027762299,0.0034361834203081,0.268216672078262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,-0.007219753733397,0.00653980945937029,-0.0200377802737628,0.00559827280696877,0.26962550811732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCIN,Adseverin,39586,-0.00765536819323139,0.00694414322654041,-0.0212658889172506,0.00595515253078781,0.270302906132545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.0049907525458333,0.00452904686369198,-0.0138676843986696,0.00388617930700298,0.27051054902977
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,42103,0.00717104586921093,0.00651774688856871,-0.00560373803238374,0.0199458297708056,0.271249851449431
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM1,Myomesin-1,39586,-0.00506869716042597,0.0046085261416018,-0.0141014083979655,0.00396401407711356,0.271420667167279
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RSPO1,R-spondin-1,42016,0.00349476534259148,0.00317850295328719,-0.0027351004458514,0.00972463113103437,0.271569578699083
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.00384376028539429,0.00349830194613199,-0.010700432099813,0.00301291152902442,0.271896449890949
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,39539,0.00372451027739494,0.00339073474082412,-0.00292132981462033,0.0103703503694102,0.272037659901304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,42137,-0.00633253511381836,0.00577066558927838,-0.017643039668804,0.00497796944116727,0.272500729771203
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00451250249626753,0.00411239309123221,-0.0125727929550827,0.00354778796254761,0.272537130990544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRK1,Protein BRICK1,41839,0.004641872100382,0.00423668054986181,-0.00366202177734715,0.0129457659781111,0.27325675317088
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.00693897384440503,0.00633451022905984,-0.0193546138933623,0.00547666620455225,0.273354248433137
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,42165,-0.00547997715834741,0.00500371720223383,-0.0152872628747257,0.0043273085580309,0.273456691745954
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00531882873037876,0.00485872262440042,-0.0148419250742036,0.00420426761344607,0.27367399331123
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00417991260950036,0.00383531792926318,-0.00333731053185546,0.0116971357508562,0.275803984742108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,41839,-0.00480768037537929,0.0044177619631332,-0.0134664938231204,0.00385113307236178,0.276499480623219
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,-0.0105948775892154,0.00975253692727051,-0.0297098499666656,0.00852009478823476,0.277338391474277
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.00345692768570374,0.00318488836219696,-0.00278545350420231,0.00969930887560978,0.27776130664426
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00197128623052513,0.00181667271264241,-0.00553196474730425,0.001589392286254,0.277896779509188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,41913,0.00612538327758374,0.00566262773412595,-0.00497336708130313,0.0172241336364706,0.27939611675509
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0170297034773285,0.0157445857949626,-0.0138296846807982,0.0478890916354552,0.279439712772038
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,41900,-0.0108303485875828,0.0100257357596855,-0.0304807906765664,0.00882009350140086,0.280048346000587
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.00565405656311905,0.00526260697895071,-0.0159687662418624,0.00466065311562433,0.282674410576392
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0106601267455025,0.0099225277825338,-0.0301082811992687,0.00878802770826376,0.282695669427723
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.00714767430725164,0.00665746107343084,-0.0059009493966728,0.0201962980111761,0.283010485731587
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00342469749750803,0.00319654272146025,-0.00968992123157012,0.00284052623655406,0.284024191802284
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.00344749957550543,0.00322220037945229,-0.00286801316822106,0.00976301231923193,0.284677644522526
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,39586,-0.00982122340226577,0.00918110478488297,-0.0278161887806364,0.00817374197610485,0.284768275057202
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,42132,-0.0191573557043667,0.0179407692145964,-0.0543212633649756,0.0160065519562423,0.285624698457134
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C7,Complement component C7,39722,-0.00333796232824003,0.0031273931756801,-0.00946765295257302,0.00279172829609296,0.285845756878219
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,39934,-0.0046855624238218,0.00440556496008577,-0.0133204697455899,0.0039493448979463,0.28755281236894
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTN,Titin,39575,-0.00691030150567601,0.00650665106114979,-0.0196633375855296,0.00584273457417758,0.288242443289771
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD177,CD177 antigen,42123,0.0127209134028759,0.0120112691242868,-0.0108211740807262,0.036263000886478,0.289581562604562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00538054835263985,0.00509586263541532,-0.0153684391180539,0.00460734241277418,0.291052486003936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPN1,Epsin-1,39757,-0.00428041024443785,0.00407531942905886,-0.0122680363253932,0.00370721583651752,0.293591423095517
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.00259845704346973,0.00247897720645527,-0.0022603382811826,0.00745725236812206,0.294569987361236
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.00806408766497439,0.00774418828842707,-0.0232426967102915,0.00711452138034267,0.297755393269358
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,39575,0.00418806303286616,0.00402397235738551,-0.00369892278760943,0.0120750488533417,0.298001388955381
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.00676112789502507,0.00649670607086993,-0.0194946717939301,0.00597241600387999,0.298036933597317
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,-0.00434034701632947,0.00417163634862576,-0.012516754259636,0.00383606022697702,0.298157366536441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,-0.00755074753203974,0.00725842718870242,-0.0217772648218965,0.006675769757817,0.29823573791411
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.0056822895440583,0.00548129854477546,-0.0164256346918182,0.0050610556037016,0.29990931095516
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD109,CD109 antigen,42137,-0.00329037899607375,0.00318276114073681,-0.00952859083191789,0.00294783283977039,0.301242185599783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,42119,-0.00542588010787929,0.00525788566376411,-0.0157313360088569,0.00487957579309836,0.302113556453577
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.00601260384925607,0.00583208184396166,-0.0174434842634209,0.00541827656490879,0.302585483431256
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00458294410980844,0.00445149730886277,-0.0133078788351795,0.00414199061556259,0.303254001899838
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.0051553016103068,0.0050152291314683,-0.0149851507079847,0.00467454748737107,0.304004915669966
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00505288542611095,0.00491722300178056,-0.0146906425096008,0.00458487165737895,0.304165713622293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,41913,-0.00553491197942744,0.00540316698990449,-0.0161251192796402,0.00505529532078536,0.305673058788247
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.00812216323143246,0.00793064899572561,-0.00742190880018973,0.0236662352630547,0.305783794924043
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,-0.00387631785178975,0.00379083781613811,-0.0113063599714204,0.00355372426784095,0.30654359516934
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.0048409135764143,0.00475049647992963,-0.00447005952424779,0.0141518866770764,0.308205831715999
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00373780251211558,0.00367343656182959,-0.00346213314907041,0.0109377381733016,0.308927480468638
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,42249,-0.00304117574237405,0.00300175128537456,-0.00892460826170818,0.00284225677696009,0.311014205751991
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00393713776244874,0.00389178805924959,-0.00369076683368046,0.0115650423585779,0.311726435344724
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,-0.00808300870837383,0.00801066078467879,-0.0237839038463443,0.0076178864295966,0.312977990046446
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,42016,-0.00343653609814463,0.00340869796013918,-0.0101175841000174,0.00324451190372816,0.313392577939338
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2,Interleukin-2,41913,0.00300939056388716,0.00298595641084483,-0.00284308400136869,0.00886186512914302,0.313545696681841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,39736,-0.00429822755556242,0.00428285958574798,-0.0126926323436285,0.00409617723250363,0.315598926607819
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.00685980626203889,0.00687032267491945,-0.020325638704881,0.00660602618080323,0.318069484558605
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.00536221088577229,0.00540708014060023,-0.00523566618980417,0.0159600879613487,0.321364874163294
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDAN1,Codanin-1,39929,-0.00203150882046841,0.00205163912368151,-0.00605272150288418,0.00198970386194735,0.32210329379883
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.00612496055403292,0.00623127100039543,-0.00608833060674212,0.018338251714808,0.32565867583975
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,-0.0113449184452835,0.0115673225380977,-0.0340168706199551,0.011327033729388,0.326722577509642
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.00259763237657361,0.00266028924212631,-0.00261653453799395,0.00781179929114118,0.328864038125818
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,39934,0.00317880068024219,0.0032613917577197,-0.00321352716488843,0.00957112852537281,0.329741740892959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSB,Lupus La protein,41839,-0.00532958123598377,0.0054916070574845,-0.0160931310686534,0.00543396859668585,0.331817178929099
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.00543260726325753,0.00560355730166349,-0.0055503650480029,0.016415579574518,0.332320698641848
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.00328809933175406,0.00339775786464906,-0.00337150608295809,0.00994770474646621,0.333198705524378
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,-0.00502896919765966,0.00522289156019941,-0.0152658366556505,0.00520789826033118,0.335633288254787
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,41933,0.00305323499452728,0.00317193988052362,-0.00316376717129902,0.00927023716035359,0.335777519511333
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.00486157404944846,0.00505066056438238,-0.00503772065674101,0.0147608687556379,0.335788640341581
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.00563671465391529,0.00586288585882736,-0.0171279709372169,0.00585454162938634,0.336360619106664
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.00741390083536954,0.00775091166815435,-0.0226056877049521,0.007777886034213,0.338830771748861
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN4,Nectin-4,42181,-0.00299573169451566,0.00314048295181064,-0.00915107828006452,0.0031596148910332,0.340147210071469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.00554830711738986,0.00583262844194747,-0.00588364462882719,0.0169802588636069,0.341496728506761
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,39657,-0.00265297078673304,0.00278931727509417,-0.0081200326459176,0.00281409107245153,0.341565100411149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00323453720635356,0.00340341924744666,-0.0034361645186419,0.00990523893134902,0.341940643442566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.0148400829016962,0.0156157600536669,-0.0157668068034909,0.0454469726068833,0.34196624828734
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RELB,Transcription factor RelB,39657,-0.00419066139345383,0.00441213285993125,-0.0128384417989191,0.00445711901201142,0.342232617558894
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.00430034381234594,0.00455257736542087,-0.0132233954485709,0.00462270782387898,0.344882264580046
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00246357887364394,0.00260817465983494,-0.00757560120692042,0.00264844345963254,0.344899998651341
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,42181,-0.00270042421836335,0.00286739817696096,-0.00832052464520684,0.00291967620848013,0.346328116577412
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,39586,-0.00590988685646121,0.00627886765241024,-0.0182164674551853,0.00639669374226285,0.346605395944294
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.00351720589265916,0.00375846661789309,-0.00384938867841129,0.0108838004637296,0.349392145805826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,-0.00416766462885042,0.00445863474699461,-0.0129065887329599,0.00457125947525903,0.349939233182047
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.0056566443715106,0.00605679680852946,-0.0175279661162284,0.00621467737320714,0.350358697184745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,-0.00418889294941563,0.00449954751442656,-0.0130080060776917,0.00463022017886043,0.351895400214671
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,39649,-0.00525027601328674,0.00570669898402626,-0.0164354060219782,0.00593485399540473,0.35758250176172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD276,CD276 antigen,42123,-0.00307866070470706,0.0033517329628767,-0.00964805731194538,0.00349073590253127,0.358358868954979
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00393699216059843,0.00432681441625676,-0.0124175484164617,0.00454356409526482,0.362888917969094
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.007375459199962,0.00811769006803419,-0.023286131733309,0.008535213333385,0.36359875488251
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,39657,-0.00263121403585851,0.00289616389950006,-0.00830769527887862,0.00304526720716161,0.363624955926111
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.00292854211156973,0.00322497118325292,-0.00924948563074545,0.003392401407606,0.363850725773995
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSLN,Mesothelin,42048,-0.0049187403977952,0.00543094381540145,-0.015563390275982,0.00572590948039164,0.365117265595122
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.00921057254026825,0.0102250953335412,-0.0292517593940091,0.0108306143134726,0.367724468359537
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00231961516764436,0.00257637524187011,-0.00273008030642106,0.00736931064170979,0.367958467029941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.00267216415981455,0.00297200804841033,-0.0031529716150697,0.00849729993469879,0.368610060618703
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.00339029002102246,0.00377119934529981,-0.00400126069576517,0.0107818407378101,0.368674287777539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.00423489335685344,0.0047331541797229,-0.00504208883540346,0.0135118755491103,0.370951275816916
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00216503858834987,0.00242364805557517,-0.00258531160057745,0.0069153887772772,0.371713870954225
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17A,Interleukin-17A,41877,-0.00357918788141368,0.00400908944459595,-0.0114370031928217,0.00427862742999438,0.371997457776969
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0022065710648125,0.00247916190335637,-0.00265258626576598,0.00706572839539098,0.373456224549023
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17F,Interleukin-17F,41913,-0.00605183320100077,0.00685246000452554,-0.0194826548098708,0.00737898840786929,0.377164624307227
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,39586,-0.00280484624531682,0.0031826259297632,-0.0090427930676527,0.00343310057701905,0.378175084010948
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.0071618272378402,0.00812790526950015,-0.0230925215660605,0.0087688670903801,0.378260883218179
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00245449096015857,0.0027875932953354,-0.00300919189869882,0.00791817381901596,0.3786020053233
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSV,Cathepsin L2,42200,0.00328793427488712,0.00373889316927947,-0.00404029633690063,0.0106161648866749,0.379206982721748
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GH2,Growth hormone variant,41843,-0.013294127041143,0.0151492418041965,-0.0429866409773681,0.0163983868950821,0.380207121922235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0120872789292137,0.0137849107282967,-0.0391057039566752,0.0149311460982479,0.38058812555469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.00600157300330197,0.00685144411742579,-0.0194304034734565,0.00742725746685257,0.38107235838053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,-0.00244673573849782,0.00281691657808264,-0.0079678922315398,0.00307442075454415,0.385089080913962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL24,Interleukin-24,41913,-0.00389454926468374,0.00450245479784513,-0.0127193606684602,0.00493026213909273,0.387063411905348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL31,Interleukin-31,39657,0.00451789518977508,0.00522941273986905,-0.00573175378036826,0.0147675441599184,0.38763997601618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,-0.00403102875743046,0.00476912687608142,-0.01337851743455,0.00531645991968911,0.397998438104918
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,42249,-0.0022420932562134,0.00265442147683797,-0.00744475935081582,0.00296057283838902,0.398313481319271
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,39575,-0.00382781587748949,0.00454483140742275,-0.0127356854360381,0.0050800536810591,0.399674803921937
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.00320558900784511,0.00380685062801417,-0.00425583822306266,0.0106670162387529,0.399770546525433
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,42181,-0.00302212412630033,0.00358961549189491,-0.0100577704904144,0.0040135222378137,0.399854568754044
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.00144392842548629,0.00172162644932334,-0.00481831626616003,0.00193045941518745,0.401655190965436
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.00451711020153443,0.00538664991105004,-0.00604072362412364,0.0150749440271925,0.40172608138927
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,-0.0031291283084518,0.00375483592765982,-0.0104886067266651,0.00423035010976145,0.404660151512634
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00285352507545341,0.00343769648644272,-0.00959141018888114,0.00388436003797432,0.406517741420081
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,-0.00321954422011627,0.00388297743886428,-0.0108301800002903,0.00439109156005771,0.407041327863599
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00258044400658867,0.00312937828254689,-0.00355313742720324,0.00871402544038057,0.409624123715565
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.002034996142862,0.00246998611134924,-0.00280617663538251,0.00687616892110651,0.410020130698372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,39919,0.00308159168901035,0.00374584967884145,-0.00426027368151888,0.0104234570595396,0.410713991987587
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,41913,-0.00328196341927044,0.00399350387424868,-0.0111092310127978,0.00454530417425697,0.411190921598285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0093079958038563,0.0113431037067105,-0.0315404790690089,0.0129244874612963,0.411899202524977
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,39575,0.00271091391661487,0.00331532173684996,-0.00378711668761106,0.00920894452084079,0.413550511213013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,39575,-0.00522099105049582,0.00638578665189285,-0.0177371328882058,0.00729515078721418,0.413605891199004
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,39657,0.00360659703124889,0.00443826911061219,-0.00509241042555099,0.0123056044880488,0.416457231549626
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.010557935163916,0.013003493457573,-0.036044782340759,0.014928912012927,0.416848417789399
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,39649,0.00365912673815027,0.00451045043540579,-0.00518135611524508,0.0124996095915456,0.417236559678133
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,39919,-0.00268474038981239,0.00330978184547426,-0.00917191280694195,0.00380243202731717,0.417294709162461
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.00529655551752098,0.00654774716390327,-0.00753702892372942,0.0181301399587714,0.418579491107767
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00467537129812943,0.00578368468349727,-0.0160113932777841,0.00666065068152521,0.418893448457299
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.0027913739829445,0.00345359871240625,-0.00956042745926076,0.00397767949337175,0.41896036613685
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,41973,0.00185993847677477,0.00230141865775542,-0.00265084209242586,0.00637071904597539,0.419006860802613
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.00245606983247713,0.00305656395093369,-0.00844693517630715,0.0035347955113529,0.421677099816953
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00272916369973659,0.00340497537113989,-0.0039445880276976,0.00940291542717077,0.422846574480761
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA5,Annexin A5,41780,-0.00226344506933306,0.00283532449502698,-0.00782068107958593,0.00329379094091981,0.424709671013968
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.00667935594760255,0.00838991982070808,-0.00976488690098529,0.0231235987961904,0.425978092782221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.00659233343767135,0.00828330156084953,-0.0228276044969364,0.00964293762159374,0.426131576185441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,-0.00386123497951608,0.00485712194752824,-0.0133811939966714,0.00565872403763926,0.426651606942726
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,42079,-0.00212148105908265,0.00267873915407022,-0.00737180980106028,0.00312884768289498,0.42839210359505
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,39990,0.00480700892602433,0.00609326278201217,-0.00713578612671952,0.0167498039787682,0.430183622271311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,39990,0.00178616325292492,0.00226931729840527,-0.00266169865194942,0.00623402515779926,0.431243934669188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.00342139007966485,0.00434998291003449,-0.00510457642400275,0.0119473565833325,0.431574299296436
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,-0.00275643039373022,0.00351201057616211,-0.00963997112300795,0.00412711033554752,0.432553392437742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00305115775979323,0.00391453236025266,-0.00462132566630199,0.0107236411858885,0.435735154019272
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00459041305529186,0.00590610630624797,-0.0161663814155379,0.00698555530495416,0.437038833879386
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00211798840954951,0.00274555014297427,-0.00326328987068006,0.00749926668977908,0.440468250598874
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.017464860040788,0.0226451246298864,-0.0618493043153654,0.0269195842337895,0.440579880889094
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,-0.00461592435081667,0.00601251741576087,-0.016400458485708,0.00716860978407462,0.442670374645816
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,41300,0.0035578458621163,0.00466055373815141,-0.00557683946466047,0.0126925311888931,0.445241729101763
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,-0.00290915066271006,0.00381247936821723,-0.0103816102244158,0.0045633088989957,0.445443477865394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.00595662588535559,0.00782159351547572,-0.021286949175688,0.00937369740497682,0.446334986643186
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB5,Serpin B5,41900,-0.00344371922841291,0.00453956899285226,-0.0123412744544033,0.00545383599757752,0.448105026576769
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00330687646139024,0.00438004608627622,-0.0118917667904916,0.00527801386771116,0.450273173941477
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,-0.00234376451696145,0.00310623631989838,-0.00843198770396228,0.00374445867003939,0.450540946971226
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTR,Methionine synthase,39575,-0.00460896687835819,0.0061381291754377,-0.0166397000622161,0.00742176630549969,0.452744070790676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00530389584650533,0.00708461454114374,-0.00858194865413639,0.0191897403471471,0.454081496839714
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00420184244092076,0.00561476560004972,-0.0152067830170182,0.00680309813517669,0.454258804208282
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,0.00440970162464737,0.00590519753101889,-0.00716448553614965,0.0159838887854444,0.455227760901125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,42007,-0.00342948544619364,0.00459792674380016,-0.0124414218640419,0.00558245097165467,0.455755107192541
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00257794226603329,0.00346590571160227,-0.00937111746077374,0.00421523292870717,0.457012544201241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.00328740752022813,0.00443311564140989,-0.0119763141773915,0.00540149913693525,0.458368991360108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.00365412082458214,0.00494690573911155,-0.0133500560732408,0.0060418144240765,0.460124177364254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.00394445915776985,0.00534172918192511,-0.00652533003880337,0.0144142483543431,0.460272747232435
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,-0.00429803975399557,0.00582081167118724,-0.0157068306295226,0.00711075112153142,0.460292153871429
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.00330757809914237,0.00448156968879615,-0.00547629849089808,0.0120914546891828,0.460503096333799
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00333122940302422,0.00451838040103235,-0.0055247961829992,0.0121872549890476,0.460978900402311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.0020705697772905,0.00280982760841297,-0.00343669233519892,0.00757783188977992,0.461197108190087
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.00340062408744062,0.00463193688011003,-0.0124792203724563,0.00567797219757503,0.46286098175787
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.00230906506831774,0.00315226988762814,-0.00848751404806889,0.00386938391143341,0.463873808378545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0102188867208412,0.0139934408254799,-0.0376460307387818,0.0172082572970994,0.465242328015517
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.00284080031317043,0.0038910774205752,-0.00478571143115697,0.0104673120574978,0.465356358505396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00507366568525185,0.00702107552484363,-0.0188349737139454,0.00868764234344167,0.469920364853584
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00206726781783627,0.00286635736614048,-0.00768532825547161,0.00355079261979908,0.470790663229385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.00305817940410092,0.00426438151657392,-0.0114163671765858,0.00530000836838395,0.473299849730663
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAG,S-arrestin,39586,-0.00352613954232273,0.00492074104088081,-0.0131707919824491,0.00611851289780365,0.473644140537378
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.00229160636201057,0.0032123333512014,-0.00400456700634417,0.00858777973036532,0.475624437742146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCLN,Nicalin,41913,0.00341089345994994,0.00478160911515038,-0.0059610604057448,0.0127828473256447,0.475650429108618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00239648163358982,0.00335988684677172,-0.00418889658608275,0.0089818598532624,0.475698440517596
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00242546689410685,0.00340618623419354,-0.00425065812491249,0.00910159191312618,0.476431749262001
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.00261254603398597,0.00366957418717491,-0.00457981937287685,0.00980491144084879,0.476512125670601
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG3,Desmoglein-3,42196,-0.00232938855166562,0.00328027543317321,-0.00875872840068511,0.00409995129735387,0.477642024877388
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00228448023687484,0.00323157954509521,-0.00861837614526146,0.00404941567151177,0.479628890435052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,-0.0018301466297846,0.00260222415211557,-0.00693050596793113,0.00327021270836193,0.481880194933111
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.00566338017300497,0.00808854280595024,-0.0215169240726674,0.0101901637266575,0.483833933708513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.00475971798444345,0.00680993410628109,-0.00858775286386749,0.0181071888327544,0.484605690729115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.00549865743171389,0.00787380872142547,-0.0209313225257078,0.00993400766228003,0.484972073533982
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,39575,0.0031207076884693,0.00447098554868049,-0.00564242398694445,0.0118838393638831,0.485197607930603
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,41913,-0.00204890148950447,0.00294555313130758,-0.00782218562686734,0.00372438264785839,0.486696881643678
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,-0.00336559986739679,0.0048457071932289,-0.0128631859661254,0.00613198623133186,0.487347737531026
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,39934,-0.00386012430881911,0.00559758590917787,-0.0148313926908077,0.00711114407316951,0.490456619300068
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.00504137515930074,0.0073204146627982,-0.0193893878983852,0.00930663757978373,0.491040856972228
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.00569352730383625,0.00831281133582876,-0.0219866375220606,0.0105995829143881,0.493414749548129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,39979,-0.00135262638726552,0.0019795447897875,-0.00523253417524901,0.00252728140071798,0.494430110951833
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.00176228958225272,0.00258852739509353,-0.00683580327663605,0.0033112241121306,0.496004719720324
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),39775,0.0116070220776499,0.0171206367043728,-0.0219494258629208,0.0451634700182205,0.497814231909821
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,39575,0.00265726499289661,0.00392319240884647,-0.00503219212844248,0.0103467221142357,0.498215877070985
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,39657,0.00187965913580243,0.00278617213720945,-0.00358123825312809,0.00734055652473295,0.499919538584291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.00436132100920258,0.00646941073432008,-0.00831872403006477,0.0170413660484699,0.500233225076376
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,0.00390769758398711,0.00583920298496743,-0.00753714026654905,0.0153525354345233,0.503370542447198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.0017269945410585,0.00258091413928218,-0.00333159717193456,0.00678558625405156,0.503417141561619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,39586,-0.00472715205966434,0.00706596039104894,-0.0185764344261203,0.00912213030679157,0.503507318545736
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,39657,0.00361400579141822,0.00540341078499293,-0.00697667934716793,0.0142046909300044,0.503612866124542
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00454826293982611,0.00680992504554269,-0.0178957160290898,0.00879919014943756,0.504219519177384
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,41913,-0.00294018618637969,0.00442928771986981,-0.0116215901173245,0.00574121774456514,0.506826208076757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00398274680802737,0.00603134264302511,-0.0158041783883566,0.00783868477230185,0.509048479507783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00567030489686014,0.00859928770834456,-0.0225249088052155,0.0111842990114952,0.509657680153089
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00267880497940877,0.00407832929412237,-0.00531472043707107,0.0106723303958886,0.51129569011029
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,39934,-0.00230632224086316,0.0035178457188077,-0.00920129984972626,0.00458865536799994,0.512090700148181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.00248171874536594,0.00378780018502817,-0.00494236961728928,0.00990580710802116,0.512360873314286
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,39757,-0.00318733278387654,0.00486535224158998,-0.0127234231773929,0.00634875760963982,0.512411515074678
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0029155754954314,0.00445177238285136,-0.0116410493658201,0.00580989837495726,0.512527282951841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,39575,-0.00308640158258863,0.00472527064136942,-0.0123479320396727,0.00617512887449544,0.513660840449786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.0024096236440412,0.00371041574570622,-0.00486279121754299,0.00968203850562539,0.516079581458981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BSND,Barttin,39560,-0.0020471553745827,0.00315253284677774,-0.00822611975426708,0.00413180900510167,0.516113858251034
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,41967,-0.0063199335978379,0.00983921177406961,-0.0256047886750143,0.0129649214793385,0.520675715042024
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.00268649868532075,0.00418561500236424,-0.0108903040899547,0.00551730671931316,0.520987636427072
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTN,Neuroplastin,41843,-0.00468391255739597,0.00731875082043654,-0.0190286641654516,0.00966083905065965,0.522191485190728
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,39657,0.00234914670293329,0.00367526994420838,-0.00485438238771513,0.00955267579358171,0.522721266107953
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00210275511100584,0.00330000175809097,-0.00436524833485246,0.00857075855686413,0.52400677876222
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,39934,-0.00924923353863518,0.0146824892075455,-0.0380269123854244,0.019528445308154,0.52874002101288
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00293384620330824,0.00467738739517609,-0.0121015254978534,0.00623383309123691,0.530514732259589
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,39575,-0.00276366496596856,0.00446270235706368,-0.0115105615858134,0.00598323165387626,0.535744381102705
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,39560,-0.00241011552190153,0.00393481329346285,-0.0101223495770887,0.00530211853328567,0.540212581927596
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.00654367439517394,0.0107829957534683,-0.0276783460719718,0.0145909972816239,0.543961796350364
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,-0.00519608328396085,0.00865097639377532,-0.0221519970157605,0.0117598304478388,0.54809519736723
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,-0.00217570017377681,0.00362283811809632,-0.00927646288524559,0.00492506253769198,0.548150859614529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00304719586820147,0.00509271566350206,-0.0130289185686655,0.00693452683226256,0.54962267842761
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.00352697558028602,0.00589754172102761,-0.0150861573535001,0.0080322061929281,0.549824499903817
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,-0.0021208705241135,0.00355361182315451,-0.00908594969749634,0.00484420864926934,0.550637030253758
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,-0.00316400980656139,0.00530156393879447,-0.0135550751265985,0.00722705551347577,0.550648252192158
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,-0.00340211722367022,0.00570158871403102,-0.014577231103171,0.00777299665583058,0.550722419771729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,39586,-0.00414054082007161,0.00694613315387345,-0.0177549618016636,0.00947388016152036,0.551125432197069
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.00244114749675728,0.00414005515274899,-0.0105556555961453,0.00567336060263075,0.555441164143202
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,39959,-0.00123872584018991,0.00210855006941625,-0.00537148397624576,0.00289403229586593,0.556894697558167
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,39560,-0.00645417329234802,0.0109915580389716,-0.0279976270487323,0.0150892804640363,0.557085739547103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00424325806709528,0.00724927199273425,-0.0184518311728544,0.00996531503866385,0.558334031281027
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,41913,-0.00263418028830114,0.00450791659522798,-0.011469696814948,0.0062013362383457,0.558997860267659
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.00145842706737899,0.0025058290346237,-0.00636985197524144,0.00345299784048346,0.560569254701722
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00177306121023094,0.0030514404599962,-0.00775388451182348,0.00420776209136161,0.561213875977977
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00202279675963658,0.00349789519388243,-0.00483307782037298,0.00887867133964615,0.563080219714207
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,39560,-0.00347589767164063,0.00605759002848846,-0.015348774127478,0.00839697878419675,0.566109056269891
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,-0.0054296826504879,0.00946697548896553,-0.0239849546088603,0.0131255893078845,0.566291153908978
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00302862151354061,0.00528188646134762,-0.0133811189777819,0.00732387595070072,0.566387121633025
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00316277300198508,0.00552291700296388,-0.00766214432382414,0.0139876903277943,0.566884300162083
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,39539,-0.00412590968848276,0.00725388598076656,-0.0183435262107852,0.0100917068338197,0.569512969538179
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0035794217875449,0.00630584681328121,-0.0159388815415761,0.00878003796648627,0.570294185417727
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,42207,-0.00827090489336186,0.0146079821787785,-0.0369025499637677,0.020360740177044,0.57127343109827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00258370865106659,0.00457435336585904,-0.0115494412481503,0.00638202394601713,0.572202443517538
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESR1,Estrogen receptor,39657,0.00302885164526913,0.0053761089571632,-0.00750832191077075,0.013566025201309,0.573180058084249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,-0.00211890063633845,0.00376490265839919,-0.00949810984680087,0.00526030857412396,0.57357805717139
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,-0.00166303592580898,0.00295697078521931,-0.00745869866483882,0.00413262681322086,0.573844635572022
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00181179511394663,0.00323048295626836,-0.00451995148033935,0.00814354170823261,0.574915647489826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.0017548967155636,0.00314034657462958,-0.00440018257071038,0.00790997600183759,0.576294197064613
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00180744306792588,0.0032427062861178,-0.004548261252865,0.00816314738871676,0.577271989597427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00215368805184438,0.00387036679932859,-0.00543223087483965,0.00973960697852841,0.577910685135482
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPS,Calcyphosin,39929,0.00495773850988647,0.00891538217829037,-0.0125164105595627,0.0224318875793356,0.578161568038446
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.00364411347173306,0.00657978994065465,-0.00925227481195006,0.0165405017554162,0.579703165565788
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.00257040683090376,0.0046454782886319,-0.00653473061481477,0.0116755442766223,0.58005952784597
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.00278890308414701,0.00504792164430041,-0.00710502333868179,0.0126828295069758,0.580626905961179
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,-0.00340227622440995,0.00616292802059096,-0.0154816151447682,0.00867706269594834,0.580919568609949
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,-0.00474647592089456,0.0086167140258204,-0.0216352354115025,0.0121422835697134,0.581750896653392
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,39649,-0.00251032205551859,0.00457386631427948,-0.0114751000315064,0.00645445592046918,0.583126156985723
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00161846414953036,0.00296698231450186,-0.007433749485954,0.00419682118689328,0.58542648010783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00390321663528117,0.00718434523395895,-0.0101781000232784,0.0179845332938407,0.586937772018797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.00268126473127462,0.00493808801551583,-0.00699738777913642,0.0123599172416857,0.587156779102605
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.00429906402153115,0.0079492286852243,-0.0112814242015085,0.0198795522445708,0.588645901847779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.00207134154281676,0.0038308181627381,-0.00543706205614991,0.00957974514178344,0.588721705701901
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.00198032973941025,0.00366631807536264,-0.00916631316712103,0.00520565368830053,0.58910848446489
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,41839,-0.00233694393014879,0.00432735592012522,-0.0108185615335942,0.00614467367329665,0.589178747781649
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.00140027729299971,0.00259611713180639,-0.00368811228534081,0.00648866687134023,0.589637869338417
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.00283052654618742,0.00525297629503507,-0.00746530699208132,0.0131263600844562,0.590006497503573
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,41839,-0.00279165992158701,0.00518239008172557,-0.0129491444817691,0.00736582463859511,0.590115397343956
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,41843,0.00272644049310943,0.00507739806320309,-0.00722525971076862,0.0126781406969875,0.591293269014819
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.00411612075288361,0.00766720898329152,-0.0109116088543678,0.019143850360135,0.591383965204471
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,39959,0.00193724461215638,0.00361763686793117,-0.00515332364898871,0.00902781287330146,0.592314628208277
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTTG1,Securin,39757,0.00209933827832063,0.00392064115181368,-0.00558511837923418,0.00978379493587544,0.592343934559009
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFD,Complement factor D,39979,-0.00101387993820937,0.00189932371099447,-0.00473655441175852,0.00270879453533979,0.593482711967623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH4,Cadherin-4,39586,-0.00233128571533839,0.00437815776021625,-0.0109124749253622,0.00624990349468547,0.594403683738221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,-0.00195557222853304,0.00367970147988047,-0.00916778712909875,0.00525664267203268,0.595118701122795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSPN,Claspin,41820,0.00174341086321433,0.00331349880889562,-0.00475104680222109,0.00823786852864975,0.59878999395865
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,39560,0.00383429268738465,0.00730207269345291,-0.0104777697917831,0.0181463551665524,0.599526742647126
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00206248658095586,0.00392946217032465,-0.00976423243479217,0.00563925927288045,0.599678829267953
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.00198495081617166,0.00380358581442143,-0.00943997901243766,0.00547007738009435,0.601776161931287
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,39757,-0.00285095955298296,0.00549632983291752,-0.0136237660255013,0.00792184691953538,0.603978565248696
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.00225496772415283,0.00436521656245133,-0.0108107921865574,0.00630085673825177,0.605462323306328
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.00130792215476316,0.00253380257605368,-0.00365833089430206,0.00627417520382838,0.605732140572542
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,-0.00236385744354518,0.00458870880546587,-0.0113577267022583,0.00663001181516792,0.606461001350722
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,39757,-0.00416336136193048,0.00813971947247082,-0.0201172115279733,0.0117904888041123,0.60902015390324
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,-0.00117836111540725,0.00230965478754207,-0.00570528449898971,0.0033485622681752,0.609929044985289
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.00114503403278369,0.0022464221514948,-0.00325795338414612,0.0055480214497135,0.610259774602438
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0127873259431125,0.025096146200221,-0.0619757724955457,0.0364011206093207,0.61038854475572
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMNB1,Lamin-B1,39908,0.00292317479979713,0.00574371588099711,-0.0083345083269572,0.0141808579265515,0.610808111395543
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00256214437243297,0.00504773983460061,-0.00733142570338424,0.0124557144482502,0.611756060055844
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,39638,0.00195474825393892,0.0038619884073363,-0.00561474902444023,0.00952424553231807,0.612760948016812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,-0.00252296015000867,0.00502860470085975,-0.0123790253636938,0.00733310506367644,0.615871587621385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.00496290062864678,0.00995526678179665,-0.0145494222636746,0.0244752235209682,0.618127493418185
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDC4,Syndecan-4,42145,0.00219931556393357,0.00441966132870647,-0.00646322064033111,0.0108618517681983,0.618759393267373
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00189403043404597,0.00380884749860126,-0.00935937153130444,0.00557131066321249,0.619007730245013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00251436041499873,0.00506591802650107,-0.0124435597469408,0.00741483891694337,0.619672463593189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,0.00251599761549657,0.00508605417782196,-0.00745266857303448,0.0124846638040276,0.620831924062368
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,41976,-0.00256836193725401,0.00521040653896943,-0.0127807587536341,0.00764403487912608,0.622070650193633
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00119569626491861,0.00245012708431747,-0.00360655282034362,0.00599794535018084,0.625549702673633
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTOA,Otoancorin,39586,-0.00241264204082391,0.00494518655841031,-0.0121052076953081,0.0072799236136603,0.625646809095102
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00238998647641048,0.00490602719438378,-0.0120057997774027,0.00722582682458172,0.626159564085608
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0016143337151703,0.00336980997206461,-0.00821916126041693,0.00499049383007633,0.631906998160539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROK1,Prokineticin-1,42119,-0.00221723532102624,0.00463769804207575,-0.0113071234834947,0.00687265284144223,0.63259414610245
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,39897,-0.00121088504818924,0.00254410290841409,-0.00619732674868085,0.00377555665230236,0.634113807436015
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.0011981551483309,0.00253665919115344,-0.00377369686632983,0.00617000716299164,0.636694688964737
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,0.0025918560770248,0.00553393978899148,-0.0082546659093985,0.0134383780634481,0.639538979348747
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEB,Nebulin,39575,-0.00174934732920409,0.00373989223932158,-0.00907953611827439,0.00558084145986621,0.639970232845816
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.00265851666770837,0.00570130596614178,-0.00851604302592951,0.0138330763613463,0.641008638923093
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00186008088329176,0.00400370893472861,-0.00970735039535983,0.00598718862877631,0.642234713593534
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.000873100334510016,0.00188372837675957,-0.00456520795295877,0.00281900728393874,0.643017879744452
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.00310227321043371,0.0067237704742417,-0.01007631691908,0.0162808633399474,0.644528674056879
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A16,Protein S100-A16,41814,-0.00260610375728496,0.00567594712157608,-0.0137309601155741,0.00851875260100417,0.64613493734351
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.00196005064374828,0.00427175778936581,-0.00641259462340871,0.0103326959109053,0.646356864792248
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,39757,0.00100049845708281,0.0021805880531999,-0.003273454127189,0.00527445104135463,0.64637202436705
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK4,Kallikrein-4,42262,0.00263779684977042,0.00584874730916816,-0.00882574787619916,0.01410134157574,0.651995251095316
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,41843,-0.00372419481707195,0.00826902594432226,-0.0199314856679436,0.0124830960337997,0.652444628563031
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST6,Cystatin-M,41864,0.00208322693539412,0.00464088528216901,-0.00701290821765714,0.0111793620884454,0.653521461695124
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,41913,0.00141855944397565,0.00318330296554093,-0.00482071436848458,0.00765783325643588,0.655875381449639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,39560,0.00327001818390485,0.00735349537921974,-0.0111428327593658,0.0176828691271755,0.656553332509701
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSAP,Prosaposin,39886,-0.00118492466388771,0.00267674317049257,-0.00643134127805315,0.00406149195027773,0.658010019227129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00127394951036428,0.00288586720759404,-0.00438235021652004,0.0069302492372486,0.658898576385361
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.00383598264743837,0.00871067871521233,-0.0132369476343778,0.0209089129292545,0.659672471200474
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00104239688723323,0.00237974973310972,-0.00570670636412828,0.00362191258966182,0.661374376647455
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.00198603786128695,0.00454374787740579,-0.00691970797842839,0.0108917837010023,0.662051258041078
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.0012460405631945,0.00285232085042592,-0.00683658943002931,0.0043445083036403,0.662227653021361
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,41839,-0.00267247193203482,0.00613339181090338,-0.0146939198814054,0.0093489760173358,0.663043394339458
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,-0.00264842919967024,0.00611739159466782,-0.0146385167252192,0.00934165832587869,0.665070934060667
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL11,Interleukin-11,41913,-0.00244419051659576,0.00568839436917377,-0.0135934434801764,0.00870506244698483,0.667435231357461
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,39575,0.00234252430912715,0.00547733679516718,-0.00839305580940053,0.0130781044276548,0.668895573672542
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.00439176140092798,0.0103257662685593,-0.0246302632873042,0.0158467404854483,0.67060971441664
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,-0.00161337403237157,0.00382127562164574,-0.00910307425079721,0.00587632618605407,0.672881246899612
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,39560,0.00237460478049514,0.0056385250449925,-0.00867690430769016,0.0134261138686804,0.673661586089986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.00261596826873275,0.00627840631666971,-0.0149216446494054,0.00968970811193989,0.676932845374854
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.00125212933734276,0.0030093384460801,-0.00464617401697422,0.00715043269165975,0.67735713331434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,0.00208741706866433,0.00504922017096752,-0.007809054466432,0.0119838886037607,0.679311568110699
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.00242458114217265,0.00588929295504791,-0.0139675953340665,0.00911843304972125,0.680572379398217
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,39979,-0.000714213613156353,0.00176410874711751,-0.00417186675750667,0.00274343953119396,0.685589471821215
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK1,Kallikrein-1,42016,0.004814654196915,0.0119508929516634,-0.0186090959883453,0.0282384043821753,0.687050407333173
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.00262457137014176,0.00652348399352114,-0.0154105999974432,0.0101614572571597,0.687451481817566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,39518,0.00166520896463758,0.00414963134702981,-0.00646806847554084,0.009798486404816,0.688213875331084
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.00113663221123673,0.00283847732577915,-0.00670004776976387,0.00442678334729041,0.688841978172739
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,41774,0.00236223735033669,0.00592198800993174,-0.00924485914912953,0.0139693338498029,0.689978787901803
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00152708748480394,0.00383684106569849,-0.00904729597357298,0.0059931210039651,0.690633116681957
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH22,Cadherin-22,39757,0.00102695810270984,0.00259696077395022,-0.00406308501423258,0.00611700121965227,0.692521226934144
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00171981369820809,0.00435546369816304,-0.00681689515019147,0.0102565225466077,0.692951291966141
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,0.0020630083572819,0.00530880561102902,-0.00834225064033499,0.0124682673548988,0.697577280948068
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,39575,-0.00116161932349806,0.00300629822930732,-0.0070539638529404,0.00473072520594428,0.699211466007065
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,42181,0.000986371338338459,0.00257118937353012,-0.00405315983378057,0.00602590251045749,0.701262754656449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCAN,Versican core protein,42249,-0.00107234755551472,0.00280793031698392,-0.0065758909768032,0.00443119586577377,0.702541758441863
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,39657,-0.00118853051558275,0.00312209499113189,-0.00730783669820126,0.00493077566703575,0.703445315913674
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,-0.00137041992673868,0.0036000053813766,-0.00842643047423682,0.00568559062075945,0.703454080031352
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00126253955675915,0.00332418433780413,-0.00777794085885524,0.00525286174533695,0.704098027719181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,39649,0.00133935753524351,0.00356527527142654,-0.00564858199675252,0.00832729706723953,0.707171421003541
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,39657,0.00152100950925324,0.00405968124368997,-0.0064359657283791,0.00947798474688558,0.707918819249998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,39657,-0.000977001402042226,0.00262377948922908,-0.00611960920093122,0.00416560639684677,0.709628883479828
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,41839,-0.00190200773035442,0.00514708980561933,-0.0119903037493683,0.00818628828865947,0.711738100320359
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,-0.00152518353367017,0.00424816136208863,-0.00985157980336389,0.00680121273602354,0.719585461046555
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,-0.000904783493407517,0.00252683545463978,-0.0058573809845015,0.00404781399768646,0.72029658323047
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,-0.00113509853939396,0.003194007865675,-0.00739535395611695,0.00512515687732903,0.722308723366647
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C5,Complement C5,39979,0.000489920320389659,0.00140970603821385,-0.0022731035145095,0.00325294415528881,0.728196851811992
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,-0.0018402963204714,0.00531197430615112,-0.0122517659605276,0.0085711733195848,0.729016761927642
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.00162587635662955,0.0047762715916382,-0.00773561596298132,0.0109873686762404,0.733555303309425
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,42070,-0.00210622598282443,0.00620519163025828,-0.0142684015781307,0.0100559496124818,0.734291382125889
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.00140502920038516,0.00414453727585812,-0.00952832226106707,0.00671826386029674,0.734610372637369
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FZD10,Frizzled-10,39649,-0.00189727014631316,0.00560835700001183,-0.0128896498663363,0.00909510957371002,0.735148526090741
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,42208,-0.00352682263117714,0.0104410249011164,-0.0239912314373653,0.0169375861750111,0.735530350131538
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.00211698251693507,0.00630467198579728,-0.0102401745752276,0.0144741396090977,0.737043229465075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA4,Annexin A4,42088,-0.00225721423790707,0.00675972658085408,-0.0155062783363811,0.0109918498605669,0.73844441104395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.00156407415228351,0.0047043135647365,-0.00765638043460002,0.010784528739167,0.739535754020364
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNPO1,Transportin-1,39757,-0.00110972448460195,0.00334265679566705,-0.00766133180410936,0.00544188283490547,0.739903982657206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.00388397705122425,0.0118019556115042,-0.0270158100497724,0.0192478559473239,0.74208828899655
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPHS1,Nephrin,39657,0.00102450363495683,0.00313254978313154,-0.00511529393998099,0.00716430120989465,0.743635479709501
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00205213578562891,0.00633193867735764,-0.0103584640219921,0.0144627355932499,0.745873906406348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00170961925755118,0.0053710257108424,-0.0122368296508023,0.00881759113569992,0.750260321133577
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPHS2,Podocin,39657,-0.00302311461875134,0.00958453228373864,-0.0218087978948791,0.0157625686573764,0.75245178987973
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP73,Tumor protein p73,39649,0.00100932528274058,0.00322200657234408,-0.00530580759905382,0.00732445816453498,0.75408916705753
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.00251041378964705,0.00805935571277055,-0.0132859234073832,0.0183067509866773,0.755432479421666
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,0.0025037145353893,0.00805048760511465,-0.0132752411706354,0.018282670241414,0.755805318928215
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,39757,-0.00129324939216772,0.00418343529739604,-0.00949278257506395,0.00690628379072851,0.757224040987084
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PODXL,Podocalyxin,42070,-0.000436818122111257,0.00141336412189534,-0.00320701180102613,0.00233337555680361,0.757278617300656
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,-0.00161829671067781,0.00525771915290375,-0.0119234262503692,0.00868683282901355,0.75824458917838
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL9,Interleukin-9,39757,0.00158347482007202,0.00529004020334259,-0.00878500397847945,0.0119519536186235,0.764692820260713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,39560,-0.00101060277857948,0.00343445644876243,-0.00774213741815385,0.00572093186099489,0.768569341206304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMCH,Pro-MCH,39575,-0.00227153303186021,0.00775378359966777,-0.017468948887209,0.0129258828234886,0.769559784140165
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,41839,0.00138182388525193,0.00472722070139497,-0.0078835286894822,0.0106471764599861,0.770052576654245
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00158374039277165,0.00544894688808247,-0.00909619550787,0.0122636762934133,0.771323859169972
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.000829587441923281,0.00287347468752648,-0.00480242294562861,0.00646159782947517,0.772812169936428
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00143816948684992,0.00499633695684268,-0.0112309899222616,0.00835465094856172,0.773470908113026
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL25,Interleukin-25,39510,0.000923914642417651,0.00322699858466731,-0.00540100258353029,0.00724883186836559,0.774647873700507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,-0.00108438935892568,0.00388813517249972,-0.00870513429702513,0.00653635557917377,0.780328202642869
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.0012016687475524,0.00431507751094059,-0.00965922066899596,0.00725588317389116,0.780648062755017
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,39560,-0.0010235015051371,0.00376235405396918,-0.00839771545091669,0.00635071244064248,0.785598286328288
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.00113781375313519,0.00419006533908562,-0.00935034181774301,0.00707471431147263,0.785971879011198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,41913,0.00104169684941924,0.0038567044405543,-0.00651744385406719,0.00860083755290568,0.787087313248985
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.000803127401511664,0.00298036227472792,-0.00503838265695506,0.00664463745997839,0.787570721324302
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.00110172790360948,0.00413360279926984,-0.00920358939017837,0.00700013358295941,0.789836305062443
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MLLT1,Protein ENL,39560,0.00162401154374603,0.00623371943525585,-0.0105940785493554,0.0138421016368475,0.794467218495925
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.000978712760782895,0.00376341782407672,-0.00639758617440748,0.00835501169597327,0.794822721078293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00107001709730125,0.0041415226092046,-0.00704736721673977,0.00918740141134226,0.796131300534791
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD99,CD99 antigen,42137,0.000476305272055934,0.00185921343951009,-0.00316775306938384,0.00412036361349571,0.797810771557738
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.00164596552777969,0.00650523635355367,-0.0111042977251855,0.0143962287807449,0.800256199714389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRP15,RRP15-like protein,39586,0.00213123996166059,0.00858256802432253,-0.0146905933660116,0.0189530732893328,0.803889964474175
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00170913512377639,0.00703295252382339,-0.0120754518229175,0.0154937220704702,0.80799587283089
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.000667920973349009,0.0027733229792839,-0.00476779206604743,0.00610363401274545,0.809684475893281
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,39721,-0.00130450899312543,0.00545703130529888,-0.0120002903515112,0.00939127236526037,0.811070412850473
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,39978,-0.00255765619300816,0.0107178012101795,-0.0235645465649601,0.0184492341789437,0.811391929304067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F2,Prothrombin,39979,-0.000332606981923652,0.00139512598713063,-0.00306705391669969,0.00240183995285238,0.811570187093233
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,0.000573863735079459,0.00244284441888943,-0.00421411132594383,0.00536183879610274,0.814278005179238
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.0013527465956678,0.00581148287328345,-0.0127432530273034,0.0100377598359678,0.815942555391005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,41900,0.0013114050925923,0.00567735311283281,-0.00981620700856,0.0124390171937446,0.817327041112501
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPGN,Epigen,39919,-0.00100457734702785,0.00435181930250606,-0.00953414317993973,0.00752498848588402,0.817442673647027
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.00121269490391568,0.00527605856143669,-0.0115537696843316,0.00912837987650023,0.818213673698934
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,39979,-0.000556413128158568,0.00242291284720213,-0.00530532230867475,0.00419249605235761,0.818370703082654
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,-0.00106435379095171,0.00464990301393147,-0.0101781636982574,0.00804945611635396,0.818952411402682
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,-0.000339443454897278,0.00150567145739471,-0.00329055951139092,0.00261167260159636,0.821637835241311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.00107096625913229,0.00478360307595377,-0.0083048957697371,0.0104468282880017,0.822851939842722
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,39560,0.00137025866976973,0.00614051539344005,-0.0106651515013728,0.0134056688409122,0.823422586495986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.000900838500236365,0.00405072795598578,-0.00703858829349577,0.0088402652939685,0.8240149585909
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUK1,Guanylate kinase,39575,0.000836535647169885,0.00378191120921018,-0.00657601032288206,0.00824908161722183,0.824945582459226
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL33,Interleukin-33,41913,0.000811417167947676,0.0036832089370172,-0.00640767234860604,0.00803050668450139,0.825639579009183
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0005152700631258,0.00235377788521773,-0.00409813459190096,0.00512867471815256,0.826721950204158
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C3,Complement C3,39445,-0.00094795874232677,0.00433452730621327,-0.00944363226250479,0.00754771477785125,0.826888291915285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,41900,0.00142426465829296,0.0065529703684616,-0.0114195572638918,0.0142680865804777,0.827941716684966
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,39560,-0.000812836743720749,0.00374696349195192,-0.00815688518794651,0.00653121170050501,0.828265281161987
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00102917913661539,0.00474663451021135,-0.00827422450339885,0.0103325827766296,0.828350382348608
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,39657,0.000857204186423917,0.00401282448825606,-0.00700793181055795,0.00872234018340578,0.830850329476762
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,41665,0.000973254408843366,0.00455623558410612,-0.00795696733600463,0.00990347615369136,0.830855059896618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.00137237063454841,0.00642970174394825,-0.0112298447835902,0.013974586052687,0.830985852815525
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,39720,0.000725016952769271,0.00342326247690724,-0.00598457750196891,0.00743461140750746,0.832273796287169
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.000967300700090875,0.00457200160510968,-0.00992842384610585,0.0079938224459241,0.832445916018161
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,39757,0.00139275669980646,0.00689861239853812,-0.0121285236013283,0.0149140370009412,0.840006871870609
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,39624,-0.00127287357622547,0.00631976100746992,-0.0136596051508665,0.0111138579984156,0.840380412129606
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.000610299171461181,0.00308606319193818,-0.00665898302766002,0.00543838468473765,0.843236039425374
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,-0.000502760552814831,0.00255065569106398,-0.00550204570730023,0.00449652460167056,0.843744744131749
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,-0.0035153152601718,0.0179306644485362,-0.0386594175793027,0.0316287870589591,0.844573614224173
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,39657,-0.000674921947316975,0.00345909848362406,-0.00745475497522012,0.00610491108058617,0.845306517009571
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.000572058296390013,0.00293601991200412,-0.00518254073113805,0.00632665732391808,0.845520069226421
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00119621210415794,0.00615357812452404,-0.0132572252282251,0.0108648010199092,0.845871761758553
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.00166573738228571,0.00866828582828484,-0.018655577605724,0.0153241028411526,0.847616835984916
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.000612768141830586,0.00319557403553923,-0.00565055696782631,0.00687609325148748,0.847937438662614
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,39657,0.00107954074375896,0.00580265714398678,-0.0102936672584551,0.0124527487459731,0.852414858941238
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.00112909169745801,0.0061448437693032,-0.0131729854852923,0.0109148020903763,0.854215309886795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.000682639500984883,0.00379363456383238,-0.00675288424412657,0.00811816324609634,0.857200325266753
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,39657,0.00101532228263253,0.00566340866669732,-0.0100849587040942,0.0121156032693593,0.857723023709922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,42286,-0.000505116668589086,0.00282252949673727,-0.00603727448219413,0.00502704114501596,0.857972652047232
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,41839,-0.000535249499190324,0.00304066767298297,-0.00649495813823695,0.00542445913985631,0.860272867587302
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,-0.000496726354416362,0.00282559882748191,-0.00603490005628091,0.00504144734744818,0.860457627745591
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.000632641139525611,0.00362077540947075,-0.00646407866303705,0.00772936094208827,0.861298143704784
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,39919,-0.00059254447598438,0.00339910171234474,-0.00725478383218008,0.00606969488021132,0.861614079124029
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHGA,Chromogranin-A,39966,-0.00134132799507374,0.00797631380733505,-0.0169749030574504,0.014292247067303,0.866457336329906
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,-0.000575282797802491,0.00345942976750718,-0.00735576514211657,0.00620519954651159,0.867928519264031
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,-0.000910339439186282,0.00557266390607864,-0.0118327606951004,0.0100120818167278,0.870239456675533
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.000348508105625301,0.00222296687211576,-0.0040085069637216,0.0047055231749722,0.875424166360318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,39586,-0.000849615067130236,0.00550894195712117,-0.0116471413030877,0.00994791116882726,0.877435379343818
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,39560,-0.00067366103623589,0.0043991252988516,-0.00929594662198503,0.00794862454951325,0.87829445817372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.000418357129249114,0.00276878346590201,-0.00500845846391883,0.00584517272241705,0.879901313245806
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,39560,0.000704923999275442,0.00469531763431831,-0.00849789856398845,0.00990774656253933,0.880662132097612
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,39398,0.000993147582098015,0.00663142752535161,-0.0120044503675911,0.0139907455317872,0.880953791865805
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSC1,Hamartin,39657,0.00104238412713205,0.00696055073482931,-0.0126002953131334,0.0146850635673975,0.880959868410292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,39919,-0.000788463679890292,0.00537704401815075,-0.0113274699554658,0.00975054259568518,0.883422615798753
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.000384217051570772,0.00266899295495189,-0.00484700914013493,0.00561544324327647,0.885537497876957
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00065959839478742,0.00459782554773537,-0.00835213967877391,0.00967133646834875,0.885930502784681
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.000741494478442441,0.00520546581559462,-0.0109442074770079,0.00946121852012301,0.886730846338859
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,41839,-0.000698496042901132,0.00492861339307625,-0.0103585782933306,0.00896158620752832,0.887301257146599
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.000315289318397803,0.00227059469373752,-0.00413507628132774,0.00476565491812335,0.889565147540869
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,0.000694183299927638,0.00506633947614651,-0.00923584207331952,0.0106242086731748,0.891018522856858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC3B,Tetranectin,39726,-0.000268692103085445,0.00197181145613623,-0.00413344255711245,0.00359605835094156,0.891612968171634
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.00042157504402434,0.00318740777242816,-0.00582574418993485,0.00666889427798353,0.894778502067522
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,0.000543021118524507,0.00459300081026183,-0.00845926046958867,0.00954530270663769,0.905889202614163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.000604130818969397,0.00518721998591357,-0.01077108199136,0.0095628203534212,0.907285964244277
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.000466023515449688,0.00401094869452095,-0.00739543592581138,0.00832748295671076,0.90750578962496
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.000320502070281845,0.00276832636609292,-0.00574642174782396,0.00510541760726027,0.907833242278287
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,39575,-0.000454656868998602,0.00398734540748709,-0.00826985386767329,0.00736054012967609,0.909220099271488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.000433749486056075,0.00394327702949863,-0.00816257246387338,0.00729507349176123,0.912413580911004
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.000354938617287197,0.00327592812096539,-0.00606588049980496,0.00677575773437935,0.913721994314468
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,39736,0.000830197434597361,0.00786535442670206,-0.0145858972417387,0.0162462921109334,0.915940362709145
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.000628536812201991,0.00596657290836442,-0.0110659460881923,0.0123230197125962,0.916105214479916
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNM1,Dynamin-1,39930,0.00111572163210164,0.0108823357895051,-0.0202136565153284,0.0224450997795317,0.918341044016986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,-0.000478103254135652,0.00475055090485201,-0.00978918302764559,0.00883297651937429,0.919836461155592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,42113,-0.000272328830642688,0.00274589630921859,-0.00565428559671112,0.00510962793542575,0.920999475493362
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.000320602611320917,0.0032519812682028,-0.00605328067435657,0.0066944858969984,0.921468104644023
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL3,Interleukin-3,39560,0.000558634059657782,0.00575399239609192,-0.0107191910366824,0.0118364591559979,0.922659604266075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPN3,Calpain-3,39919,-0.000346449561987124,0.00366614602459654,-0.00753209577019634,0.00683919664622209,0.92471392324079
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,39958,-0.000315396490470378,0.00334372231802075,-0.00686909223379105,0.0062382992528503,0.924852683008596
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.000441866752316214,0.00477162945257301,-0.00891052697472688,0.00979426047935931,0.9262207254541
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGR,Progesterone receptor,39657,-0.00082742577380864,0.00942682312607809,-0.0193039991009217,0.0176491475533044,0.930058246544656
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,39929,-0.000356880618093244,0.00410047474235236,-0.00839381111310386,0.00768004987691738,0.93064604422533
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.000340597128844203,0.00395467729413159,-0.00741057036765371,0.00809176462534212,0.931368485858048
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,39649,-0.000226620586904003,0.00265223609220756,-0.00542500332763083,0.00497176215382282,0.931909085139481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HK2,Hexokinase-2,41900,0.000214762976274846,0.00254499519455614,-0.00477342760505519,0.00520295355760489,0.932750491967407
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPON2,Spondin-2,42070,-0.000271170320111463,0.00325733743801456,-0.00665555169862,0.00611321105839708,0.933654731053025
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.000218927487267135,0.00273515411963073,-0.0051419745872091,0.00557982956174337,0.936205218733408
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS53,Serine protease 53,39929,0.000286388557032076,0.00358490176837934,-0.00674001890899144,0.00731279602305559,0.936328205431229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,-0.000439917484109755,0.00552890794536242,-0.0112765770570201,0.0103967420888006,0.936583256014999
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOC,Myocilin,42137,0.000321447849646031,0.00417196105755372,-0.00785559582315927,0.00849849152245133,0.938585241262124
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.000593394170595657,0.00771394847312074,-0.0157127331779123,0.014525944836721,0.938684724373483
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.000457307817832792,0.00596572370214882,-0.0121501262740445,0.0112355106383789,0.938898676016545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,39560,0.000662011509557311,0.00870507878203756,-0.0163999429032363,0.0177239659223509,0.939381596565145
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,-0.000529479691907761,0.00699180488783514,-0.0142334172720646,0.0131744578882491,0.939636347421103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.000437390284058808,0.0057830536785965,-0.0108973949259903,0.0117721754941079,0.939712379471207
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,39929,0.000278328289134972,0.00375966468113,-0.00709061448587982,0.00764727106414976,0.94098775500062
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISM2,Isthmin-2,39966,-0.000300966023995079,0.00407188268891007,-0.00828185609425881,0.00767992404626865,0.941080724952444
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,42137,0.000168461340359448,0.00228997374881275,-0.00431988720731354,0.00465680988803244,0.941357809517636
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,39586,0.000314315877291535,0.00439989745204647,-0.00830948312871954,0.00893811488330261,0.943051190534292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,0.000572204833095681,0.00834014353949011,-0.0157744765043049,0.0169188861704963,0.945302484321457
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,42119,0.000395830822730573,0.00578928914188244,-0.010951175895359,0.0117428375408202,0.9454897590915
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.000379245213619073,0.00560064716046836,-0.0113565136481371,0.0105980232208989,0.946014111537431
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.00063022561673329,0.00950893969134204,-0.0192677474117637,0.0180072961782971,0.947158365808084
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.000244018017814043,0.00368713664264518,-0.0069827698017705,0.00747080583739859,0.947234797561434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.000134086869774791,0.002035296807625,-0.00385509487317021,0.00412326861271979,0.947473963732369
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.000167109892154594,0.00269386060809182,-0.00511285689970537,0.00544707668401456,0.950537196939691
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRN1,Neuritin,39934,-0.000202788401061182,0.00326928448484617,-0.00661058599135968,0.00620500918923732,0.950541329980014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.000363024363450837,0.00596611973112805,-0.0113305703095601,0.0120566190364618,0.951481651080795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0002122730943061,0.00367392999741381,-0.00698862970062497,0.00741317588923717,0.95392615310608
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.000290768583936035,0.0053781543487662,-0.0108319511075178,0.0102504139396457,0.956884557627821
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,0.000298236798622552,0.00564342137401921,-0.0107628690944551,0.0113593426917002,0.957854899796362
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.000309165460154792,0.00619880445806565,-0.0124588221979635,0.0118404912776539,0.96022289592018
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALLD,Palladin,39657,0.000177652921346192,0.00358651863045761,-0.00685192359435072,0.0072072294370431,0.960495013109588
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.000127235582199994,0.00266059183501615,-0.00508752441443166,0.00534199557883164,0.96185858070769
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.000111609502337097,0.00238742054394616,-0.00479095376847157,0.00456773476379738,0.962714135305288
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",42262,-0.000315180825854562,0.00679055801429058,-0.0136246745338641,0.012994312882155,0.962980502764325
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,41843,0.000416952736079676,0.00924962921447854,-0.0177123205242983,0.0185462259964576,0.964045993337211
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,0.000337091266367781,0.00754289035873654,-0.0144469738367558,0.0151211563694914,0.96435525759419
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-6.73612671345942e-05,0.00172217672377101,-0.00344282764572577,0.00330810511145658,0.968800163653273
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,-0.000109380024569963,0.00291244344199886,-0.00581776917088772,0.00559900912174779,0.970042286293816
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD82,CD82 antigen,39757,0.000146267376476807,0.00390388576530504,-0.00750534872352106,0.00779788347647468,0.970113222396324
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESPL1,Separin,39560,-0.000184588859904416,0.00501436123894064,-0.0100127368882281,0.00964355916841924,0.970635545495647
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.000581897634981422,0.0161842895824182,-0.032303105216521,0.0311393099465582,0.971319292560591
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,39657,6.99379446280698e-05,0.00206375546854252,-0.00397502277371528,0.00411489866297142,0.972966533322801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,39657,7.45334926755557e-05,0.00246461326805326,-0.00475610851270884,0.00490517549805995,0.975875032670609
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,41992,0.000129678837999398,0.00441240238745753,-0.00851862984141737,0.00877798751741616,0.976554287663129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,0.000227564015601064,0.00838100790195699,-0.0161992114722346,0.0166543395034368,0.978338703754244
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,8.91422707550221e-05,0.00371241842620075,-0.00718719784459844,0.00736548238610848,0.980843535131024
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL4,Interleukin-4,41913,0.000208630295055892,0.0088130041364403,-0.0170648578123671,0.0174821184024789,0.981113793283877
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP8,Caspase-8,42224,0.000132687298617448,0.00571021382349566,-0.011059331795434,0.0113247063926689,0.98146169644905
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.000104580347039572,0.00517108502471065,-0.0102399069954725,0.0100307463013933,0.983865000810444
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,-8.96528737793662e-05,0.00466820611195793,-0.00923933685321692,0.00906003110565818,0.984677922232137
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDSN,Corneodesmosin,42246,7.24598719588288e-05,0.00408635543627895,-0.0079367967831479,0.00808171652706556,0.98585279106326
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,39979,5.11286453382263e-05,0.00311353671975981,-0.006051403325391,0.00615366061606745,0.986898491772372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRH,Corticoliberin,41830,0.00012734663038479,0.00800941423046945,-0.0155711052613353,0.0158257985221049,0.987314714135618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNN,Tenascin-N,39966,6.42882221074125e-05,0.00405532684429416,-0.00788415239270913,0.00801272883692396,0.987352116104125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,-3.91404716224199e-05,0.00352462576037297,-0.00694740696195344,0.0068691260187086,0.99113998830493
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,3.2891781020279e-05,0.00380481086673056,-0.00742453751777162,0.00749032107981217,0.993102669296208
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,-3.60393045370246e-05,0.00452306246042347,-0.00890124172696702,0.00882916311789297,0.993642721299184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-1.88056187790324e-05,0.00342424339738124,-0.00673032267764626,0.0066927114400882,0.995618215787041
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,39806,-1.00213134802136e-05,0.00335292552270401,-0.00658175533798006,0.00656171271101964,0.997615318036732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-5.05054202161221e-06,0.00251304697390052,-0.00493062261086662,0.0049205215268234,0.998396504966525
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPC1,Glypican-1,42262,-5.30721922331701e-06,0.00276127000090281,-0.00541739642099282,0.00540678198254618,0.998466478039681
